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Abstract of Thesis 
 
 
This study assessed Australian diabetes health professionals’ knowledge and 
scope of practice in the area of oral health complications.  It described the extent 
of interventions, health promotion and the driving and restraining forces impacting 
upon their management of oral health issues in the person living with diabetes.   
Using a 28 item web-based questionnaire developed for the study, a 
descriptive, cross-sectional design was employed to survey 153 members of the 
Australian Diabetes Society and the Australian Diabetes Educators Association.  
The data were collected between May 17th and August 22nd, 2010.  The categorical 
and continuous data collected was analysed using the Statistical Package for 
Social Sciences version 20. 
This study found Australian diabetes health professionals do not receive adequate 
education and training to manage oral health complications within diabetes care.  The 
inclusion of oral health information within the formal curriculum appears inconsistent 
and confirms a lack of recognition for and impact of oral health complications at a 
fundamental level.  Participants acknowledged the significance of an increased risk of 
oral health problems in the person living with diabetes, especially for those patients 
who had more specific management needs, were isolated, or who experienced other 
diabetes complications.  This was strongly associated with an increased level of 
likelihood to investigate the patients’ oral health complaints.  Participants’ levels of 
likelihood to recommend treatment options were however, confined to the patients’ 
glycaemic management in the context of the xerostomia condition. 
Participants indicated low levels of confidence to undertake an assessment of oral 
health signs or symptoms, and to provide diabetes related oral health information to 
patients.  Education in oral health complications was found to have a positive impact 
upon participants’ levels of confidence to undertake oral health practices.  However, a 
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proportion of participants indicated they would never undertake an oral assessment as 
they perceived it was outside of their scope of practice. 
The current study data indicated people living with diabetes, who have oral health 
complications, receive limited support from their diabetes health professionals.  This 
was due to the confines of the current oral health system delivery model.  Timely 
access to appropriate and affordable oral health services for patients was identified as a 
major barrier affecting management.  In addition, a diabetes-specific oral health 
screening tool and clinical practice guideline were identified as potential factors which 
would enable improved management of oral health complications in people living with 
diabetes. 
This study has shown Australian diabetes health professionals’ knowledge base of 
oral health complications is limited.  It appears there is inadequate education and skill 
mastery to enable confident assessment, appropriate health promotion, and 
management of patients’ oral health issues within diabetes care.  The absence of the 
clinical practice guideline and diabetes-specific oral health screening tool contributes 
to this deficit. 
Australian diabetes health professionals were cognisant of the increased risk of 
oral health problems in people living with diabetes, and the need to monitor outcomes 
for those at greater risk.  There is therefore, the potential to change practice behaviours 
especially in those who have previously believed oral health complication management 
to be outside of their scope of practice.  Overall, within the more specialised area of 
diabetes management, there is a need for the enhanced provision of diabetes-specific 
oral health education, clinical resource tools and the delivery of oral health services for 
people living with diabetes. 
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Introduction 
 
Background to the Study 
Diabetes Mellitus (diabetes) is a chronic endocrine disease the incidence of which 
is increasing worldwide at an alarming rate.  In 2011the prevalence rate was estimated 
to be between 220-285 million (International Diabetes Federation [IDF], 2011b; World 
Health Organisation [WHO], 2009).  A further seven million people were expected to 
develop diabetes each year, with the total number of people affected reaching 438 
million within the next 20 years (IDF, 2011b).  The current estimates indicate that 366 
million people are diagnosed with diabetes and the projection for 2030 is expected to 
reach 552 million (IDF, 2013).  A large proportion of this increase will occur in 
developing countries and may be related to ageing, unhealthy diets coupled with a 
sedentary lifestyle and increased rate of obesity (Petersen & Ogawa, 2005). 
Diabetes is a life-long condition that, without proper management, leads to 
complications as a result of damage to major organs and tissues especially nerves and 
blood vessels (IDF, 2011a).  There is growing acceptance of seminal research 
undertaken by the dental profession which indicates diabetes is associated with 
increased occurrence, extent and severity of oral health problems (Loe, 1993; Safkan-
Seppala & Ainamo, 1992; United States [US] Department of Health and Human 
Services, 2000).  These problems include xerostomia and salivary gland dysfunction; 
susceptibility to bacterial, viral and fungal infections; taste impairment; autoimmune 
inflammation of the oral soft tissues; nerve dysfunction; dental caries; periapical 
abscesses; gingivitis; periodontal disease; loss of teeth and an impaired ability to wear 
dental prosthesis (Vernillo, 2003).  The research evidence indicates the bidirectional 
association between the incidence of periodontal disease and control of blood glucose 
(US Department of Health and Human Services, 2000).   Both diabetes and 
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periodontitis are thought to share a common pathogenesis, with an enhanced 
inflammatory response at a local and systemic level, resulting in difficulties in 
management of either condition when the other is present (Southerland, Taylor & 
Offenbacher, 2005). 
The presence of oral health complications in the individual with diabetes poses 
additional management requirements that have not always been appreciated by health 
care professionals.  Accordingly, recommendations for care are emerging from the 
WHO, IDF, the Fédération Dentaire Internationale (FDI; also known as the World 
Dental Federation) and peak bodies for dental health and diabetes care in the United 
States, Canada and Europe.  These organisations identify the need for initiatives such 
as heightened surveillance and promotion of oral health care, whilst also calling for 
multi-disciplinary collaboration to prevent and manage oral health issues in the person 
with diabetes (IDF, 2008, 2009; Petersen & Ogawa, 2005; Gillis & Saxon, 2003; US 
Department of Health and Human Services 2003; WHO n.d).  There is however, an 
absence of specific oral health clinical guidelines to direct the health professional to 
provide evidence-based best-practice care to meet this emerging aspect of diabetes 
management. 
While acknowledgement of the need for improved diabetes and oral health 
management has begun internationally (IDF, 2005a, 2008), within the Australian 
health care system it appears to be neither well identified nor managed appropriately.  
The dearth of recognition of diabetes and oral health complications within the 
Australian Department of Health and Ageing (DOHA) publications, such as the 
‘Australian National Diabetes Information and Benchmarking (ANDIAB) Surveys 
2004-2009’ (2010a), and ‘National Service Improvement Framework for Diabetes’ 
(2010e) is evident. 
 Introduction 
3 
For the majority of people with diabetes, a multidisciplinary health care team 
provides care.  The team care is co-ordinated by the General Practitioner (GP) utilising 
the ‘Guidelines for Diabetes Management in General Practice’.  This annually updated 
Royal Australian College of General Practice [RACGP] publication has, until this year, 
neglected to include oral health specialists within the team.  The primary care 
guidelines do identify “the need for a full system review checking for vascular, renal, 
eye, nerve and podiatric problems” (RACGP, 2011, p. 30).  However, diabetes related 
oral health problems are not included within the section that identifies complications.  
The attention herein, focused upon the issues of macrovascular changes, hypertension, 
dyslipidaemia, renal and eye damage, foot problems, and neuropathy.  While annual 
oral health screening by an oral health professional is recommended, it does neglects to 
identify the role that other team members may play in oral health screening and care 
provided to people living with diabetes. 
Based upon the lack of specific guidelines, which encompass oral health 
complication screening within diabetes management, it would appear that a gap in 
practice by health professionals specialising in diabetes may be present.  As a result the 
oral health care for people with diabetes is likely to be insufficient.  Previous research 
in oral health care has primarily focused upon the consumers’ oral health knowledge, 
self-care beliefs and efficacy (Allen, Ziada, O’Halloran, Clerehugh & Allen, 2007; 
Blicher, Joshipura & Eke, 2005; Moore, Orchard, Guggenheimer & Weyant, 2000). 
There is an apparent lack of studies investigating the provision of oral health care 
by diabetes care team members, including those in Australia.  More specifically, team 
members’ knowledge of oral health complications and their scope of practice within 
either the primary or tertiary care context is not known.  This is important as health 
outcomes in the individual with diabetes are not only related to the self-care 
behaviours enacted, but also the extent and quality of education provision and support 
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systems (Colagiuri, Girgis, Eigenmann, Gomez, & Griffiths, 2009; Colagiuri, 
Williamson & Frommer, 1995).  These enable uptake and continuation of positive 
health behaviour change to achieve and maintain optimum health (Australian Diabetes 
Educators Association [ADEA], 2007).  Careful consideration of the diabetes-related 
oral health burden in light of the projected increase in the prevalence of diabetes within 
the Australian community is required, as these issues will further challenge the finite 
service delivery resources.  It is therefore imperative that Australia’s health care 
system and health care professionals address any potential deficiencies in care 
provision to people with diabetes to be able to manage the future demand. 
With the limited empirical evidence related to diabetes and oral health 
complications, a descriptive, cross-sectional study was designed to investigate the 
current practice of Australian health professionals specialising in diabetes care.  In 
particular to establish what the professionals know about the oral complications, 
prevention, screening and management.  Additionally the driving and restraining 
factors affecting health professionals’ roles in oral health care as part of diabetes 
management were explored. 
This chapter continues with an overview of diabetes, its pathophysiology, major 
types, incidence and prevalence, the recognised diabetes associated complications, and 
principles of best practice in diabetes management.  The intention is to provide 
sufficient background to understand the nature of oral health complications and the 
management that is required from health care professionals as discussed in Chapter 2.  
Finally the study’s purpose and significance are presented. 
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Context of the problem:  Diabetes Mellitus 
Diabetes mellitus is a chronic metabolic disorder which is caused by inherited and 
or acquired deficiency in production of insulin by the pancreas, or by the 
ineffectiveness of the insulin produced, thereby affecting carbohydrate, fat and protein 
metabolism (WHO, 2002, 2006, 2013).  Several processes have been identified in the 
development of diabetes.  These may range from the autoimmune destruction of the 
insulin producing beta cells of the pancreas resulting in a diminished or complete 
absence of circulating insulin, to other abnormalities resulting in reduced insulin action 
within the target tissues of the body known as insulin resistance (American Diabetes 
Association [ADA], 2004).  The changes that occur are linked to the type of diabetes 
of which several forms exist.  Type 1, type 2 and gestational diabetes are the most 
common. 
 
Diabetes types. 
Type 1 diabetes.  This form of diabetes occurs due to the cellular-mediated 
autoimmune destruction of the beta cell of the pancreas.  It accounts for 10% to 15% of 
diagnosed cases of diabetes (Australian Institute of Health and Welfare [AIHW], 
2008C, 2010a).  Whilst genetic predispositions are identified in the autoimmune 
destruction, many related environmental factors that are still poorly understood may 
also be at play.  Autoimmune markers are indicative of the physiological changes and 
one or more of these autoantibodies are usually present in 85% to 90% of individuals 
when fasting hyperglycaemia is initially detected.  This type of diabetes commonly 
occurs in childhood and adolescence, but it can occur at any age, even in the eighth 
and ninth decade of life.  The insulin production for type 1 is markedly reduced or 
absent, such that endogenous replacement therapy is required to counteract the 
consequential rise of blood glucose (ADA, 2004). 
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Type 2 diabetes.  Type 2 diabetes, which accounts for 85% to 90% of diagnosed 
diabetes cases (AIHW, 2008c, 2010a), is characterised by insulin resistance in muscle, 
fat and the liver combined with beta cell failure leading to insufficient insulin secretion 
to compensate for the insulin resistance (Scobie & Samaras, 2010).  Insulin resistance 
refers to the reduced ability of circulating insulin to mediate cellular glucose uptake in 
the receptors upon the cell surface.  In response to this impaired signalling of the 
receptors, the pancreas hyper-secretes insulin until beta cells fail, leading to the 
hyperglycaemic state (Scobie & Samaras, 2010). 
Insulin resistance, although associated with central obesity, is not present in every 
person with type 2 diabetes.  Other identified factors include genetic mutations within 
the receptor, the increased circulating levels of fatty acids (from obesity or nutrient 
excess) causing damage to the beta cells (lipotoxicity), and systemic inflammation 
which interferes with insulin action (Scobie & Samaras, 2010).  Whilst there is a 
strong genetic predisposition, the risk of developing type 2 diabetes increases with age, 
obesity, and the lack of physical activity.  It is more frequent in women with a prior 
history of gestational diabetes, in individuals with hypertension and deranged blood 
fats (dyslipidaemia), and is also recognised to occur at greater rates in certain 
racial/ethnic groups (ADA, 2004). 
Regardless of the cause, Scobie and Samaras (2010) identify reduced insulin 
secretion and cellular resistance as the pathophysiology for the trademark 
hyperglycaemia.  Management of type 2 diabetes may initially involve a combination 
of changes, which include a healthy diet, increased exercise and weight loss.  When 
glycaemic control remains suboptimal despite lifestyle changes, oral and injectable 
antihyperglycaemic agents, and in some cases, insulin replacement is necessary to 
achieve normal glucose targets for optimum health (IDF, 2005b). 
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Other specific types of diabetes.  The main primary causes of diabetes categorised 
as ‘Other specific types’ are pancreatic trauma or disease through inflammation, 
infection, chemical or drug induction, carcinoma, cystic fibrosis and 
haemochromatosis.  Genetic defects can affect beta cell secretion or insulin receptor 
function (ADA, 2004), which according to Cochran, Musso and Gorden (2005), 
“represents a major therapeutic challenge in terms of achieving glycaemic control, 
having more extreme forms of insulin resistance than typical type 2 diabetic patients” 
(p. 1240). 
 
Gestational Diabetes (GDM).  Gestational diabetes mellitus is defined as any 
degree of glucose intolerance with onset or first recognition during pregnancy (WHO, 
2002, 2013).  The incidence of GDM is estimated by the Australasian Diabetes in 
Pregnancy Society (ADIPS) to be in the vicinity of 5.5% to 8.8% of all pregnancies.  
Australian Indigenous, Polynesian and South Asian [Indian], Middle Eastern and other 
Asian groups are at greater risk (Hoffman, Nolan, Wilson, Oats & Simmons, 1998). A 
later review by the ADIPS identified the data contained within their management 
guideline remained current (Simmons, Walters, Wein & Cheung, 2002).  The AIHW 
report ‘Australia’s Health’ (2012) further confirms the prevalence rate for GDM 
remains stable at 5%. 
During pregnancy there is reduced insulin sensitivity.  This is attributed to 
increased food intake, increased adiposity and decreased activity levels, along with 
growth of the foetus and increasing pregnancy hormones which decrease insulin-
mediated glucose uptake (Buchanan & Dornhorst, 1996).  This, in combination with 
deficient or poorly-timed insulin release from the pancreas, result in the abnormal 
increase in blood glucose levels (BGL).  Failure of the pancreatic beta cells to meet 
this increased demand is responsible for the development of gestational diabetes 
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mellitus (Harmel & Mathur, 2004).  Research evidence indicates women with GDM 
are at greater risk for the development of type 2 diabetes later in life, with their baby 
also at increased risk for the development of obesity and/or diabetes.  GDM adds an 
intrauterine environmental risk factor to an already increased genetic risk (Hoffman et 
al., 1998; 2002).  Therefore treatment to maintain BGL’s within the target range for 
pregnancy is focused upon a combination of dietary adjustment, oral 
antihyperglycaemic agents and insulin therapy (WHO, 2002; 2006; 2013). 
Irrespective of the type of diabetes, the normal blood glucose variation of 3.5 to 
7.8 millimoles per litre is not maintained.  The insulin released in response to a 
postprandial BGL rise is deficient with consequent elevated BGLs (hyperglycaemia) 
(Baker IDI, 2010b).  The resulting hyperglycaemia damages many of the body’s 
systems, in particular the blood vessels and nerves (WHO, 2002), and it is these 
pathological changes that are more closely aligned with the oral health complications 
of interest in this study.  These issues are discussed next. 
 
Chronic diabetes complications.  Chronic hyperglycaemia has traditionally been 
identified as the major factor associated with the development of long term 
complications in people with diabetes.  Glycosylation, the process of glucose 
chemically attaching, without the aid of enzymes, to proteins and nucleic acids within 
tissues was recognised by Brownlee, Vlassara and Cerami (1984) as the common 
biochemical link between chronic hyperglycaemia and a number of patho-
physiological processes involved in complication development.  Current research 
studies continue to focus on the factors identified by Brownlee (1994); those being the 
interplay of molecular pathways and the influence of insulin resistance and 
inflammation in complication pathogenesis (Villeneuve & Natarajan, 2010). 
Complications are broadly categorised into three main areas: those affecting the 
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macrovascular (large arteries), microvascular (veins and capillaries), and nervous 
systems, as detailed in Table 1.1. 
(Scobie & Samaras, 2010, pp. 69-93) 
It is the duration and extent of hyperglycaemia, often in combination with 
hypertension and dyslipidaemia, which exacerbates a range of cellular factors within 
the individual with diabetes that leads to tissue injury and loss of function.  Those 
factors most notably identified are: gene expression for dysfunction and disease, the 
increased stiffness of artery walls and permeability of the capillary walls, blood 
coagulation, and the formation and progression of atherosclerotic lesions within blood 
vessels.  This is in addition to the increased permeability of smooth muscle cells, the 
thickening of the cells’ basement membranes and tissue expansion, with the 
accumulation of advanced glaciated end-products (AGE’s) within the peripheral nerves 
affecting neuronal blood flow and nerve conduction (Meece, 2003; Peppa, Uribarri & 
Vlassara, 2003).  These effects are the major cause of morbidity and mortality in 
individuals with diabetes in Australia (Bate & Gerums, 2003). 
As discussed, it appears that in contrast to complications arising in other body 
organs and tissue, there remains little recognition of oral health complications.  While 
diabetes health professionals (DHPs) are cognisant of most complications and employ 
‘best practice’ screening and management, it would appear that there is little awareness 
of oral health complications.  Therefore, the current study investigates this issue. 
 
Table 1.1 
Chronic Diabetes Complications 
Microvascular Macrovascular Nervous 
Nephropathy Hypertension Acute painful neuropathy 
Diabetic foot Cardiovascular disease Autonomic neuropathy 
Retinopathy Cerebrovasular disease Proximal motor neuropathy 
Cataracts Peripheral vascular disease  Diabetic mononeuropathy 
Glaucoma Erectile dysfunction Chronic insidious 
sensorimotor neuropathy  
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Australian diabetes prevalence and incidence trends.  According to the 
Australian Institute of Health and Welfare (2010), there is limited accurate information 
available to determine the number of people with each type of diabetes. It states, “most 
of the statistics refer to 2010 or earlier. This is because some data, such as population-
based surveys, are collected every 3–5 years or even less often” (p. xiv).  Therefore, 
based upon the self-reported data within the ‘National Health Survey 2004-2005’, 
approximately “700,000 Australians (3.6% of the population) have diabetes, with 13% 
having type 1 diabetes, 83% have type 2 and a further 4% unable to identify their 
diabetes type” (Australian Bureau of Statistics [ABS], 2006, p. 10).  More recent data 
from combined databases indicates at least 45,000 new cases each year, excluding 
gestational diabetes.  The latest figure for gestational diabetes, available within the 
‘National Hospital Data’ report, indicates there was “11,000 cases of diagnosed 
gestational diabetes each year” (AIHW, 2008c, p. 11). 
Colagiuri, Borch-Johnsen, Glümer and Vistisen (2005) identify the likelihood of 
an increasing prevalence of diabetes into the future, describing the potential rise in 
type 2 diabetes cases as eventuating in a “diabetes epidemic”.  As a consequence it is 
expected that diabetes will significantly increase the burden upon the health care 
system.  According to Begg et al. (2007), “diabetes accounted for 5.5% of the total 
disease burden and the eighth leading cause of disease and injury in Australia in 2003, 
with type 2 diabetes accounting for 92% of this disease burden, ranking the second in 
males and fourth in females as the leading cause of disease” (p. 197). 
The anticipated increase in diabetes prevalence will place further demands upon 
health services (Zimmett, 2002), and oral complications will challenge this further.  
Therefore, it would appear that investigation of the current knowledge of oral health 
complications and their management by Australian health care professionals who 
specialise in diabetes care is warranted. 
 Introduction 
11 
Best-practice management principles for diabetes care.  The concern with 
diabetes primarily relates to the devastating consequences when BGLs are not 
managed within the evidence-based glycaemic targets.  The findings of the Diabetes 
Control and Complication Trial (DCCT) Research Group (1993) demonstrated that 
intensive efforts to reduce hyperglycaemia associated with type 1 diabetes decreased 
the incidence of the major chronic complications by as much as 40% to 75%.  Another 
landmark diabetes study, the 1977-1997 United Kingdom Prospective Diabetes Study 
(UKPDS), showed a continuous relationship between the risks of microvascular 
complications and glycaemia in type 2 diabetes, such that for every percentage point 
decrease in the glycosylated haemoglobin (HbAlc) e.g. 9% to 8%, there was a 35% 
reduction in the risk of complications (ADA, 2002).  Of note, these studies have not 
included oral health complications within the range of acute and chronic complications 
investigated. 
The glycosylated haemoglobin test is a measure of blood glucose attachment to 
the haemoglobin protein contained within the red blood cell.  It indicates blood glucose 
control over the approximate three month life-span of an average red blood cell, and is 
used as a gold standard in diabetes management worldwide.  A recommendation from 
the Australian Diabetes Society (2009) is for a general target HbAlc of ≤7.0% for most 
patients.  While intensive glycaemic control is identified to be of greatest benefit early 
in the disease process, a tighter (≤6.0%) or lesser (≤8.0%) target should be based on 
patient specific factors such as the type and duration of diabetes, the type of diabetes 
medication being taken, in addition to the risk for and outcomes from hypoglycaemia, 
the presence of cardiovascular disease, other co-morbidities, and pregnancy.  Careful 
management of glycaemic control through lifestyle changes and pharmacotherapeutics 
has become the primary strategy for preventing diabetic complications. 
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The overall aim of management, as described within the ‘Guidelines for Diabetes 
Management in General Practice 2011-2012’, is to “improve quality of life and prevent 
premature death” which includes the “relief of symptoms and acute complications” as 
well as the “identification and treatment of chronic complications” (RACGP, 2011, p. 
16).  The guidelines describe evidence-based practice for managing diabetes and its 
complications; however, they appear insufficient to direct the health professional in the 
assessment and management of diabetes associated oral health problems that may 
arise.  This is of importance as oral health complications may not only influence the 
glycaemic control and medical management of diabetes, but also have a far greater 
impact in diminishing the individual’s quality of life.  The complications associated 
with diabetes are identified by Rubin and Peyrot (1999) as “the single most important 
disease-specific determinant of quality of life” (p. 205).  According to Rubin and 
Peyrot, the psychosocial effort required to manage the daily demands of diabetes is 
significant and in turn influences self-care behaviours, long-term glycaemic control 
and risk of complications.  Furthermore, research findings consistently show the 
presence of two or more complications is associated with worsened quality of life. 
According to the US Surgeon General’s report on oral health in America, oral 
health is “related to well-being and quality of life” (US Department of Health and 
Human Services, 2000, p. 146).  The consequences of oral health problems have been 
shown to include limitations in food selection, often with poor nutrition occurring due 
to the compromised ability to bite, chew and swallow foods.  Oral-facial pain is a 
major cause of sleep deprivation and depression.  When combined with other 
psychosocial factors, limitations in verbal and non-verbal communication, intimacy 
and social interaction, it impacts upon the individual’s self-esteem and further 
influences their ability to access educational and employment opportunities along with 
health services.  Overall, “reduced oral-health-related quality of life is associated with 
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poor clinical status and reduced access to care” (US Department of Health and Human 
Services, 2000, p. 147). 
With due accord to what is known about diabetes and oral complications, it is 
imperative that identification and management of oral health complications occurs as 
part of the diabetes related care.  Furthermore, if the health care team is knowledgeable 
and skilled in oral health care, their education and promotion of oral health issues as 
part of diabetes care may enhance “active, constructive coping” by the individual with 
diabetes (Rubin & Peyrot, 1999, p. 218).  In addition, Rubin (2000) states “the quality-
of-life issues are crucially important, because they may powerfully predict an 
individual’s capacity to manage his disease and maintain long-term health and well-
being” (p. 21), which is ultimately the goal of any health professional involved in 
diabetes care. 
 
Purpose and rationale for the Study 
The purpose of this study was to ascertain the current levels of knowledge and 
scope of practice amongst Australian DHPs in the prevention, promotion and 
management of diabetes related oral health complications in the varied patient1 
population that they manage.  It describes the practitioners’ experiences, practice 
settings and the patient populations managed in terms of age, types of diabetes 
identifying those, who due to their circumstances, may be at greater risk and require 
specialised medical attention. 
This study investigates the extent of health professionals’ knowledge of oral health 
complaints, the sources of prior information and whether resources are utilised in the 
acquisition of further knowledge.  It attempts to describe not only the health 
professionals’ likelihood, levels of confidence, frequency, depth and breadth of 
                                               
1 Henceforth the noun patient will be used to denote both patient and client. 
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screening for oral health complications in the person living with diabetes, but also the 
levels of concern if oral health problems are detected.  The extent of treatment 
recommendations provided to the high risk patient to further manage their diabetes and 
oral health is also explored.  Finally, the driving and restraining factors affecting the 
health care professionals’ role in oral health care as part of diabetes management is 
surveyed. 
 
Study objectives 
Specifically the objectives of this study were to: 
1. Assess Australian DHPs’ levels of knowledge of oral health issues that impact 
upon the person with diabetes. 
2. Determine the DHPs’ scope of practice regarding intervention, health promotion 
and care management of oral health issues in persons with diabetes. 
3. Identify the restraining and driving forces that influence the provision of oral 
health care prevention and intervention for people with diabetes. 
 
Significance of the Study 
Health care professionals can have significant input in supporting people with 
diabetes to self-manage the condition.  Australia’s health care system appears to be 
lagging behind in implementing evidence based clinical care and preventative health 
care activities in diabetes and oral health at both a primary and tertiary level.  Given 
the rising prevalence of diabetes with recognition that diabetes related oral health 
promotion and care is under serviced, it would therefore appear timely that an 
Australian study examining current DHPs’ levels of knowledge and health promotion 
activity in clinical practice, may provide a level of evidence to support guideline 
development.  From this there may be an improved level of diabetes care management. 
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Overview of the thesis 
This thesis is presented in five chapters.  The first chapter has provided an 
overview of the diagnosis and classification of diabetes, the pathophysiology of the 
disease and the pathogenesis of complications associated with diabetes when it is it not 
well controlled or managed.  Literature relevant to the current trends in diabetes 
incidence, prevalence and management has also been provided.  An introduction to the 
study objectives, purpose and rationale for the study has been included.  Chapter 2 
discusses the available literature regarding the prevalence and severity of oral health 
complications as they impact upon the individuals with varied types of diabetes 
mellitus, the pathogenesis of periodontitis and its relationship to diabetes as well as 
oral health care management.  Chapter 3 discusses the study design, sampling method, 
measurement tool development and pilot testing phase as well as the data collection 
and method of analysis employed in the main study.  Chapter 4 presents the findings of 
the study and finally, Chapter 5 discusses the implications of the findings, limitations 
of this study and makes recommendations in relation to future diabetes and oral health 
care clinical practice and research. 
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Chapter 2:  Literature Review 
 
This chapter presents an overview of the available evidence of oral health 
complications associated with diabetes mellitus and focuses upon the major 
complication of periodontitis, the pathological processes in its development, and its 
impact upon the health outcomes in the person with diabetes.  The literature review 
details the prevalence rates in the individual with diabetes, as well as investigating the 
current management practices for oral health complications.  In addition, the guidelines 
for care, and the knowledge and skills base that currently exists for DHPs providing 
care to people living with diabetes is explored. 
 
Risks for and prevalence of periodontal disease in diabetes 
It is well established that individuals with diabetes, compared with non-diabetics, 
have an increased risk of developing periodontal disease.  Additionally they experience 
more severe and more rapid progression of the disease (Kapellas & Slade, 2008; Loe, 
1993; US Department of Health and Human Services, 2000).  Furthermore, the risk is 
independent of whether the diabetes is type 1 or type 2 (Lalla et al., 2006).  The 
increased risk is associated with the duration of the diabetes condition and to it being 
poorly controlled (Garcia, Henshaw & Krall, 2001; Loe, 1993; Tsia, Hayes & Taylor, 
2002; US Department of Health and Human Services, 2000).  This appears an 
important factor with studies showing more advanced periodontitis with tooth 
attachment loss when the individual has had diabetes for more than 10 years, rather 
than aged matched individuals without diabetes (Glavind, Lund & Loe, 1968; see also 
Hugoson, Thorstensson, Falk & Kuylenstierna, 1989, as cited in Ryan, Carnu, & 
Kamer, 2003).  In addition a greater prevalence is confirmed in individuals with 
diabetes who also experience other complications of diabetes, e.g., retinopathy, 
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nephropathy and cardiovascular disease (Southerland, Taylor, Moss, Beck & 
Offenbacher, 2006). 
Multiple dental studies have shown diabetes doubles the risk of severe 
periodontitis (Tsai, Hayes & Taylor, 2002; Khader, Dauod, El-Qaderi, Alkafajei & 
Batayha, 2006), and doubles the rate of periodontal disease progression (Yalda, 
Offenbacher & Collins, 1994).  In a study by Lalla et al. (2007), children and 
adolescents (n = 300) with diabetes, being free from diabetes complications (6-18 
years), in comparison to those without diabetes (n = 300), after adjusting for 
confounding variables, showed greater prevalence of gingival inflammation and 
periodontal disease (mean odds ratio 2.96).  Furthermore, their Mean HbA1C results 
from the preceding 2 years (8.49% +/- 1.74) were associated with the periodontal 
destruction (odds ratio, 1.31; 95 % confidence interval, 1.03-1.66; P < .03).  The results 
were the first to demonstrate the association between diabetes and an increased risk for 
periodontal destruction very early in life. 
Analysis of data collected in ‘Australia’s ‘Dental Generations: National Survey of 
Adult Oral Health 2004-06’ showed age was strongly associated with the greater 
evidence of plaque and almost double the degree of gingival inflammation in diabetic 
adults (greater than 15 years, 4% of the 4967 individuals examined) in comparison to 
the non-diabetic participants.  The results, despite adjustment for age, remained 
statistically significant.  Within the 35 to 64 year age group, the destruction seen at 
multiple sites within the periodontal tissue of the diabetic participants were elevated at 
least two-fold over that seen in the non-diabetics.  The researchers considered this as 
an important indicator of poor prognosis for subsequent tooth loss (Kapellas and Slade, 
2008). 
These studies highlight the need for both glycaemic control and surveillance of the 
periodontal condition in children.  This need also exists in individuals in the fourth 
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decade of life.  This age period is the most common for not only diagnosis of chronic 
periodontitis, but also type 2 diabetes, especially in women with a history of GDM 
(Australian Research Centre for Population Oral Health [ARCPOH], n.d.a). 
According to Salvi, Lawrence, Offenbacher and Beck (1997), in their review 
“cross-sectional, case-history, case-control and longitudinal studies indicated diabetes 
was indeed a risk factor for periodontal disease with odds ratios in the order of 2 to 3 
for diabetics as compared with non-diabetics” (p. 179).  Furthermore, they identify 
multiple factors which impact upon an individual, adjusting their level of risk, stating 
the “reported oral health differences between type 1 and type 2 diabetic patients may 
relate to differences in glycaemic control strategies, age of onset and duration of the 
disease...which determines the duration of the hyperglycaemic challenge...and the 
individual periodontal disease susceptibility” (p. 179). 
In addition, the strategies employed in diabetes care are important factors in 
prevention of oral health complications.  The data from the American Third National 
Health and Nutrition Examination Survey (NHANES III, 1988-1994) showed the 
chances of having severe periodontal disease when HbA1C was suboptimal is 
approximately 50% higher than the unaffected population (Tsai, Hayes & Taylor, 
2002).  While periodontitis is now recognised as a complication of diabetes, Hirsch 
(2004) reports an increased risk does not exist in people with well-controlled diabetes 
who have good oral hygiene practices; however, those individuals that have poorly 
controlled diabetes, poor oral hygiene practices and who are also smokers are 
significantly susceptible to periodontal disease. 
In Australia in 2004–05, there were 300 hospitalisations for people with diabetes 
with periodontal complications, with an average stay of three to seven days (AIHW, 
2000b, 2008d).  While hospital admission data were collected, dental surgery visits by 
people with diabetes and those who required, yet who were unable to access dental 
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services, was not recorded.  Therefore there is no way of determining the prevalence of 
oral complications among people with diabetes, or being able to compare this to the 
prevalence figures for other diabetes complications in this period.  These 
complications were identified as neuropathy 5%, peripheral vascular disease 4%, and 
diabetic foot 3%, with the remaining 78 % attributed to loss of ‘health life years’ and 
premature death related to ischaemic heart disease, stroke and disability (AIHW, 
2008a, 2008d, 2008e). 
 
Diabetes and oral health complications. 
There is a diverse range of oral health complications reported in people with 
diabetes.  While some may appear relatively minor, others can be extensive, severe and 
therefore devastating in their impact upon the health and well-being of the person 
affected (Vernillo, 2003).  The following section explains the nature of the oral health 
complications identified to date. 
 
Xerostomia.  Xerostomia is identified by Crockett (1993) as “dryness of the oral 
mucosa of varying severity and a reduced flow in saliva” (p. 114).  Schifter (1999) 
further explains it as “a symptom and does not itself represent a pathological entity” (p. 
17).  Diabetes can lead to a marked dysfunction of the secretory capacity of the 
salivary glands and may be related to dehydration secondary to hyperglycaemia 
(Taylor et al., 1998; Vernillo, 2003).  A study by Russotto (1981) found xerostomia to 
be associated with an asymptomatic, non-inflammatory, non-neoplastic enlargement of 
the parotid gland.  It occurred in 25% of the 400 participants with diabetes, especially 
those with type 1 and with poor metabolic control.  While the exact aetiology is 
unknown, it is thought to be related to decreased insulin production, the autoimmune 
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diseases mumps, and Sjögren’s Syndrome (Loe & Genco, 2000; US Department of 
Health and Human Services, 2000). 
Xerostomia is a common side effect of oral medications.  While the mechanisms 
are not well identified, it is understood that up to 400 medications in the classes of 
anticholinergics, antihypertensives, antidepressives, oral antihyperglycaemic agents 
and many analgesics drugs have been identified as causing xerostomia (Schifter, 
1999).  In the elderly, multiple classes of medications are frequently used in 
combination.  The aging process itself is associated with not only the decreased 
function of the salivary glands (Schifter, 1999), but also a greater proportion of denture 
use.  Xerostomia is also exacerbated by activities such as hyperventilation, mouth 
breathing, smoking and drinking alcohol (Southerland, Taylor & Offenbacher, 2005). 
Individuals with xerostomia experience problems with speaking, chewing and 
swallowing, with the tongue frequently sticking to the palate.  The wearing of dentures 
may be problematic, in particular denture retention with reports of denture sores being 
common.  Individuals experiencing xerostomia may find oral care activities, such as 
brushing and flossing, painful.  As a result, the reduction in oral hygiene practices 
leads to increased gingival inflammation (Jahn, 2004).  Further complaints of taste 
disorders (dysgeusia), a painful tongue (glossodynia), and an increased need to drink 
water at night are also common (Southerland, Taylor & Offenbacher, 2005).  Therefore 
the problems with chewing and swallowing, taste disturbance, salivary flow, 
inflammation and pain, experienced by the individual with diabetes, negatively 
impacts upon their dietary choices and oral hygiene practices, thus placing them at 
even greater risk for poorer metabolic control and oral health status (Vernillo, 2003). 
Increased rates of dental caries are observed in association with xerostomia due to 
the reduced volume of salivary enzymes, which is the primary defence to bacteria 
within the mouth.  The saliva functions to buffer the acids produced by cariogenic 
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bacterial species, as well as providing an essential re-mineralisation process which 
repairs the non-cavitated carious lesions; thereby preventing further dental decay 
(Schifter, 1999; US Department of Health and Human Services, 2000).  If the 
development of dental caries is left untreated, they can result in an infection of the 
dental pulp and resultant tooth abscess.  The onset of caries requires Streptococci 
mutans bacteria (Jahn, 2004; Southerland, Taylor & Offenbacher, 2005).  Studies show 
this bacterial species attaches well to the tooth surface and produces acids from sugars 
more readily than other bacteria species.  Thus the combination of a dry mouth and a 
greater source of glucose within the saliva of people with diabetes may lead to a higher 
dental caries risk (Southerland, Taylor & Offenbacher, 2005).  In addition, a greater 
incidence and prevalence of problems such as parotid gland enlargement, 
inflammation, cracking and fissuring of the lips (chelitis), tongue and buccal mucosa 
with subsequent ulceration, oral candidiasis, salivary gland infection (siladenitis) and 
halitosis occurs when xerostomia is present (Southerland, Taylor & Offenbacher, 
2005; Vernillo, 2003). 
 
Candidiasis.  Oral candida is a fungal infection caused by Candida albicans (US 
Department of Health and Human Services, 2000).  The infection is typically 
visualised as white or yellow spots or a film upon the tissues of the mouth.  Brushing 
reveals ulcerated areas that are tender and may bleed (Gutkowski, 2008).  Candida, 
contained within the normal flora of the mouth, usually over-colonises to cause 
infection as a side effect of taking medications such as antibiotics, antihistamines and 
chemotherapy drugs.  It is associated with the development of salivary dysfunction in 
xerostomia, salivary hyperglycaemia in diabetes, and the compromised immune system 
seen in drug abuse, malnutrition, old age and in immune deficiency disorders (D’Aiuto 
& Massi-Benedetti, 2008; Southerland, Taylor & Offenbacher, 2005; Vernillo, 2003).  
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Studies have shown significantly higher prevalence of candida in people with diabetes 
versus those without (Fisher, Lamey, Samaranayake, Macfarlane & Frier, 1987; see 
also Geerlings & Hoepelman, 1999, as cited in Southerland, Taylor & Offenbacher, 
2005).  Candida infections are common in people who wear dentures and in those who 
smoke (Guggenheimer et al., 2000, as cited in Ship, 2003).  Frequently ill-fitting 
dentures cause breaks in the mucosal membranes at the corners of the mouth that 
provide a site for candidal growth (Southerland, Taylor & Offenbacher, 2005). 
 
Lichen planus.  Oral lichen planus is a chronic inflammatory disease that appears 
as bilateral white striations, papules or plaques on the buccal mucosa, tongue, and 
gingivae.  Erythema, erosions and blisters may or may not be present (D’Aiuto & 
Massi-Benedetti, 2008; Southerland, Taylor & Offenbacher, 2005).  While the 
pathogenesis is unknown, studies indicate that lichen planus is a T-cell mediated 
autoimmune disease in which ‘cytotoxic’ (CD4+ and CD8+) lymphocytic T-Cells 
trigger the apoptosis (programmed cell death) of epithelial cells within the oral cavity.  
The individual experiences mucosal erythema, ulceration, pain and sensitivity (Lodi et 
al., 2005; Thornhill, 2001; Vernillo, 2003).  Lichen planus may predispose the 
individual to an increased risk of oral cancer (D’Aiuto & Massi-Benedetti, 2008) and 
infection by Candida albicans (Southerland, Taylor & Offenbacher, 2005). 
While previous studies have been unsuccessful in identifying the relationship 
between lichen planus and diabetes, Lundstrom (1983), in a study of 40 patients with 
oral lichen planus and 40 patients without, found “28% of patients with lichen planus 
had diabetes compared to zero in the control group, indicating that diabetes may be 
related to the immunopathogenesis of lichen planus” (p. 147).  In a report by Ship 
(2003), the association of lichen planus in people with diabetes is explained as, “In 
patients with type 1 diabetes, chronic immune-suppression is most likely a sequelae: 
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however, in type 2 patients, it is the acute hyperglycaemia causing alterations to the 
immune responsiveness” (p. 85). 
 
Burning mouth syndrome.  Burning mouth syndrome is a chronic pain condition 
associated with tingling, numbness and burning sensations of the tongue, lips and 
mucosal regions of the mouth.  The patient reports it in the absence of clinically 
detectable lesions (Vernillo, 2003).  The pathophysiology is mainly idiopathic but is 
associated with poorly controlled diabetes, hormone therapy, psychological disorder, 
neuropathy, xerostomia and candidiasis (Rhodus, Carlson & Miller, 2003; see also 
Scala, Checchi, Montevecchi, Marini, & Giamberardino, 2003, as cited by 
Southerland, Taylor & Offenbacher, 2005). 
In Australia, according to data from the Australian Diabetes, Obesity and Lifestyle 
Study (AusDiab 1999–2000) (Baker IDI, 2010a), the prevalence of clinically 
diagnosed signs of diabetes-associated neuropathy was “10.3% for males and 8.6% for 
females” (AIHW, 2008b, p. 43).  Strict glycaemic control is reported by the AIHW, 
(2008b) as having “been shown to reduce or prevent the development of neuropathy, 
and may alleviate neuropathic symptoms” (p. 43).  This is also identified by Vernillo 
(2003), as having an impact by “reducing the occurrence of associated oral 
complications; xerostomia, candidiasis, and therefore contribute more substantially to 
the resolution of the symptoms of burning mouth syndrome” (p. 27s). 
 
Gingivitis.  Gingivitis is a common inflammation of the gingival tissues in 
response to the formation of the soft, colourless, sticky film of bacteria known as 
plaque biofilm, upon the teeth and gums (Southerland, Taylor & Offenbacher, 2005).  
Gingivitis may also occur in women who are pregnant as a result of the hormonal 
changes upon the gingival tissues and their exaggerated inflammatory response to 
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plaque.  This usually develops after the second month, reaching a peak at the eight 
month of gestation and usually resolves following the birth of the baby (Coventry, 
Griffiths, Scully & Tonetti, 2000; McGraw, 2002 as cited in the American Academy of 
Pediatric Dentistry, 2007). 
The signs and symptoms of gingivitis include red, swollen, tender gums that may 
bleed when brushing teeth.  The person may or may not notice an associated halitosis 
(bad breath) or a bad taste in the mouth.  Necrotic ulcerated gum tissue commonly 
occurs at its margin with the teeth, with the gum tissue receding from the root surface, 
giving an elongated appearance to the tooth; exposing the tooth portion that is without 
dentin (enamel), to the oral environment and thus, to a greater risk for decay 
(Southerland, Taylor & Offenbacher, 2005), refer to figure 2.1. 
 
 
 
Figure 2.1 Anatomical representation of oral health problems occurring within the 
gingival and periodontal tissues of the oral cavity. 
 
 
When gingivitis is left untreated it progresses to advanced periodontal disease 
(ARCPOH, n.d.b).  Hirsch (2004) states, “while it may precede periodontitis, gingivitis 
does not inevitably progress to periodontitis” (p. 36).  Good daily oral hygiene 
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practices, such as brushing, flossing and antibacterial mouthwash along with regular 
dental visits to remove the plaque deposits have been shown to prevent periodontal 
disease progression (ARCPOH, n.d.b; Little, Falace, Miller & Rhodus, 2002).  
In the person with diabetes, especially those who have poor metabolic control, the 
gingival crevicular fluid sourced from the soft tissue pocket adjacent to the tooth 
surface, may present increased concentrations of glucose (D’Aiuto & Massi-Benedetti, 
2008; Vernillo, 2003).  This provides an environment that favours selective growth of 
pathogenic sub-gingival bacteria while also adversely affecting the individual’s 
immune defence against infection in the periodontal tissues (Hallmon & Mealey, 
1992). 
Incidence rates of gingivitis in children and adolescents with type 1 diabetes have 
been shown to be nearly twice that observed in populations of children and adolescents 
without diabetes (De Pommereau, Dargent-Pare, Robert & Brion et al., 1992).  A study 
by Lalla et al. (2006) reported “children with diabetes also had significantly more 
plaque (plaque index 1.2 vs. 1.1, respectively; unadjusted P < 0.001) and gingival 
inflammation (gingival index 1.2 vs. 1.0 and percentage of sites that bled upon 
examination: 23.6 vs. 10.2%, respectively) than control children” (p. 298).  This had 
also been observed by Gustberti, Syed, Bacon, Grossman and Loesche (1983), who 
identified in their study that children before puberty, with "high" levels of glycosylated 
haemoglobin (>10%), also had higher gingivitis levels than children with "normal" 
metabolic control of diabetes.  They noted that during puberty, the level of gingivitis 
increased independently from both the fasting BGLs and glycosylated haemoglobin 
percentage, with a specific shift to predominately anaerobic bacteria in the 
composition of marginal plaque.  They attributed this as a response to host changes 
within the child at this age period. 
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In adults with type 2 diabetes, it is generally accepted that the higher rates of 
gingival inflammation seen in these individuals, as opposed to those without diabetes, 
is more strongly correlated with the degree of metabolic control (Ryan, Carnu & 
Kamer, 2003).  This indicated the more severe gingival inflammation was detected as 
glycosylated haemoglobin levels increased. 
 
Periodontitis.  According to Loe (1993), “periodontal disease is a chronic 
inflammatory condition of the periodontal tissues that results in a loss of connective 
tissue attachment, destruction of alveolar bone, and formation of pathological pockets 
around the diseased teeth.”  Loe goes further to identify it as “the most common oral 
complication of diabetes” (p. 330). 
As identified, when gingivitis is left untreated it progresses to more advanced 
periodontal disease.  In the person with poor oral hygiene, plaque overgrowth and 
maturation occurs causing detachment of gingival tissue from the tooth surface.  This 
facilitates the infiltration into the sub-gingival tissues of anaerobic or facultative gram-
negative organisms, notably “Porphyromonas gingivalis, Bacteroides forsythus and 
Actinobacillus actinomycetemcomitans, all have virulence traits that enable these 
bacteria to evade host clearance via the antibody-complement/neutrophil axis” (Salvi, 
Lawrence, Offenbacher & Beck, 1997, p. 174).  This is further explained by Salvi et al. 
(1997) as the “bacterial organisms’ ability to evade destruction by the neutrophil or 
that the host neutrophil itself must be dysfunctional for the pathogen to invade deeper 
into the periodontal tissue for the gingivitis to progress onto periodontitis” (p. 174).  
Neutrophils are the primary defence cells of the periodontium, thus the reduced 
neutrophil function observed in individuals with diabetes is yet another mechanism 
increasing the susceptibility to periodontitis (Hirsch, 2004).  The sub-gingival bacteria 
also promote formation of calculus as a protective mechanism that serves to neutralize 
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toxic substances.  The calculus is thought to be “associated with disease as a surrogate 
marker for high numbers of metabolically active sub-gingival bacteria, especially 
black-pigmented species (Salvi et al., 1997, p. 181). 
With the escalation in inflammation and bacterial penetration into the deeper 
tissue, destruction of the connective tissue and alveolar bone supporting the teeth 
occurs.  This results in ‘pocket formation’ around the teeth, increased occurrences of 
bleeding from the gingival tissue, eventual destruction of the ligament attachments 
along with alveolar bone resorption culminating in the loss of teeth (Hallmon & 
Mealey, 1992; Salvi et al., 1997). 
 
Pathogenesis of periodontitis in diabetes 
Both diabetes and periodontitis are thought to share a common pathogenesis.  An 
enhanced inflammatory response at local and systemic levels exacerbates the 
bidirectional predisposition for complication development (Southerland, Taylor & 
Offenbacher, 2005).  Studies (e.g., Engebretson et al., 2004; Iacopino, 2001; Kurtis, 
Develioglu, Taner, Balos & Tekin, 1999) have proposed an inter-relationship of 
mechanisms in the development of periodontal disease in the person with diabetes.  
These involve 1) altered sub-gingival flora, 2) non-enzymatic glycation, 3) changes in 
components of gingival crevicular fluid, 4) an altered host response, 5) changes in 
collagen metabolism, 6) micro-vascular disease, and 7) genetic predisposition 
(Southerland, Taylor & Offenbacher, 2005).  A model of periodontal disease 
pathogenesis by the American Academy of Periodontology (1999) indicates ‘critical 
nodes’ in bacterial aetiology and components of the host response that determine the 
outcome; either control or remission of the disease, or further cyclical progression in 
disease severity which is additionally influenced by risk factors such as cigarette 
Chapter 2:  Literature Review 
28 
smoking.  An explanation of the most significant elements for periodontal disease in 
the person with diabetes is detailed further. 
 
Advanced glycation end products (AGE’s).  AGE’s are a “class of non-
enzymatically glycated proteins and lipids found in plasma, vessel walls and tissues” 
(Salvi et al., p. 181).  Accumulation during the aging process is normal; however, an 
accelerated rate in the presence of elevated glucose levels occurs (Salvi et al., 2007).  
According to Peppa, Uribarri and Vlassara (2003) “a large body of evidence suggests 
that AGEs are important pathogenetic mediators of almost all diabetes complications, 
conventionally grouped into micro- or macroangiopathies” (p. 186). 
AGEs bind to the specific cellular receptor known as the ‘receptor for AGE’ 
(RAGE).  These are found upon endothelial cells, which line the lumen of blood 
vessels, and upon the bone marrow derived white blood cell, the monocyte.  
Monocytes are immature macrophages that migrate to a site of inflammation (such as 
periodontitis) to destroy and consume pathogens and cellular debris (Cytokines & 
Cells Online Pathfinder Encyclopaedia [COPE], 2010).  The AGE receptor site binding 
initiates a pro-inflammatory cycle of events, with studies showing receptor site binding 
upon endothelial cells in particular attracts monocytes to the luminal surface of the 
endothelial cells under the influence of vascular cell adhesion molecule-1 (Lamster, 
Lalla, Borgnakke & Taylor, 2008).  In addition, the influence of AGE’s upon the 
monocytes is the release of pro-inflammatory cytokines (tumour necrosis factor-alpha, 
interleukin1-beta, interleukin 6 and prostaglandin E2) in a poorly controlled manner 
(Salvi et al., 1997; Southerland, Taylor, & Offenbacher, 2005).  Cytokines are a 
diverse group of soluble proteins and peptides that regulate the function of individual 
cells, mediating not only the interactions between cells, but also regulating processes 
Chapter 2:  Literature Review 
29 
that take place in the extracellular environment in both normal and pathological 
conditions (COPE, 2008a). 
The accumulation of AGE’s within the periodontal tissue, along with an increased 
expression of various genes regulated by the cytokine; transcription nuclear factor-KB 
(NF-KB) plays a primary role in the expression and severity of periodontal disease, 
with diabetes and smoking having further adverse modification at a number of levels in 
the pathogenic pathway (Kirstein et al., 1990; Salvi et al., 1997). 
 
Bacterial biofilm: a crucial factor in periodontal pathogenicity.  A diverse 
bacterial community is found upon the stratified squamous mucosa, teeth and at the 
muco-gingival margins within the oral cavity (Marsh and Bradshaw, 1995).  A clean 
tooth surface comes into contact with not only bacteria, but also positively charged 
proteins and glycoproteins, and products from the gingival crevicular fluid within the 
sub-gingival spaces.  These are absorbed into the negatively charged tooth surface to 
make a layer of conditioning film, called the ‘acquired enamel pellicle’ (Marsh and 
Bradshaw, 1995; Seneviratne, Zhange and Samaranayake, 2011). 
The primary bacterial colonisers within this pellicle are either aerobic or 
facultative aerobes such as Streptococcus and Fusobacterium species.  These develop 
reversible short-range ‘van der Waals bonds’ through use of their cell surface 
adhesion molecules to develop stronger irreversible short-range attachments to the 
teeth.  With the subsequent reduction in available oxygen, Gram-negative bacteria; 
Actinomyces species, use protein-protein or carbohydrate-protein (lectin) interactions 
to co-attach to receptors upon the primary colonisers.  Co-aggregation of Gram-
negative to Gram-positive species have been also been shown to occur in this manner 
(Seneviratne, Zhange and Samaranayake, 2011).  According to Marsh & Bradshaw 
(1995), this process contributes to determining the pattern of bacterial succession.  At 
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this stage in the biofilm development, bacterial colonies secrete extracellular 
polymeric substances which provide a three-dimensional scaffold structure 
(Seneviratne, Zhange and Samaranayake, 2011).  According to Overman (2011) the 
biofilm matrix contains channels through which nutrients, oxygen, enzymes, 
metabolites and waste-products can flow to meet the need of the micro-colonies 
contained; those being differing pH levels, nutrient availability and oxygen 
concentrations.  Furthermore, chemical signalling known as ‘quorum sensing, 
communicates the need between the micro-colonies and enables the bacteria to evade 
the host defenses, and provides a protective barrier against destruction by 
antimicrobial agents. 
Finally, Seneviratne, Zhange and Samaranayake, (2011) identify the maturation 
of the biofilm favours tertiary colonisation by Gram-Negative anaerobes mainly 
Porphyromonas gingivalis and Aggregaribacter actinomyetemcomitans.  It is 
generally assumed to have occurred after 72 hours, yet individual differences in the 
rate and thickness of dental plaque formation is dependent upon the dietary intake 
and host immunity.  However, once established is considered to be in a homeostatic 
state, with drastic changes in diet or host immunity believed to initiate the 
pathological sequelae of infection into the sub-gingival tissues, evading the 
concurrent host inflammatory response and representing a shift from a healthy to 
pathological biofilm which results in the progression to periodontal disease. 
 
Altered connective tissue (Collagen) metabolism.  According to Graves, Liu, 
Alikhani, Al-Mashat and Trackman (2006) the robust inflammatory response seen in 
individuals with diabetes contributes to the periodontal tissue destruction.  The 
gingival tissue, periodontal ligament and alveolar bone is predominately comprised of 
type I collagen (Lindhe & Karring, as cited in Salvi et al., 1997), with type IV collagen 
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found in the basement membrane of blood vessels (Salvi et al., 1997).  The 
hyperglycaemia and AGE accumulation in collagen results in increased thickness and 
rigidity of blood vessel walls thereby impairing migration of white blood cells in 
response to inflammation with reduced oxygen diffusion and metabolic waste removal 
from the site of infection (Salvi et al., 1997).  Thus the interaction of AGEs with their 
receptors has been shown to have a crucial role in the development of microvascular 
damage within the periodontal tissues (Salvi et al., 1997). 
Furthermore, Graves et al. (2006) identify the formation of reactive oxygen 
species with elevated levels of AGEs and cytokines in the periodontal tissues of people 
with diabetes.  These have the potential to affect the response to bacteria induced 
periodontitis and oral healing.  This occurs as a result of not only the inhibition of 
collagen production by the osteoblastic and fibroblastic cells within the gingivae and 
skin, but also through promotion of inflammation and enhanced apoptosis.  This 
enhanced process of apoptosis, the sequence of programmed events leading to cell 
death of the matrix-producing cells, is also strongly implicated in development of 
neuropathic, nephropathic and cardiovascular complications seen in the person with 
diabetes (Huang et al., 2001; see also Yamagishi et al., 2002 and Kaji et al., 2003, as 
cited in Graves et al., 2006). 
 
The altered host response to periodontal infection.  Often the severity and 
progression of periodontitis in the person with diabetes does not correlate with the 
bacterial burden observed in the clinical environment.  It is believed that the hyper-
responsive inflammatory state during the bacterial challenge presented in periodontitis, 
is associated with the individual’s ‘host response’.  Not only is this determined by 
genetic regulation of the antibody/antigen response, but also related to the release of 
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cytokines and the magnitude of their effect in tissue destruction (Rituparna & Neeraj, 
2007; Salvi et al., 1997; Southerland et al., 2006). 
According to Salvi et al. (1997) and Southerland, Taylor and Offenbacher (2005) 
multiple studies have shown the levels of inflammatory mediators are significantly 
higher in periodontitis if the person has diabetes when compared to those without 
diabetes.  The elevated levels of cytokines found in the gingival crevicular fluid of 
people with diabetes and periodontitis have been shown to influence the metabolism of 
fibroblasts and lymphocytes causing destruction of collagen and glycoprotein in the 
connective tissues with subsequent impairment of wound healing.  Prostaglandin E2 
inhibits the production of antibodies by plasma cells at the site of inflammation.  This 
adversely influences the body’s ability to fight, at the earliest opportunity, the bacterial 
invasion into periodontal tissues, which results in resorption of alveolar bone and tooth 
loss (Graves et al., 2006; Hirsch, 2004; Salvi et al., 1997).  According to Southerland 
et al. (2006), the interleukin (IL)-1β, tumour necrosis factor-α, and IL-6, furthermore 
blocks the activity of the enzyme, lipoprotein lipase.  This leads to decreased 
transportation of lipids from the circulation into the cells, resulting in the clinically 
elevated low-density lipoprotein and total cholesterol levels, frequently seen in the 
person with diabetes.  The tumour necrosis factor-α, and IL-1β promote glycogenolysis 
and induces insulin resistance by blocking the insulin receptor tyrosine kinase and 
other signalling proteins, causing impaired glucose uptake.  Therefore a periodontal 
infection presents a significant metabolic stressor and demand for insulin secretion in 
the person with diabetes, resulting in further elevation of the individual’s blood 
glucose and lipid levels (Southerland et al., 2006). 
The increased susceptibility to periodontal disease in diabetes is also considered to 
be associated with an impaired neutrophil function.  The neutrophil, a bone marrow 
derived white blood cell, produces superoxide and microbiocidal proteins to ingest 
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pathogens, cell debris and defective host cells; which are mainly blood cells.  This 
process, known as phagocytosis, plays an important role in mounting the initial host 
defence against acute and chronic inflammation (COPE, 2008b). 
Bacterial products, such as the endotoxin lipopolysaccharide, are thought to 
propagate the inflammatory response through Toll-like proteins receptors and induce 
the inflammatory cascade which ultimately contributes to tissue destruction (Wittebole 
et al., 2005).  These receptors have been shown to play an important role in the innate 
immune response, especially between an infecting microorganism Porphyromonas 
gingivalis and monocytes (Kirschning, Wesche, Ayers & Rothe, 1998), and may be 
regulated by gene expression influencing the extent of the up-regulated inflammatory 
response (Salvi et al., 2007).  Lipopolysaccharide in the periodontal tissue is believed 
to alter the neutrophils’ ‘oxidative burst capacity’ thereby impairing phagocytosis of 
the invading pathogen (Salvi et al., 2007).  Thus the oral pathogens and their products 
have ready access into the systemic circulation aided by an accentuated inflammatory 
response.  Here they are able to further disrupt the body’s homeostasis with major 
impact. 
The systemically elevated levels of lipids, especially low-density lipoproteins, 
triglycerides and unsaturated fatty acids, hallmarks of the metabolic syndrome 
frequently observed in diabetic individuals, is thought to exaggerate monocyte function 
and impair the neutrophils’ phagocytotic function (Ryan, Carnu, & Kamer, 2003; Salvi 
et al, 1997).  The adipocyte, the major storage site for triglycerides formed from 
circulating fatty acids, produces large quantities of cytokines in the presence of 
inflammation (Hotamisligil, Shargill & Spiegelman, 1993; Sniderman & Durrington, 
2010).  From animal studies, it is thought that the increased inflammatory-stimulated 
cytokine release contributes to not only insulin resistance, but also further beta cell 
destruction (Southerland, Taylor & Offenbacher, 2005). 
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According to Ryan, Carnu, and Kamer (2003), the monocytes, having being 
exposed to elevated serum lipids and the endotoxin challenge presented by 
periodontitis, expresses “an inflammatory phenotype rather than a reparative or 
proliferative one” (p. 38S).  Furthermore, macrophages internalise low density 
lipoproteins from tissue fluids and these are absorbed into the endothelial wall of the 
artery leading not only to activation and release of cytokines but also foam cell 
formation which is associated with the increased morbidity and mortality of coronary 
artery disease (Rituparna & Neeraj, 2007; Southerland et al., 2006).  Southerland et al. 
(2006) go further to state “the combined effect of chronic periodontitis and diabetes 
could potentially constitute an even greater risk for developing sub-clinical coronary 
artery disease than would be predicted by either diabetes or periodontal disease alone” 
(p. 137). 
 
 
Figure 2.2 Pathogenesis of periodontitis in diabetes. 
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Smoking:  The additional risk.  The risk for periodontal disease associated with 
tobacco smoking has been extensively studied in cross-sectional, case-controlled, 
longitudinal and interventional studies, with results indicating smoking was an 
independent risk factor in the order of 2.5-7.0 compared to non-smokers (Salvi et al., 
1997).  The volume of cigarette consumption over time was positively correlated with 
increasing levels of risk for periodontal disease in current smokers with more severe 
periodontitis noted among those who currently smoked in comparison to those ex-
smokers and the least severe observed in those who never smoked (Salvi et al., 1997).  
In addition, the U.S National Institute for Dental and Craniofacial Research (2000) 
reports the odds ratio (OR) for severe periodontitis in individuals with diabetes who 
also smoke is increased to 20.  According to Tsai, Hayes and Taylor (2002), dental 
examination data from the American NHANES III studies showed an OR = 2.3 for 
severe periodontal disease in patients who smoke and had better controlled diabetes 
(HbA1C <9%) while patients who smoke and had poorly controlled diabetes (HbA1C 
>9%) had an OR = 4.6, suggesting a combined effect of smoking and glycaemic 
control on developing periodontal disease. 
Tobacco smoking introduces a highly reactive and toxic form of AGE products 
into the circulation (Peppa, Uribarri & Vlassara, 2003).  One of the by-products of 
smoking, nicotine, exert vaso-constrictive effects, reducing not only blood flow, but 
also oedema and inflammation.  Therefore, in the person who smokes, the outward 
clinical signs of periodontal disease may appear less aggressive despite the underlying 
damage (Hanes, Schuster & Lubas, 1991, as cited in Salvi et al., 1997).  The biological 
effects of nicotine range from neutrophil chemotaxis at low concentrations to impaired 
phagocytosis at higher concentrations with up-regulated release of cytokines in 
response to the bacterial product, lipopolysaccharide, and reduced levels of 
immunoglobulin G2 (IgG2), which normally provides a key immune response against 
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periodontitis causing bacteria (Salvi et al., 1997).  In addition, carbon monoxide (CO) 
rather than Oxygen (O2), binds with haemoglobin (Hb) in the order of 210 times 
greater affinity.  This results in decreased O2 carrying capacity and a slower 
dissociation-rate of O2 from Hb within the body’s tissues.  The resulting oxidative 
stress within the endothelial tissues increases their permeability, with oedema and fatty 
acid oxidation the end result (Rietbrock, Kunkel, Worner & Eyer, 1992).  Furthermore, 
the decreased oxygen tension in the deep periodontal tissues creates a favourable 
environment for gram-negative organisms to flourish, with the gingival fibroblasts 
binding and internalising nicotine, re-releasing it un-metabolised (Loesche, Gustberti, 
Mettraux, Higgins, & Syed, as cited in Salvi et al., 1997, p. 185). 
Thus the effect of smoking in the person with diabetes is to exacerbate the oral 
tissue destruction via up-regulation of the pathogenic factors previously discussed.  
This is in combination with the reduction of blood and oxygen volumes available 
within the oral tissues to enable repair, predisposes the individual to a greater risk of 
periodontal disease occurrence and severity. 
 
Diabetes and oral health management strategies 
In light of the research describing the bi-directional interaction of diabetes and 
oral health, providing evidence of greater prevalence, incidence, severity, extent or 
progression of periodontal disease in individuals with diabetes, the WHO called for 
careful management of periodontal disease in patients with diabetes as an adjunctive 
treatment to other regular diabetes care.  The FDI, and IDF in their symposium, ‘Oral 
Health and Diabetes’ at the 2007 FDI Annual World Dental Congress in Dubai, 
recognised the need for greater awareness among healthcare providers and the general 
public for oral complications in diabetes.  Further at this symposium, the FDI and IDF 
focussed on the need for more research and evidence-based education programs to 
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raise awareness of oral health complications and promotion of oral health care as a 
component of diabetes education and care (D’Aiuto & Massi-Benedetti, 2008). 
There is some evidence to suggest that action has been taken towards improving 
oral health care for people with diabetes.  At the World Diabetes Congress in 2009, the 
IDF launched its guideline ‘Oral Health for People with Diabetes’.  This guideline 
recommends the diabetes care provider should: enquire annually as to the frequency of 
a dental professional’s review and the individual’s oral hygiene practices, reinforce the 
need for oral health care as part of ‘normal’ diabetes self management, and provide 
advice as required.  It also highlights oral assessment and patient education as to the 
implications of periodontal disease, with referral to a dental practitioner if symptoms 
are present.  Peak bodies within America and Canada, i.e., the American Dental 
Association, American Diabetes Association, Diabetes Educators Association of 
America, Canadian Dental Association, and Canadian Dental Hygienists Association 
have position statements that identify their promotion of oral health care within 
diabetes management. 
Within Australia, the Commonwealth Government endorses the National Health 
and Medical Research Council (NHMRC) framework for diabetes management via the 
provision of documents ‘Clinical Practice Guidelines: Type 1 Diabetes in Children and 
Adolescents’, and the ‘National Evidence Based Guidelines for the Management of 
Type 2 Diabetes Mellitus – Part 1’ (NHMRC, 2005a, 2005b).  Within the ‘Clinical 
Practice Guidelines: Type 1 Diabetes in Children and Adolescents’ (NHMRC, 2005a) 
there is acknowledgment that “maintenance of dental health and the prevention of 
dental disease is important for children and adolescents with diabetes mellitus” (p. 
180).  Furthermore “the assessment of dental health should be a part of the regular 
medical follow-up” (p. 180).  There is an explanation of periodontal disease signs and 
symptoms with the inclusion of oral hygiene practices for prevention, with 
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recommendations for “twice yearly examination” and “regular cleaning and scaling of 
teeth by the dentist” (p. 180).  However, within the updated version, i.e. ‘National 
Evidence-Based Clinical Care Guidelines for Management of Type 1 Diabetes in 
Children, Adolescents and Adults’ (NHMRC, 2011), the oral health care needs of the 
person with diabetes is mentioned only once.  In doing so, it cites Simpson et al. 
(2010) “Increased periodontal disease prevalence is also reported and may lead to 
improvement in glycaemic control when treated” (p.150).  The guidelines are limited 
by a lack of oral health screening items to guide the DHP in undertaking the oral 
examination, and for information as to what constitutes the appropriate and timely 
referral to a dental practitioner for this diabetes age-specific population. 
This is important as gingivitis precedes periodontitis (Loe, 1993; Salvi et al., 1997; 
Vernillo, 2003).  Children with diabetes have been shown to exhibit not only greater 
incidence of gingivitis than non-diabetic children (Gustberti, Syed, Grossman & 
Loesche, 1983), but also a clear tendency towards higher gingival index scores when 
metabolic control is poor (Gislen, Nilsson & Matsson, 1980).  It is identified that 
metabolic/glycaemic control in children with diabetes is frequently challenged by: the 
frequency of episodes of illness, heightened levels of activity which predisposes to 
hypoglycaemia requiring additional treatment with oral glucose, and the psychosocial 
issues impacting upon management of the condition (NHRMC, 2005a).  In addition the 
physiological host changes during puberty can have a significant effect on glycaemic 
control and has been shown to further predispose the individual with diabetes to 
periodontal disease (Gustberti et al., 1983). 
As identified by Lalla et al. (2006), in their study of children and adolescents, 
“periodontal diseases are largely preventable and progression of destruction can be 
best arrested when identified in early stage”.  Furthermore, they state the opinion that 
“screening for periodontal changes and implementing prevention and treatment 
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programs should be considered as a standard of care for young patients with diabetes” 
(p. 299).  This evidence is also supported by studies that indicate management of 
periodontal infections in adults with diabetes can have a positive effect on the 
glycaemic control in these individuals (D’Aiuto & Massi-Benedetti, 2008; Lalla et al., 
2007; Salvi et al., 1997; Southerland, Taylor, Moss et al., 2006; Southerland, Taylor   
& Offenbacher, 2005). 
Within the document ‘National Evidence Based Guidelines for the Management of 
Type 2 Diabetes Mellitus- Part 1’ (NHMRC, 2005b), there is an absence of 
information regarding diabetes related oral health complications.  References to 
complication management extends only to general statements citing Colagiuri et al. 
(1995) “screening for and appropriate treatment of complications” and “additional 
expertise...should be available as required as should referral access to specialist 
services for the management of identified complications” (p. 2). 
While there are Australian consensus statements, position statements and practice 
management guidelines for other complications associated with diabetes, those for oral 
health in diabetes care are notably lacking.  The peak Australian bodies for DHPs, the 
Australian Diabetes Society (ADS) and the Australian Diabetes Educators Association 
(ADEA) do not appear to have endorsed any such related protocols. 
Consumer information, concerning oral health issues associated with diabetes, is 
available as print and electronic resources.  This is most notably from dental 
practitioners and dental health companies, such as Colgate Palmolive, or via 
organisations, such as The Australian Diabetes Council (2008), State-based member 
organisations of Diabetes Australia (Diabetes Australia 2006), and the Australian 
Research Centre for Population Oral Health (ARCPOH, n.d.a, n.d.b).  In some 
Australian states, e.g., South Australia, the Government Department of Health and 
Human Services have been proactive in providing information that target older persons 
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and those within rural/remote communities (Government of South Australia, 2012).  
There has also been targeted promotion within the indigenous population of the 
Northern Territory (NT Government, 2007), as well as a broad health promotion 
approach by the Victorian Government via the ‘The Better Health Channel’ Website 
(Government of Victoria, 2010). 
However, the paucity in Australian publications of evidence-based diabetes and 
oral health articles targeting DHPs’ acquisition of knowledge and skills, practice 
guidelines and a screening tool to guide the assessment and referral processes for 
specialised care when problems exist, is of concern.  Extensive searches via PubMed, 
ProQuest, CINAHL, Medscape, and Google Scholar databases utilising search term 
combinations, e.g., diabetes, type 1, type 2, adults, children, oral health, gingivitis, 
periodontitis, periodontal disease, oral health quality of life, complaints, conditions and 
complications, was undertaken.  As a result it was determined that there was no 
previous evidence of studies pertaining to DHPs’ knowledge and scope of practice 
within the Australian context.  Two recent studies were found which specifically 
investigated the relationship between practitioner knowledge and clinical practice with 
the knowledge and self-management practices of oral health in individuals with 
diabetes.  However, a direct comparison of data from these studies with Australian 
health practices is somewhat difficult given the cultural, educational and health system 
differences.  Al-Habashneh, Barghout, Humbert, Khader and Alwaeli (2010), noted 
70% of Jordanian doctors responding to their survey identified knowledge of the 
association of diabetes and oral health.  However only 50% identified advising their 
patients of the need for dental management in diabetes care and only 30% agreed that 
oral health was an issue in diabetes control.  Their data showed the significant factors 
in patients being advised was being a specialist in diabetes and positive knowledge of 
the association of diabetes and oral health.  They concluded that:  
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“There is limited knowledge of the relationship of oral health and diabetes.  The 
more knowledgeable doctors are, the more likely they are to make dental referrals.  
Screening and referral by health professionals may benefit diabetic patients by 
improving access to dental care.  Therefore, there is a need to educate doctors 
about oral health and diabetes” (p. 980). 
In the second study, within an American community, Yuen et al. (2009) found 
“participants who received oral health information related to diabetes had 2.9 times the 
odds of demonstrating adequate oral health knowledge compared to participants who 
did not receive that information controlling for education and race (OR = 2.86, 95% CI 
1.31–6.24, P = 0.008)” (p. 243).  They further identified “consistent trends between 
specific oral health information received from health professionals and the specific 
self-reported oral health behaviours among dentate participants” (p. 244).  This study 
showed the provision of diabetes and oral health information by DHPs did improve 
patient knowledge, and a statistically significant association between a particular area 
of oral health information received, and the frequency of engaging in specific oral 
health behaviours corresponded to the information received (p. 244). 
In conclusion, it would appear from the limited studies of diabetes and oral health 
knowledge and clinical practice undertaken to date, that DHPs are ideally placed to 
provide information regarding diabetes and oral health information to the individuals 
in their care.  As with any diabetes-associated complication, a concentrated focus is 
required to not only improve recognition, but also the implementation of education and 
health promotion, prevention strategies, and referral processes.  The specialised 
management of identified oral health problems has been shown to improve the health, 
welfare and quality of life in the person with diabetes.  These issues should be at the 
forefront of not only researchers, but also the practitioner involved in care management 
of the person with diabetes.  It is unclear however, whether Australian DHPs possess 
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sufficient knowledge and skills to undertake oral health complication management 
within their practice.  Furthermore, identification of the driving and restraining forces 
impacting on their scope of practice is required.  The purpose of the current study is to 
explore the relationship of these issues further. 
 
Chapter summary 
This chapter has discussed the available evidence indicating the risks for 
periodontal disease in the individual with diabetes at the varying stages of age and by 
diabetes type.  It has highlighted the differences in glycaemic control, age of onset and 
duration of the diabetes condition as the major influencing factors in incidence, 
prevalence and severity of periodontitis.  Little statistical evidence exists to indicate 
the true periodontal prevalence rate in people living with diabetes, or potential for 
estimation of the magnitude of the periodontal disease rate in this vulnerable 
Australian population. 
Building upon the information provided in Chapter 1, the oral health problems 
associated with diabetes was presented, describing both symptoms and issues for 
diabetes management.  Periodontal disease pathogenesis was explored and presented in 
a manner to enable the reader to understand the compounding complexity and 
bidirectional nature of periodontal disease in diabetes and its impact upon the varied 
body systems, with the additional behavioural risk factor; cigarette smoking, discussed. 
The literature regarding diabetes and oral health care strategies examined both 
international and national documents.  In the absence of Australian oral health care 
specific position statements and guidelines for DHPs from diabetes peak body 
organisations, the NHRMC documents regarding management of diabetes were 
discussed.  From these it was identified an insufficient level of attention has been given 
to oral health complications. 
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Finally the literature review identified only two previous studies which have 
explored the topic of knowledge of oral health complications and clinical practice in 
the area of diabetes management, with data indicating not only a significant lack of 
practitioner and patient knowledge, but also insufficient promotion and management of 
oral health problems within diabetes care models.  The evidence from these studies 
indicate the view that the health professionals’ knowledge and practice can have an 
impact upon preventing and managing oral health complications in individuals with 
diabetes, however further research is required to establish this outright.  Therefore a 
study into the Australian health professionals’ knowledge and scope of practice in the 
area of diabetes and oral health complications is worthy of further investigation. 
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Chapter 3:  Methodology of the Study 
 
This chapter describes the research design, sampling method, instrument 
development, data collection procedure and statistical analysis used to meet the study’s 
aim.  Ethical considerations are also discussed.  The invitation to participate in the 
pilot and main phase of the study, the information sheet and data collection instrument 
are described. 
 
Study design 
This descriptive study utilised a cross-sectional design to survey the providers of 
specialised diabetes care in Australia.  Members of the Australian peak organisations 
for DHPs, the ADS and the ADEA, were recruited as the study participants.  These 
professional bodies represent health professionals who are direct service providers to 
people living with diabetes. 
A cross-sectional approach is commonly used in health and social sciences to 
describe the prevalence of an association between a subject of interest and identified 
determinants of health in the study subjects at a single point in time (Levin, 2006; 
Moser & Kalton, 1986).  It was therefore considered an appropriate method for this 
study in order to meet the objectives which were to: 
1. Measure Australian DHPs’ level of knowledge of oral health issues which impact 
upon the person with diabetes. 
2. To describe the DHPs’ scope of practice regarding intervention, health promotion 
and care management of oral health issues in persons with diabetes. 
3. To identify the restraining and driving forces that influence the provision of oral 
health care prevention and intervention for people with diabetes. 
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The advantages associated with this form of design are that it is relatively 
inexpensive, with a shorter administration time, and without the requirement to follow-
up the participants within the sample population (Levin, 2006; Moser & Kalton, 1986).  
Furthermore, multiple factors and outcomes of interest are able to be analysed thereby 
indicating associations which exist, thus allowing further hypothesis generation which 
is useful for future research (Barratt & Kirwan, 2009).  Whilst the cross-sectional 
design was considered a suitable method for this study, there are however, notable 
disadvantages associated with this approach. 
A major disadvantage in using a cross-sectional study design is its inability to 
establish a causal relationship between the variables of interest and outcome, nor the 
sequencing of the events leading to the outcome (Levin, 2006; Moser & Kalton 1986).  
As it was the intention of this study to measure and describe the association between 
the DHPs’ knowledge and scope of practice in the delivery of care to people living 
with diabetes rather than the cause and effect relationship, this disadvantage was 
therefore not considered a barrier to achieve the study objectives. 
A further disadvantage of a cross-sectional design is the increased susceptibility to 
bias (Barratt & Kirwan, 2009).  Bias also known as systematic error, occurs when a 
factor or number of factors within a research study design has an effect upon the data 
acquired.  This results in the systematic distortion of the true association between the 
study factors and the outcome factors (Dorak, 2009).  The most commonly seen biases 
occur in the selection and measurement phases of a study.  The response bias occurs 
when there is a low response rate.  This could be important for the present study if 
sample size inequality within the professional sub-groups occurred, as the 
characteristics and responses of those who participate versus the non-responders may 
differ significantly.  A recall bias, may occur when the participants’ reflections upon 
their actual level of knowledge and recall of previous experiences have led them to 
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adjust their answers within the survey.  It is acknowledged that these bias factors could 
arise within this study and are therefore considered in the analysis and reporting of the 
data presented in subsequent chapters. 
The study comprised of two stages.  Firstly, an initial pilot phase explored the 
measurement tools’ construct; face and content validity, along with estimates of 
completion time.  Amendments were made to the instrument based upon feedback 
from the pilot testing prior to use in the main study.  Secondly, the main study 
concentrated upon the ethical considerations in undertaking the study, communication 
with the executive and administration staff of the sample groups to ensure the 
distribution of the instrument to their membership, the data collection period, analysis 
of the data collected and reporting of the results. 
 
Sampling method 
Participants were sought from the membership of the ADS and ADEA.  The ADS 
and ADEA clinical practitioner membership for 2007-2008 was 404 and 1473 
respectively.  For this period the majority of the ADS membership represents medical 
professionals in endocrinology practice, research and teaching (94.1%).  A further 
5.9% of members were pharmaceutical representatives or otherwise not categorised 
(ADS, personal communication, January 19, 2009).  The ADEA membership for this 
period comprises nurses (49.3%), dietitians (5.2%), other allied health professionals 
(1%), pharmaceutical representatives (1%), pharmacists and podiatrists (0.5% each), 
medical practitioners (0.1%) and a further 42.4% of members not categorised to a 
profession (ADEA, personal communication January 19, 2009).  For the sample data to 
be representative of these organisations at a 95% confidence interval, it was calculated 
that 197 ADS members responses and 305 ADEA member responses was required 
(Sample size calculator, 2010). 
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All members of these two organisations were invited to be a part of the study.  No 
exclusion criteria for participation existed.  The invitation to participate in the study 
was disseminated via the organisations’ email, and additionally, for the ADEA 
members, the ‘members only’ accessible pages on the organisation’s website.  Thus 
respondents involved in the study formed a convenience (a non-probability) sample.  It 
is acknowledged that a weakness of this form of sampling method is its inability to 
ensure representation from the varied groups within the study population (Barratt & 
Kirwan, 2009).  However, by involving ADS and ADEA an attempt was made to gain 
participants who have an interest in diabetes care sufficient to join these professional 
organisations.  The decision was made to avoid approaching more general 
organisations, such as the Royal College of Physicians and General Practitioners, 
Nurses Registration Boards and registering bodies for each Allied Health Professional 
category in each State of Australia.  This is explained further within Chapter 4. 
 
Measurement tool 
A survey was developed by the researcher for the study.  An extensive literature 
search failed to identify any established instruments suitable for inclusion in this study, 
therefore, item generation for the study instrument was based upon the literature 
review, mapping of clinical evidence-based guidelines from dental and diabetes 
association’s within the US, Canada and Europe and the research objectives guiding 
the study.  The US, Canada and Europe were selected due to the existence of several 
research studies undertaken in the area of diabetes and oral health complications that 
resulted in the development of consensus statements for diabetes care management in 
these countries.  This is in contrast to Australia where there is currently an absence of 
diabetes and oral health complication research with supportive clinical documents.  
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Given this, the instrument was tested prior to its use in the main study to determine its 
face and content validity, and reliability. 
The instrument used in the main study was comprised of three parts and totalled 
28 items (Appendix A).  Part One addressed the socio-demographic data and consisted 
of ten questions seeking information on professional membership, employment 
experience, the nature of the participants’ work setting and location (determined by 
postcode), and the principal diabetes population managed.  Part Two focussed on the 
extent and form of diabetes and oral health education received by participants; a total 
of seven items, with two questions requiring participants to identify the extent of their 
knowledge of specific diabetes related oral health complications were included.  
Finally, the Part Three concerned participants’ practice and efficacy relative to oral 
health issues in diabetes care.  Eleven items related to diabetes and oral complication 
management practices undertaken and the levels of confidence in decision making 
which guided the practice.  The form of the items was a mixture of open-ended and 
closed-ended questions, and Likert scale statements. 
Open-ended items allow flexibility in testing the limits of respondents’ 
knowledge.  They also provide a frame of reference for respondents’ answers with a 
minimum of restraint on the manner and content of the reply, thereby facilitating a 
richness and intensity of response (Burns, 2000).  The closed items allow the 
respondent to choose from two or more fixed alternatives.  The advantage of these 
items is that it achieves greater uniformity of measurement and therefore greater 
reliability in the data which, when used in conjunction with open-ended and scale 
items, overcomes the apparent superficiality of a forced ranking response (Burns, 
2000).  These items have been structured to account for the myriad of potential 
answers across each of the professional sub-groups as identified from the pilot phase 
testing.  The Likert scale items are a set of statements to which the respondent has been 
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asked to consider a range of clinical circumstances and indicate their degree of 
agreement, confidence, concern and likelihood to action in their practice on a scale of 
1 to 5.  The lower score reflects a more negative response with the highest score 
reflecting a more positive response for each of the Likert items. 
  
Data collection 
Pilot Phase – Questionnaire validity and reliability testing.  The instrument 
was circulated in word document format to a pilot panel of seven diabetes clinicians, 
including an Endocrinologist, a Registered Nurse with diabetes education 
qualifications, a student diabetes educator, two dietitians and two podiatrists.  The 
diverse representation of health professional groups included in the pilot was deemed 
necessary to reflect the professions within the ADS and ADEA membership.  These 
individuals responded to a group email request for participation in a pilot group and 
were sourced from the researcher’s place of employment, a tertiary diabetes centre.  
There was no risk that the participating pilot members would later be included in the 
final study sample, as it was confirmed they were not members of the professional 
organisations sampled. 
The pilot phase participants were provided with an explanation of the purpose and 
objectives of the study along with the Information sheet for pilot phase participants in 
reviewing the study questionnaire, (Appendix B).  Further explanation was provided in 
the use of the Content Validity Index (Waltz & Bausell, 1983) (Appendix C) to enable 
an assessment of the face and content validity of the Study questionnaire (pilot phase 
version) (Appendix D).  Further questionnaire refinement was based upon the feedback 
received (Appendix E). 
Review of the instrument by the panel involved completion of the questionnaire 
twice.  The instrument was provided at two separate occasions to measure the test-
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retest reliability, with a period of 21 days between administrations.  According to Huck 
and Cormier (1996), the basic idea of reliability can be summed up by the word 
consistency, with the test-retest approach representing an estimate of consistency 
overtime, providing a single numerical index called the reliability coefficient.  A 
descriptive summary of the data consistency normally assumes a value between 0.00 
and 1.00 with the two endpoints representing where consistency is either totally absent 
or total present.  The degree of stability of an item with an increasing timeframe to re-
test is usually reduced; therefore, a high coefficient of stability is more impressive 
when the time frame is longer (Huck & Cormier, 1996). 
 
Recording of the instrument commencement and completion time.  The 
participant’s start and finish time was recorded on both occasions to enable estimation 
of the completion time for inclusion within the main study. 
 
Completion of the Content Validity Index prepared by Waltz and Bausell (1983).  
The pilot phase participants were asked to critically review each question within the 
questionnaire against four criteria within the index: relevance, clarity, simplicity and 
ambiguity.  The rating scale ranges between 1 ‘not relevant’ to 4 ‘very relevant’, refer 
to Table 3.1. 
 
Content validity is concerned with the degree to which the various items 
collectively cover the material that the instrument is supposed to measure (Huck & 
Table 3.1 
Content Validity Index 
Rating Criteria 
1 Not relevant 
2 Item needs some revision 
3 Relevant, but needs some minor revision 
4 Very relevant 
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Cormier, 1996).  This can be determined from the literature review, representatives of 
the sample population and clinical experts who carefully compare the content of the 
test against an outline that specifies the instruments’ claimed domain (Burns & Grove, 
1993).  Subjective opinion from these experts may either establish or not, the content 
validity without statistical procedures being applied to the data (Huck & Cormier, 
1996).  The detailing of the content validity process is an important factor in 
identifying the concept of measuring and thus ensuring the interpretations of results are 
precise (Yaghmaie, 2003). 
Assessment of the study instruments’ content validity was completed on one 
occasion only during the pilot phase.  A further column was added to the index to 
enable the panel members to recommend changes to further improve the questionnaire, 
thereby addressing the face validity, which is the presentation of items within the 
instrument in relation to the question formulation and order.  The evaluative comments 
resulted in modifications to the instrument before their transcription into the electronic 
format for distribution to the study sample.  In general these changes were to wording 
to improve clarity in the questioning, and the addition of questions to expand and 
improve the data collection.  A full description of these changes is reported within 
Appendix E. 
 
Second stage:  Main study.  Contact with the ADEA and ADS organisations 
were initiated by email (Appendices F and G) prior to the study being approved by the 
Curtin University of Technology Human Research and Ethics Committee.  This was 
done to gauge the organisations’ levels of interest and potential support for the 
research project. 
Feedback from both organisations requested further information on the research 
methodology and ethical considerations whilst in-principle support for the study was 
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indicated.  A further submission to the ADEA and ADS Executive Boards was made.  
This included the research proposal which, contained the study questionnaire (pilot 
phase) version one, the Participant information sheet version one and the Curtin 
University of Technology Human Research and Ethics Committee Approval 2009 
(Appendix H).  Following their consideration of the documentation, a preparedness to 
progress support for the electronic dissemination to their memberships was 
communicated. 
During the time period in which final changes to the study questionnaire and 
transcription into the electronic format were undertaken, changes to the Executive 
Board of Management membership for both the ADEA and ADS occurred.  This in 
conjunction with further disruption to telephone, email and website functions due to 
office relocation along with staff leave resulted in a significant delay in the 
dissemination of the finalised survey.  A secondary review of the documents was 
required by the new executive members of the ADS with feedback identifying a 
requirement for a Curtin University of Technology Human Research and Ethics 
Committee Approval document that would extend past the planned survey distribution 
date (Appendix I).  A further requirement was that the information on the background 
of the study be contained within the Study invitation to ADEA and ADS members 
(version one) (Appendix J) as well as a request to place the revised Participant 
Information Sheet (version one) (Appendix K) ahead of the Study questionnaire, 
within the electronic format upon the SurveyMonkey website prior to the secondary 
approval for dissemination to the membership. 
“SurveyMonkey” is an easy-to-use web based tool for the creation of online 
surveys (SurveyMonkey, 2009).  Its primary strength is its interface with the Statistical 
Package for Social Sciences (SPSS), which enabled the electronic collection and 
transport of study participants’ data into the SPSS program for further analysis.  Given 
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a page word limit constraint within the SurveyMonkey format and mindful of the need 
to meet the ADS requirements to keep information succinct for the survey respondents, 
further amendments to the Study invitation to ADEA and ADS members (version two) 
were necessary (Appendix L), with a final decision made to keep the format of the 
Participant Information sheet (version two) the same for distribution to both the ADEA 
and ADS membership via the SurveyMonkey website, (Appendix M). 
The ADEA membership was the first to receive the invitation posted on the 
ADEA member only Webpage on May 17th, 2010; however a limited response to the 
questionnaire, of 2 members within the first seven days, was received.  A further 
request of the ADEA administration to distribute an individual invitation to members 
via emailed newsletter resulted in an improved response rate totalling 117 members by 
June 6th.  Another notice of the survey extension to July 1st was posted on the 
members’ website with a further 23 member responding to the questionnaire.  Three 
further ADEA members accessed the questionnaire past this date, due to delayed 
closure of the SurveyMonkey collector for the ADS members. 
The ADS members received their invitation via an emailed newsletter on June 
2nd, 2010, which resulted in five responses in the first five days.  Communication with 
the ADS administrative staff informed them of the poor response with a further request 
for the distribution of an individual invitation to the membership via email in 
additional to an ADS Webpage link to the survey.  However, feedback from the ADS 
executive informed this was rejected in favour of a second invitation, within the 
electronic newsletter distributed to the membership on August 5th, 2010 (Appendix 
N).  The outcome remained limited to a total response rate of 13 participants received 
by the extended survey closure date of August 22nd, 2010.  As a result of 
administrative factors, outside of the control of the researcher, the combined survey of 
the sample populations from the planned four week survey period was extended.  
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Closure of the online questionnaire occurred on 17th September, 2010.  The date of the 
last survey response was September 11th, 2011. 
 
Data analysis 
The data collected was analysed using the Statistical Package for Social Sciences 
(SPSS), version 20.  Percentages and frequencies with measures of central tendency 
and variability where appropriate were calculated, with percentage rates rounded and 
reported to the first decimal place.  Cross tabulations and Pearson’s Chi-Square Tests 
were used to determine the relationships between categorical variables, for example, 
health professional groups’ oral health education and their recommendations for 
patient care in practice.  In addition parametric tests, t-test and ANOVAs were used on 
normally distributed data to seek relationships between demographics and nominal 
data.  Where assumptions of normality were not met, the non-parametric equivalents 
Mann-Whitney U Tests and Spearman’s Rank-Order Correlation Tests were utilised to 
measure differences between and amongst subgroups of the sample.  In addition, the 
internal reliability of the instrument was assessed.  Tables were used as appropriate to 
illustrate the data. 
 
Ethical considerations 
Permission to conduct this study was sought from the Human Research Ethics 
Committee at Curtin University of Technology.  In addition, support for the project 
was gained from the ADEA and ADS executive boards with consideration of the 
research proposals undertaken by their respective research committees. 
This project adhered to the NHMRC guidelines for the ethical conduct in research 
involving humans (2007a, 2007b).  The study was considered to be minimal risk; as no 
harm was expected to any participants.  Completion of the electronic questionnaire was 
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considered implied consent.  Participants were not coerced into participation through 
inducements nor payments.  Personal identification details were not required and the 
information obtained remains anonymous.  Storage of data will be maintained for a 
period of five years in a locked file at the home of the researcher. 
In summary, this chapter described the advantages and disadvantages of the cross-
sectional research design used to survey the Australian diabetes health service 
professionals via the ADEAS and the ADS.  The sampling method for this study was a 
convenience sample of members who completed the questionnaire developed by the 
researcher from an extensive literature review, mapping of clinical evidence-based 
guidelines from appropriate sources and the research objectives guiding the study.  A 
description of the questionnaire parts as well as the individual questions was provided, 
along with the explanation of amendments made to the instrument as a result of the 
pilot phase testing prior to its implementation within the main study.  Finally the 
statistical analysis undertaken on the data acquired was detailed, as were the ethical 
considerations in undertaking the study.  In the following chapter, the results of the 
study are detailed 
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Chapter 4:  Results of the Study 
 
This chapter presents the findings of the study against the three study objectives.  
It identifies the socio-demographic characteristics of the sample population of 
Australian DHPs and the patient population they manage.  It measures the level of the 
participants’ knowledge of diabetes and oral health complications, and describes their 
scope of practice in regard to the intervention, health promotion and management of 
oral health complications in the person with diabetes.  Along with this is the 
identification of the driving and restraining forces influencing the DHPs’ decision 
making practices that impact upon the level of intervention and preventative care 
implemented for their patients experiencing oral health problems. 
 
Initial analysis 
Statistical analysis performed on the data used a significant level of alpha < 0.05 
for all tests.  The results of the univariate tests are presented first.  The Kolmogorov-
Smirnov Statistic (with Lilliefors Correction) was used to test the assumption of 
normality for all variables prior to the undertaking of bivariate analyses.  Where this 
was significant (p <0.05), indicating the violation of the assumption of a normal 
distribution, a logarithmic transformation of data was undertaken.  Despite the attempts 
at transformation using natural logarithm, logarithm to the base 10, and adjustment 
using the square root of the skewed variables, the normality of variables remained 
inconsistent and therefore inconclusive.  The inconsistency was particularly true for 
the professional categories and the items’ levels of confidence.  Thus, as recommended 
by Bland (2005), the non-parametric Mann-Whitney U Test and Spearman’s Rank 
Correlation Test were employed for outcomes.  The data test statistics are herein 
reported against the probability value < 0.05 two tailed unless otherwise indicated. 
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Sample response rate 
Participants were sought from the membership of ADS and ADEA.  The ADS and 
ADEA clinical practitioner membership for 2007-2008 was 404 and 1473 respectively.  
From this membership, 153 members (8.2%) responded to the electronic invitation to 
participate by accessing the online questionnaire.  This low response rate is a 
recognised limitation of this study and the results obtained should be interpreted with 
caution. 
The questionnaire was organised in an a priori manner to retain the respondents’ 
interest and to achieve a high completion rate.  Given the potential for clinical practice 
diversity among participants, it was considered necessary to limit the number of items 
which were not applicable.  As a result, on four occasions participants were directed to 
skip subsequent items that were not relevant to their situation and to proceed to the 
next section of the questionnaire.  This, along with the unexplained attrition of 21 
participants at various stages of the survey, accounts for the change in the number of 
survey responses noted across the survey data. 
Furthermore, 12.4% (n = 19) of participants indicated they did not undertake 
assessment or screening of oral health status as part of the diabetes management.  At 
this point, these individuals were advised that they had completed the survey and were 
asked to submit their responses. 
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Socio-demographic characteristics of the participants 
Professional membership.  Of the 153 participants, just over 90% were members 
of the ADEA with the remainder being members of the ADS.  Nearly three-fourths of 
participants were credentialled by their organisations, as detailed within Table 4.1.  
The professional representation included 123 diabetes nurse educators, 10 
endocrinologists and 6 dietitians.  The remaining nine participants identified 
themselves as endocrinology trainees, diabetes nurse practitioners, podiatrist, oral 
health therapist, university nursing academic, and Registered Nurses with dual 
professional roles, one of which was within the area of diabetes care. 
 
Work location and setting.  The work location, setting and roles performed in 
diabetes care varied among the sample.  The majority of participants were from 
Victoria (30.1%) and New South Wales (20.3%), with the least representation from the 
Australian Capital Territory (2.6%) and Northern Territory (2.0%).  The greatest 
proportion worked within a public hospital (43.1%), community health centre (20.9%) 
and the general practice setting (11.1%).  Analysis via a Pearson Chi–Square Test did 
not find a significant preference among the participants for a primary employment 
setting across the various States and Territories (see Table 4.2).
Table 4.1 
Professional Membership Status of Participants 
Professional membership status Frequency Percent 
Organisational membership 
Australian Diabetes Society 13 8.5 
Australian Diabetes Educators Association 140 91.5 
Credentialed status   
Currently credentialled 113 73.9 
Not credentialed 40 26.1 
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Table 4.2 
Descriptive Statistics for Participants’ Primary Employment Setting by Australian State or Territory 
Participants’ primary employment setting Australian State and Territories Total NT ACT NSW VIC QLD SA TAS WA 
Private practice  
Frequency 0 2 5 2 0 2 1 1 13 
% work in private practice setting 0.0 15.4 38.5 15.4 0.0 15.4 7.7 7.7 100 
% of setting within Australian State or Territory 0.0 50.0 16.1 4.3 0.0 14.3 4.3 5.9 8.5* 
General practice  
Frequency 1 0 4 8 0 1 1 2 17 
% work in general practice setting 5.9 0.0 23.5 47.1 0.0 5.9 5.9 11.8 100 
% of setting within Australian State or Territory 33.3 0.0 12.9 17.4 0.0 7.1 4.3 11.8 11.1* 
Public hospital   
Frequency 1 1 13 15 5 6 18 7 66 
% work in public hospital setting 1.5 1.5 19.7 22.7 7.6 9.1 27.3 10.6 100 
% of setting within Australian State or Territory 33.3 25.0 41.9 32.6 33.3 42.9 78.3 41.2 43.1* 
Private hospital   
Frequency  0 0 0 1 1 2 1 1 6 
% work in private hospital setting 0.0 0.0 0.0 16.7 16.7 33.3 16.7 16.7 100 
% of setting within Australian State or Territory 0.0 0.0 0.0 2.2 6.7 14.3 4.3 5.9 3.9* 
Community health centre  
Frequency 0 1 5 13 5 2 1 5 32 
% work in community health centre setting 0.0 3.1 15.6 40.6 15.6 6.2 3.1 15.6 100 
% of setting within Australian State or Territory 0.0 25.0 16.1 28.3 33.3 14.3 4.3 29.4 20.9* 
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Note. *Total percentage of participants across all Australian States and Territories working within the primary employment setting.   
 
 
 
 
 
 
 
 
 
 
 
Table 4.2 Continuation 
Descriptive Statistics for Participants’ Primary Employment Setting by Australian State or Territory 
Participants’ primary employment setting 
Australian State and Territories 
Total NT ACT NSW VIC QLD SA TAS WA 
Other primary setting  
Frequency 1 0 4 7 4 1 1 1 19 
% work in other primary setting 5.3 0.0 21.1 36.8 21.1 5.3 5.3 5.3 100 
% of setting within Australian State or Territory 33.3 0.0 12.9 15.2 26.7 7.1 4.3 5.9 12.4* 
Total   
Frequency of all primary employment settings 3 4 31 46 15 14 23 17 153 
% of all primary employment settings 2.0 2.6 20.3 30.1 9.8 9.2 15.0 11.1 100 
% of all settings within Australian State or Territory  100 100 100 100 100 100 100 100 100 
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Of the 19 participants who indicated an ‘Other’ primary employment setting, the 
descriptions offered for this category included: Aboriginal health services, correctional 
health facility, non-Government and not-for-profit organisations, Divisions of General 
Practice, community nursing agencies, rural and remote area health services, 
residential aged care facilities, diabetes clinical trials, university, and private mobile 
diabetes service.  This illustrates the diverse clinical settings in which DHPs practice.  
The descriptive statistics for these ‘Other’ responses may be located within Appendix 
O. 
 
Work experience within diabetes care management.  Within the sample 69.3% 
(n = 106) of participants indicated they worked solely in diabetes care with a further 
22.2% (n = 34) stating they did not.  The remaining 8.5% (n = 13) indicated a working 
role that, while not the primary focus, included diabetes care.  These included a 
lecturer working within the tertiary education setting, along with those who practice 
clinically within endocrinology, internal and general medicine, and endocrine nursing.  
Furthermore, roles in areas such as lifestyle modification programs for diabetes 
prevention, chronic disease self-management programs, medication management, 
cardiac rehabilitation programs, general practice nursing, and private practice nursing 
where eighty percent of the clientele had diabetes, were identified.  A Registered 
Nurse, and a Dietitian who also managed clients with conditions other than diabetes 
such as coeliac disease, obesity, coronary health, and malnutrition, identified part-time 
roles.  This data indicates DHPs in these roles, while not primarily working in the area 
of diabetes management, have significant input into the care of people who live with 
diabetes.  It would appear that these DHPs were in a position to perform an assessment 
for diabetes related oral health complications or otherwise, advocate for oral health 
service delivery to these patients. 
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The ‘years of experience’ data were collected from 119 individuals (77.8%) who 
worked specifically with people living with diabetes.  The 34 individuals (22.2%) who 
identified working within a generalised health care area were not required to answer 
this question.  Overall most DHPs working solely in diabetes care were concentrated in 
the 1-5, 6-10 and 11-15 year categories detailed in Table 4.3.  These year categories 
were also reflected by those participants who identified having work roles that were 
not solely within diabetes specific care management, yet were qualified and whose 
clinical practice overlapped into caring for people living with diabetes.  They are 
identified in the column labelled ‘Other’ within Table 4.3. 
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Table 4.3 
Descriptive Statistics for Participants’ Experience in Diabetes Care Management 
Years of experience in diabetes care Work solely in diabetes care  Yes Other Total 
< 1 year (4.2%) 
Frequency 5 0 5 
% with <1 year experience 100.0 0.0 100 
% working solely in diabetes care 4.7 0.0  
1 - 5 years (26.9%) 
Frequency 27 5 32 
% with 1-5 years experience  84.4 15.6 100 
% working solely in diabetes care 25.5 38.5  
6 - 10 years (26.1%) 
Frequency 28 3 31 
% with 6-10 years experience  90.3 9.7 100 
% working solely in diabetes care 26.4 23.1  
11 - 15 years (23.5%) 
Frequency 24 4 28 
% with 11-15 years experience 85.7 14.3 100 
% working solely in diabetes care 22.6 30.8  
16 - 20 years (11.8%) 
Frequency 13 1 14 
% with 16-20 years experience  92.9 7.1 100 
% working solely in diabetes care 12.3 7.7  
21 - 25 years (4.2%) 
Frequency 5 0 5 
% with 21-25 years experience  100.0 0.0 100 
% working solely in diabetes care 4.7 0.0  
> 25 years (3.4%) 
Frequency 4 0 4 
% with < 25 years experience  100.0 0.0 100 
% working solely in diabetes care 3.8 0.0  
Total  
Frequency 106 13 119 
% within all years of experience  89.1 10.9 100 
% working solely in diabetes care 100.0 100.0  
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Of those participants who identified working solely in diabetes care, the majority 
(48.1%, n = 51) worked within a public hospital, 20.8% (n = 22) within a community 
health centre, 9.4% (n = 10) within GP practices, 7.5% (n = 8) within private practice, 
and 2.8% (n = 3) within a private hospital setting.  A further 11.3% (n = 12) identified 
working within an ‘Other’ setting as outlined previously and within Appendix O.  To 
examine if there was a relationship between those participants who work solely in 
diabetes care and the length of experience in the area, the data for those variables were 
analysed using the Pearson’s Chi-Square Test.  The findings were not statistically 
significant. 
 
Management of the patient population according to age.  Participants were 
asked to nominate age groupings for the people whose diabetes care they managed.  
Ninety-six percent of participants in the survey (n = 150) categorised the management 
of their patient population across the age continuum from “Least” to “Most managed” 
or, otherwise indicated they did not work with patients within the age category.  The 
frequency and percentage rates for patient populations by age group categories are 
detailed within Table 4.4. 
 
Table 4.4 
Descriptive Statistics for Participants’ Management of Diabetes Patient Population 
by Age Group 
Management Status 
Age Group 
Paediatric Adolescent Adult 
n % n % n % 
Most managed 8 5.2 4 2.6 143 93.4 
Second most managed 7 4.6 104 68.0 2 1.3 
Least managed 40 26.1 7 4.6 3 2.0 
Do not see 95 62.1 35 22.8 2 1.3 
Not answered  3 2.0 3 2.0 3 2.0 
Total 153 100.0 153 100.0 153 100.0 
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Management of patients from groups with more specific management needs 
or who are socially isolated.  Within the survey, participants were asked to identify 
whether they worked with patients who were from a range of special needs groups.  
These groups reflect individuals who may have more specialised diabetes education 
and management needs or, were limited in their access to oral health services due to 
social isolation.  A total of 145 participants (94.8%) indicated that they indeed worked 
with the patient groups identified.  In addition, three participants acknowledged 
working with patients within the ‘Other’ option.  The frequencies and percentage rates 
for each of the nominated patient groups are described in Table 4.5. 
 
Education in diabetes related oral health complications 
To achieve the first objective of this study, which was to assess the Australian 
DHPs’ levels of knowledge of oral health issues impacting on the persons with 
diabetes, the participants were asked to identify their prior education in diabetes and 
oral health complications.  This section, which formed Part 2 of the questionnaire, was 
completed by 96.1% (n = 147) of participants.  Included items sought to determine the 
Table 4.5 
Descriptive Statistics of Special Needs Patient Groups Seen by Participants 
Client Group Frequency % of n,a 
Patients from culturally and linguistically diverse 
backgrounds 114 76.0 
Physically and intellectually disabled 107 71.3 
Pregnant women 102 68.0 
Aboriginal or Torres Strait Islander people 94 62.7 
Residential Aged Care clients 79 52.7 
Rural and/or Remote communities  64 42.7 
Clients within secure facilities 41 27.3 
None of the above patients seen 5 3.3 
Other 3 2.0 
Aged care in the home 
Mental illness 
War Veterans 
Note. na = percentage of total, n = 145 
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manner in which education may have been delivered; part of a structured formal course 
or through self-directed learning.  If the respondents answered in the negative, they 
were advised to skip two questions which were not applicable.  This in part accounts 
for the variation in the total numbers of participants seen in the results across this 
section.  Furthermore, the responses from these health professionals were categorised 
into three defined groups: endocrinologists, diabetes educators, and allied health 
professionals.  This was to enable data analysis within and between groups.  Table 4.6 
illustrates the frequencies and percentages for each professional group within the items 
which identified the form of education in diabetes and oral health complications that 
had been undertaken.  
Of those participants who recalled receiving education in oral health complication 
as part of their professional education course, the greatest proportion was diabetes 
educators (40.0%), followed by allied health professionals (20%), and endocrinologists 
indicating the least (16.7%).  A slightly larger percentage of participants within the 
allied health professional (60%) and diabetes educator (55.2%) groups identified 
having attended an education session on diabetes related oral health complications 
either within the last five years or greater than five years prior, in comparison to the 
endocrinologist group (41.7%) who recalled diabetes and oral health complication 
education occurring only within the last five years.  Those participants (n = 80) who 
had attended an education session were asked to further identify the form in which this 
education was delivered.  This included 39% (n = 59) attending a professional 
association session and only 9.2% (n = 14) having the information delivered at an in-
service session.  Others received the information at a university (3.9%, n = 6) and at an 
industry sponsored seminar (1.3%, n = 2).  A further 1.3% (n = 2) of respondents 
identified a presentation by either a dental care company representative or a medical 
registrar as the ‘Other’ form of education received. 
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One-third of participants (n = 49) reported undertaking diabetes and oral health 
self-directed learning.  A comparison of the results among the professional groups 
indicated the endocrinologists showed greater initiative (41.7%) than diabetes 
educators (33.9%) and allied health professionals (20%) in respect to this.  The forms 
used to acquire the extra knowledge for the most part involved journals (19.6%, n = 
30).  To a lesser extent the use of web-based instructional modules (2.6%, n = 4), core 
textbooks (1.3%, n = 2), or a combination of all/most of these (7.2%, n = 11) were 
reported.  A further 3.9% (n = 6) identified ‘Other’ forms of self-education.  The 
descriptive statistics for the responses obtained may be located within Appendix P.
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Table 4.6 
Descriptive Statistics for Participants’ Education in Diabetes and Oral Health Complications by Professional Category 
Education form undertaken 
Endocrinologist Diabetes Educator Allied Health Professional 
n %a %b n %a %b n %a %b 
Oral health complications covered in professional education 
Yes 2 3.7 16.7 50 92.6 40.0 2 3.7 20.0 
No 10 19.2 83.3 36 69.2 28.8 8 11.5 60.0 
Cannot recall 0 0 0 39 95.1 31.2 2 4.9 20.0 
Total 12 8.2 100.0 125 85.0 100.0 10 6.8 100.0 
Attended education session on diabetes and oral health complications 
No 7 10.4 58.3 56 83.6 44.8 2 6.0 40.0 
Yes, in last 5 years 5 7.6 41.7 58 87.9 46.4 3 4.5 30.0 
Yes, more than 5 years ago 0 0 0 11 78.6 8.8 3 21.4 30.0 
Total 12 8.2 100.0 125 85.0 100.0 10 6.8 100.0 
Undertaken self-directed learning 
No  7 7.2 58.3 82 84.5 66.1 8 8.2 80.0 
Yes  5 10.2 41.7 42 85.7 33.9 2 4.1 20.0 
Total 12 8.2 100.0 124 84.9 100.0 10 6.8 100.0 
Note. %a = Percentage of professional group identified within the oral health educational sub-category, %b = Professional group proportion within specified educational category. 
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Education undertaken across the professional categories.  To examine the 
statistical relationship between the variables ‘professional categories’ and ‘education’, 
the Pearson Chi-Square Test was employed.  The findings indicated a statistically 
significant association between the categories of health professionals and the receipt of 
diabetes related oral health education within their professional course (χ² [4, n = 147] 
= 17.546, p = 0.002).  However, this result should be viewed with caution given the 
small sample size obtained within the endocrinologist and allied health professional 
categories.  For this reason the Fisher’s Exact Test statistic was consulted, this 
provided very strong evidence of an association (χ² = 15.874, p = 0.001). 
The data results from the Pearson Chi-Square analyses of the associations between 
the individual health professional groups and their attendance at an education session, 
along with the undertaking of self-directed learning in diabetes and oral health 
complications were not found to be statistically significant.  A final Pearson Chi-
Square analysis of the association between the professional categories and their 
undertaking of diabetes related oral health education via a combination of delivery 
methods were also not found to be statistically significant. 
 
Extent of knowledge of diabetes related oral health complications 
To ascertain the level of knowledge of diabetes related oral health complications, 
participants (n = 147) were asked to categorise their knowledge of an association of 
diabetes with a grouping of known oral problems.  On three occasions false options 
were included within the question item as a means to determine whether participants 
had carefully considered the information and expressed their knowledge accurately.  
Participants correctly acknowledged an association of diabetes with the following 
conditions: gingivitis (94.6%), periodontitis (85.0%), dental caries (84.4%), 
candidiasis (81.0%), xerostomia (72.1%), and mouth ulcers (69.4%). 
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While none of the proposed diabetes associated oral health problems were rejected 
outright, the three false conditions (oral cancerous lesions, excessive salivation and 
dysphagia), did have a larger ‘No’ count than those of the actual conditions.  The 
largest number of ‘Don’t know’ responses, which indicated participants’ lack of 
knowledge of an association with diabetes, was for lichen planus (76.9%), glossodynia 
and stomatopyrosis (77.6%), oral neurosensory dysesthesia (72.8%), and taste 
impairment (51%).  This was in addition to the false conditions: oral cancerous lesions 
(68%), excessive salivation (61.2%), and dysphagia (50.3%).  This indicates a lack of 
knowledge of diabetes associated oral health problems in the participants who 
responded in this manner.  Relevant descriptive statistics are detailed in Table 4.7. 
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Table 4.7 
Descriptive Statistics of Participants’ Knowledge of an Association Between Diabetes and Oral Health Problems With the Receipt of Education 
 
Oral health problem 
With any oral health education 
undertaken  
Knowledge of association with diabetes Chi-Square with Fisher’s Exact 
Test Statistic Yes No Don't know 
n % n % n % χ²(n = 147, df = 2) 
Asymp. Sig* 
(two-tailed) 
Glossodynia and Stomatopyrosis 29 19.7 4 2.7 114 77.6 0.718 0.770 
Education - Yes 24 21.1 3 2.6 87 76.3   
Education - No 5 15.2 1 3.0 27 81.8   
Candidiasis 119 81.0 2 1.4 26 17.7 6.640 0.310 
Education - Yes 97 85.1 2 1.8 15 13.2   
Education - No 22 66.7 0 0 11 33.3   
Dental caries 124 84.4 7 4.8 16 10.9 4.356 0.113 
Education - Yes  99 86.8 6 5.3 9 7.9   
Education - No 25 75.8 1 3.0 7 21.2   
Gingivitis 139 94.6 1 0.7 7 4.8 0.810 0.733 
Education - Yes 108 94.7 1 0.9 5 4.4   
Education - No 31 93.9 0 0 2 6.1   
Mouth ulcers 102 69.4 4 2.7 41 27.9 0.982 0.669 
Education - Yes 81 71.1 3 2.6 30 26.3   
Education - No 21 63.7 1 3.0 11 33.3   
Lichen planus 29 19.7 5 3.4 113 76.9 0.598 0.843 
Education - Yes 24 21.1 4 3.5 86 75.4   
Education - No 5 15.2 1 3.0 27 81.8   
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Note. *P <0.05 
Table 4.7 (continuation)  
 
Oral health problem 
With any oral health education 
undertaken  
Knowledge of association with diabetes Chi-Square with Fisher’s Exact 
Test Statistic Yes No Don't know 
n % n % n % χ²(n = 147, df = 2) 
Asymp. Sig* 
(two-tailed) 
Oral neurosensory dysesthesia 37 25.2 3 2.0 107 72.8 2.704 0.277 
Education - Yes 32 28.1 2 1.8 80 70.2   
Education - No 5 15.2 1 3.0 27 81.8   
Oral cancerous lesions 9 6.1 38 25.9 100 68.0 0.501 0.889 
Education - Yes 8 7.0 29 25.4 77 67.5   
Education - No 1 3.0 9 27.3 23 69.7   
Periodontitis 125 85.0 2 1.4 20 13.6 2.302 0.283 
Education - Yes 99 86.8 2 1.8 13 11.4   
Education - No 26 78.8 0 0 7 21.2   
Excessive salivation 17 11.6 40 27.2 90 61.2 4.177 0.115 
Education - Yes 11 9.6 35 30.7 68 59.6   
Education - No 6 18.2 5 15.2 22 66.7   
Taste impairment 56 38.1 16 10.9 75 51.0 0.866 0.715 
Education - Yes 43 37.7 14 12.3 57 50.0   
Education - No 13 39.4 2 6.1 18 54.5   
Xerostomia 106 72.1 4 2.7 37 25.2 0.958 0.660 
Education - Yes 84 73.7 3 2.6 27 23.7   
Education - No 22 66.7 1 3.0 10 30.3   
Dysphagia 28 19.0 45 30.6 74 50.3 0.222 0.932 
Education - Yes 21 18.4 35 30.7 58 50.9   
Education - No 7 21.2 10 30.3 16 48.5   
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The Pearson’s Chi-Square with Fisher’s Exact Test was used to investigate the 
relationship of diabetes related oral health education upon the participants’ ability to 
correctly identify signs and symptoms of oral health issues.  Results, displayed in 
Table 4.7, indicate a single significant association between the participants who had 
undertaken combined forms of education, with the ability to identify candidiasis as 
being associated with diabetes (χ² [2, n = 147] = 6.640, p = .03).  As a result, further 
analysis of the association between participants’ diabetes related oral health education, 
in each of its forms and the ability to correctly identify diabetes related oral health 
problems was undertaken.  The data shown in Table 4.8 indicates statistically 
significant results in the category of self-directed learning with the oral health 
problems: glossodynia/stomatopyrosis (χ² [2, n = 146] = 7.280, p = .020), candidiasis 
(χ² [2, n = 146] = 8.227, p = .007), and dental caries (χ² [2, n = 146] = 6.727, p = .033).  
No other statistically significant associations were found. 
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Table 4.8 
Chi-Square With Fisher’s Exact Test Statistics for Knowledge of an Association Between Diabetes and Oral Health Problem by Type of Education 
Oral health problem 
 
Type of diabetes and oral health education (n =146) 
In Professional course Attended session Self-directed learning 
   
 χ²(n = 147, 
df = 2) 
Asymp. Sig* 
(two-tailed) 
χ²(n = 147, 
df = 2) 
Asymp. Sig* 
(two-tailed) 
χ²(n = 146, 
df = 2) 
Asymp. Sig* 
(two-tailed) 
Glossodynia and Stomatopyrosis 5.949 0.161 4.461 0.332 7.280 0.020
* 
Candidiasis 3.152 0.509 4.041 0.390 8.227 0.007
* 
Dental caries 1.216 0.913 6.469 0.128 6.727 0.033
* 
Gingivitis 4.786 0.238 5.588 0.184 4.181 0.096 
Mouth ulcers 4.205 0.357 4.869 0.275 1.359 0.562 
Lichen planus 2.546 0.652 3.790 0.384 0.666 0.725 
Oral neurosensory dysesthesia 3.769 0.419 6.063 0.152 5.151 0.077 
Oral cancerous lesions 4.528 0.335 6.626 0.134 5.840 0.049
* 
Periodontitis 1.258 0.977 5.803 0.158 1.141 0.573 
Excessive salivation 6.271 0.176 6.556 0.145 2.655 0.276 
Taste impairment 4.972 0.292 0.985 0.935 2.662 0.283 
Xerostomia 3.695 0.433 2.948 0.533 2.106 0.372 
Dysphagia 1.948 0.757 5.091 0.276 0.314 0.844 
Note. *P <0.05 
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Acknowledgement of risk for oral health complications in people with diabetes 
The final question of participants within this section was to quantify whether there 
was awareness of the potential for oral health complications in people with diabetes in 
the absence of other diabetes related complications.  The low mean score (M = 1.80, 
SD ± 1.059, 95% CI = 1.62, 1.97) from the potential score range of 1 to 5 (‘Strongly 
disagree’ to ‘Strongly agree’) indicates that the participants did not agree with the 
item, “The significance of an increased risk of oral health problems in people with 
diabetes was only relevant if the patient had been diagnosed with another diabetes 
related complication”. 
 
Diabetes and oral health complications:  Scope of practice and efficacy 
In accordance with the second objective of this study, the participants’ scope of 
practice was explored.  This related specifically to the level of confidence to assess 
patients’ oral health signs and symptoms.  The participants’ decision making, 
especially if the patient presented with signs of other diabetes related complications, 
was investigated.  Also determined were their levels of likelihood to undertake 
diabetes related oral complication management and their levels of confidence to 
provide information to patients. 
 
Levels of confidence in assessment of oral health signs and symptoms and 
provision of diabetes related oral health information.  As shown in Table 4.9, the 
low mean scores for all three variables, out of a potential range of 1 to 5 (‘Not 
confident’ to ‘Very confident’ or ‘Highly unlikely’ to ‘Highly likely’), indicate the 
participants did not perceive they were confident in either assessing oral health signs or 
symptoms or providing diabetes related oral health information.  They were less likely 
to investigate dental problems if the patient had other complications related to their 
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diabetes.  Overall there appeared a slightly higher level of confidence among 
participants to provide diabetes related information to patients than to assess for signs 
and symptoms of oral health problems at a consultation. 
Note. n = 144 
 
The impact of education upon levels of confidence.  Statistical analysis of the 
impact of education in diabetes related oral health problems upon the clinical practice 
by the respondents was undertaken.  A Pearson Chi-Square with Fisher’s Exact Test 
analysis indicated that overall participants’ levels of confidence to assess the oral signs 
and symptoms in people with diabetes was not significantly associated with their level 
of education (χ² [4, n = 144 ] = 6.479, p = .144).  However, a very strong association 
was detected among the participants who undertook combined forms of diabetes 
related oral health education and an increased level of confidence to provide oral 
health information to patients (χ² [4, n  = 144] = 21.737, p = .000). 
The Mann-Whitney U Test indicated a significant difference (U = 1361.500, z = -
2.330, p = .020) in participants’ levels of confidence to assess oral health signs and 
symptoms between those who had (Mean rank = 76.73, n = 111) and had not (Mean 
rank = 58.26, n = 33) undertaken diabetes related oral health education.  A statistically 
significant difference (U = 929.500, z = -4.452, p = .000) was also detected in the 
levels of confidence to provide diabetes related oral health information to patients, 
Table 4.9 
Descriptive Statistics for Participants’ Levels of Likelihood and Confidence in 
Assessment of Oral Health Status and Provision of Diabetes Related Oral Health 
Information 
Questionnaire item  Mean SD 95% CI 
Confidence in assessing oral health signs 
and symptoms in people with diabetes 2.37 1.043 [2.20, 2.54] 
Confidence in providing diabetes related 
oral health information 2.91 1.064 [2.73, 3.08] 
Likelihood to investigate dental problems 
if patient has other diabetes related 
complications 
2.83 1.317 [2.62, 3.05] 
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between those who had undertaken education (Mean rank = 80.63, n = 111) and those 
who had not (Mean rank = 45.17, n = 33). 
A further comparison, using the Pearson Chi-Square with Fisher’s Exact Test, 
between the professional groups, detected a statistically significant association (χ² [4, n 
= 122] = 23.807, p  = .000) between the category of diabetes educators who had 
undertaken education and their increased levels of confidence to provide diabetes 
related oral health information to patients.  However, the association between the 
diabetes educators’ levels of confidence to assess the oral health signs and symptoms 
in patients and the undertaking of education was found not to be statistically significant 
using Pearson Chi-Square with Fisher’s Exact Test (χ² [4, n = 122] = 7.731, p = .080).  
No statistically significant associations were detected between the endocrinologists’ 
and allied health professionals’ levels of confidence to either assess their patients for 
oral health problems or, in their provision of diabetes related oral health information 
with the undertaking of diabetes related oral health education. 
Table 4.10 shows the mean differences in levels of confidence to assess oral health 
signs and symptoms and provision of diabetes related oral health information to 
patients within the categories of endocrinologists, diabetes educators and allied health 
professionals, comparing those who had undertaken diabetes related oral health 
education, with those who had not.  A Mann-Whitney U Test indicated a statistically 
significant difference (U = 896.000, z = -2.497, p = .013) in the levels of confidence to 
assess oral health signs and symptoms among the category of diabetes educators.  This 
suggests those who had undertaken diabetes related oral health education scored higher 
(Mean Rank = 65.57, n = 95) than their colleagues who had not undertaken this 
education (Mean Rank = 47.19, n = 27).  Even stronger evidence for a statistically 
significant difference (U = 558.000, z = -4.643, p = .000) in the levels of confidence to 
provide diabetes related oral health information to patients by the participants in the 
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diabetes educator category existed.  The results show those diabetes educators who had 
undertaken diabetes related oral health education rated their confidence levels higher 
(Mean Rank = 69.13, n = 95) than their colleagues who had not undertaken this 
education (Mean Rank = 34.67, n = 27). 
While both endocrinologist and allied health professionals who had undertaken 
diabetes related oral health education ranked higher in their levels of confidence to 
assess diabetes related oral health signs and symptoms, and to provide diabetes related 
oral health information, than their colleagues who had not undertaken this education, 
analysis of the differences within the Mann-Whitney U Test were not statistically 
significant.  In addition, results indicate that endocrinologists felt more confident to 
assess their patients’ signs and symptoms of oral health problems than to provide 
diabetes related oral health information, which is in contrast to results for both the 
diabetes educators and allied health professionals.
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 Table 4.10 
Descriptive Statistics for Differences in Levels of Confidence to Assess Oral Health Signs and Symptoms, and Provide Diabetes Related 
Information Against Professional Category Education 
Professional category 
Confidence items 
Diabetes and oral health education 
Mann-Whitney U Test 
Yes No 
n Mean Mean Rank n Mean Mean Rank Z* 
Asymp. 
Sig* 
(two-tailed) 
Endocrinologists 
Assessing oral health signs and symptoms 8 2.88 6.63 4 2.75 6.25 -0.176 0.860 
Providing diabetes related oral health 
information 8 3.13 6.56 4 3.00 6.38 -0.087 0.930 
Diabetes Educators 
Assessing oral health signs and symptoms 95 2.46 65.57 27 1.93 47.19 -2.497  0.013* 
Providing diabetes related oral health 
information 95 3.11 69.13 27 2/04 34.67 -4.643  0.000
* 
Allied Health Processionals 
Assessing oral health signs and symptoms 8 2.25 5.88 2 1.50 4.00 -0.847 0.397 
Providing diabetes related oral health 
information 8 3.38 6.00 2 2.50 3.50 -1.085 0.278 
Note. *p = <0 .05. 
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DHPs’ management of patients with varied levels of risk for oral health 
complications.  The relationships between participants’ knowledge and skills in 
managing patients who were considered at greater risk for oral health complications 
was explored using the Spearman’s Rank-Order Correlation Test.  The investigation of 
the participants’ levels of agreement in recognising the potential for oral health 
problems within this patient population was considered an important indicator of their 
potential motivation to undertake additional management in the workplace.  
Furthermore, variables such as the level of likelihood to investigate patients’ 
complaints, and the levels of confidence to assess the diabetes related oral health status 
was investigated. 
There was a statistically significant correlation (r = -.269, p = .001) between the 
participants’ levels of likelihood to investigate oral signs and symptoms in the patient 
who had signs of other diabetes related complications (retinopathy, nephropathy or 
neuropathy) and their levels of agreement with the questionnaire item, “The 
significance of an increased risk of oral health problems in the person with diabetes is 
only relevant if the patient has been diagnosed with another diabetes related 
complication”.  While this association is negative, the lower levels of agreement with 
the latter statement does indicate greater acknowledgement by participants of the 
increased risk for oral health problems in all people with diabetes.  Therefore, the data 
suggests this is strongly associated with the increased levels of likelihood to 
investigate oral health problems in the patient who is at greater risk. 
In addition, statistically significant positive correlations were found between the 
participants’ likelihood to investigate patients with other diabetes related complications 
for signs and symptoms of dental problems and their levels of confidence to assess for 
oral signs and symptoms (r = .382, p = .000), and to provide diabetes related oral 
health information (r = .489, p = .000).  These results indicate the participants’ higher 
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scores for confidence in assessing oral signs and symptoms and provision of diabetes 
related oral health information were associated with the higher scores for likelihood to 
investigate oral signs and symptoms in the patient when other diabetes related 
complications exist. 
The data also detected statistically significant negative correlations between the 
participants’ levels of agreement in recognising the risk for oral health problems in the 
patient free from diabetes related complications and their levels of confidence to assess 
for oral health signs and symptoms (r = -.189, p = .024), along with the provision of 
diabetes related oral health information (r = -.241, p = .004) to these patients.  The 
results indicate the participants’ lower levels of agreement with the questionnaire item, 
“The significance of an increased risk of oral health problems in people with diabetes 
is only relevant if the patient has been diagnosed with another diabetes related 
complication” (indicating acknowledgement of the increased risk for oral health 
problems in all people with diabetes) was associated with the increased levels of 
confidence in assessing oral health signs and symptoms and provision of diabetes 
related oral health information to this group of patients also. 
 
Frequency of diabetes related oral health screening within diabetes care 
management.  Participants were asked to identify how often they would include 
assessment of oral health signs and symptoms within their screening for complications 
in persons with diabetes.  Just over half (54.9%, n = 79) identified that they either did 
not routinely perform diabetes and oral health assessments, or they never performed 
this type of assessment as they considered it to be outside of their scope of practice.  
The remaining participants’ responses (45.1%, n = 65) were relatively even in 
distribution across the remaining categories for screening frequency.  The frequency 
and percentages for the responses are outlined in Table 4.11. 
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Of those responses obtained within the ‘Other’ screening category (12.5%, n = 
18), the frequency of screening regimens have been arranged under predominant 
themes and are displayed in Appendix Q.  Most notably within these, participants 
identified screening the patient on admission to their service, which in the majority of 
cases would be upon the diagnosis of diabetes, or as part of an ongoing diabetes self-
management education programme as reflected in a participant’s statement: 
“At diagnosis and annually in non-complex type 2.  As part of annual cycle of 
care for paediatric and transitioning adolescent and non-complex type 1.  Each 
trimester during pregnancy and, biannually in complex type 2.” 
On the whole, screening of patients occurred on an ad hoc basis.  This is reflected 
in the following participants’ statements: 
“This will vary from person to person.  As part of the self-management 
education.” 
“Do not routinely include it.  To identify the cause of hyperglycaemia, will then 
ask about the oral health care, admittedly this is still infrequent.” 
A Pearson Chi-Square analysis of the association between the frequency of oral 
health screening within the diabetes care regimen and the participants’ levels of 
Table 4.11 
Descriptive Statistics for the Frequency of Oral Health Screening in Diabetes Care 
Frequency of oral health complications screening Frequency Percent 
Never, it is not within my scope of practice to perform 
diabetes and oral health assessments 
19 13.2 
Each visit 15 10.4 
Quarterly 7 4.9 
Half yearly 10 6.9 
Yearly 15 10.4 
I do not routinely perform diabetes and oral health 
assessments 
60 41.7 
Other 18 12.5 
Total 144 100.0 
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confidence to assess the oral health signs and symptoms in the patient was undertaken.  
The data suggests the existence of a statistically significant association (χ² [24, n = 
144] = 45.156, p = .006); however, a Fisher’s Exact Test statistic was unable to be 
computed.  Therefore, the data should be viewed with caution due to the small sample 
size across several of the data variables.  The data indicated the DHPs’ lower levels of 
confidence, 1 out of the possible score of 5, was strongly associated with the least 
frequent subscale item, ‘Never, it is not within my scope of practice to perform 
diabetes and oral health assessments’, and the score 2 out of 5, with the item ‘I do not 
routinely perform diabetes and oral health assessments.  In addition, the higher levels 
of confidence to assess oral signs and symptoms, 3 out of 5, were associated with the 
screening frequency subscale items ‘Yearly’ and ‘At each visit’. 
The Chi-Square Test for the association between frequency of the oral health 
screening within the diabetes care regimen and the participants’ levels of confidence to 
provide diabetes related oral health information at this consultation suggested evidence 
of a statistically significant result (χ² [24, n = 144] = 43.533, p = .009).  Again for the 
reasons of cell size and the inability to compute the Fisher’s Exact Test statistic means 
this result should be viewed with caution.  The data indicated that the lower levels of 
confidence to provide diabetes related oral health information, 2 out of 5, was strongly 
associated with the frequency subscale item ‘I do not routinely perform diabetes and 
oral health assessments’.  The higher levels of confidence, score 4 out of 5, were 
associated with both frequency subscale items, ‘Each visit’ and ‘Half yearly’ at 
consultation. 
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Oral health management practices undertaken in diabetes care.  The 19 
participants who indicated it was not within their scope of practice to perform diabetes 
and oral health complications exited the study at this point.  A further nine participants 
failed to complete this part of the questionnaire.  The participants who answered in an 
affirmative manner (n = 125) were asked to indicate the type of actions which they 
would include in their assessment of a patient with diabetes against a proposed set of 
activities.  The greatest percentage of responses (81.4%) indicated recommending the 
patient seek a dentist/periodontitis appointment for assessment and care.  Over three-
fourths of the participants identified discussing risk-related behaviours.  Slightly less 
than half of the participants either discussed preventative oral health care behaviours or 
referred the patient to a dentist if they perceived the need.  The activity that 
participants included least was the specific diabetes and oral health risk assessment 
(8%).  The frequency and percentage results are further detailed within Table 4.12 
 
  
Table 4.12 
Descriptive Statistics of Oral Health Assessment, Education and Referral Processes 
Undertaken by Participants in Practice 
Oral health care activity n % 
I recommend to the patient that they attend a dentist/periodontist 
appointment for assessment and care follow–up 92 81.4 
Discuss risk-related behaviours and outcomes upon oral health 
e.g. poor oral hygiene, smoking and glycaemic control 77 68.1 
Discuss preventative oral health care behaviour e.g. brushing, 
flossing and mouthwash use 45 39.8 
I refer to a dentist/periodontist if I perceive the need 44 38.9 
Routine oral health screening questions 30 26.5 
Specific diabetes and oral health risk assessments 9 8.0 
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Circumstances prompting investigation of patients’ oral health status.  The 
circumstances in which participants would investigate the oral health status in a patient 
with diabetes were examined.  The majority of participants (85%) indicated they would 
investigate the oral health status only when a specific oral health concern or complaint 
was identified by the patient.  Just over half of the participants stated they would 
investigate when the patient was hyperglycaemic without an identified cause.  The 
responses drawn were from a set of proposed circumstances, the results of which are 
provided in Table 4.13 
 
Given the diversity of clinical practice settings and patient populations served, an 
‘Other’ option was offered to participants to enable a comprehensive capture of the 
clinical reasoning impacting upon service delivery.  The ‘Other’ responses (n = 26) are 
categorised under predominant themes and described within Appendix R.  The 
majority of responses indicated a broad spectrum of reasoning for investigation of oral 
health which was contained within the participants’ existing diabetes service delivery 
model and largely dependent upon the initiative of the health professional as reflected 
in the following participants’ statements: 
“When newly referred to service, on their second visit or, if they have any 
complaints about their oral health.” 
“As part of an annual Team Care Arrangement referral process.” 
Table 4.13 
Circumstances Requiring Investigation of Oral Health Status in Patients 
Reasons for investigation of oral health status  n % 
Only when a specific oral health concern or complaint is 
identified by the patient  96 85.0 
When the patient is hyperglycaemic without identified cause  57 50.4 
When referred by a dentist/periodontist  37 32.7 
When the patient is pregnant or planning pregnancy  35 31.0 
‘Other’ reasons 26 23.0 
When the patient is hyperglycaemic with known cause  21 18.6 
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“General discussion of issues, but not investigated.” 
“Each person with diabetes, irrespective of glycaemic control or complications or 
if patient expressed concern.” 
Many participants identified more specific concerns for the patients’ oral health as 
a trigger for further investigation such as: 
“When I can see their teeth are in terrible condition during a conversation and 
when they ask about soft drinks.” 
“When the patient identifies issues with their ability to eat certain foods or other 
symptoms related to their teeth and gums.” 
Participants also identified concern for the impact of oral health complications 
upon the patients’ other pre-existing medical conditions as a reason to investigate their 
oral health status, as reflected in the following participants’ statements:  
“When there is known cardiovascular disease.” 
“Pre-surgery especially cardiac or osteo surgical procedures.” 
“Obviously need to think about it in relation to all cases of hyperglycaemia, 
gastroparesis and gastric reflux.” 
“Those clients who take liquid meal replacements for weight loss.” 
 
Likelihood to investigate the oral health status in patients with oral 
complaints.  The final question regarding specific management of diabetes and oral 
health complications in practice focused upon identifying the participants’ likelihood 
of taking investigative action when consulting with a patient who had an oral health 
complaint.  The participants (n = 113) were asked to indicate whether they took action, 
either affirmative or negative, against a set of proposed activities.  An opportunity for 
participants to elaborate if they undertook different investigative activities in their 
practice was provided. 
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The greatest number of responses from participants indicated likelihood to 
question patients regarding: their glycaemic control (92.9%), the frequency of dental 
care visits (91.2%), referral to the dentist/periodontist (87.6%), and the frequency of 
personal dental care activity (78.8%).  The actions that participants were least likely to 
undertake were the questioning of the patient regarding recent changes in taste 
sensations (29%) and changes to food choices in respect of flavours (27%).  The 
frequency and percentages for participants’ responses, both in the affirmative and 
negative, are detailed in Table 4.14.
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Table 4.14 
Descriptive Statistics for Participants Undertaking Oral Health Assessment Activity in Clinical Practice 
Activity type 
Activity undertaken 
Yes No 
n % n % 
Inspection of the hard and soft tissues in the mouth cavity 65 57.5 48 42.5 
Inspection of the teeth 58 51.3 55 48.7 
Note number of teeth present or missing 49 43.4 64 56.6 
Note presence of oral infections 90 79.6 23 20.4 
Note presence of oral lesions 86 76.1 23 20.4 
Document oral findings and diagnosis 74 65.5 39 34.5 
Question patient regarding glycaemic control 105 92.9 8 7.1 
Question patient regarding frequency of personal dental care activity 89 78.8 24 21.2 
Question patient regarding frequency of dental care visits 103 91.2 10 8.8 
Question patient regarding recent changes in taste sensation 29 25.7 84 74.3 
Question patient regarding recent changes to food choices in respect of flavours 27 23.9 86 76.1 
Question patient regarding oral medication intake 78 69.0 35 31.0 
Question patient regarding level of hydration 82 72.6 31 27.4 
Question patient regarding referral to dentist/periodontist 99 87.6 14 12.4 
Other actions undertaken 23 15.0 130 85.0 
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The responses received within the ‘Other actions undertaken’ option were again 
categorised under predominant themes and are fully described within Appendix S.  A 
large portion of the responses indicated questioning the patient further in regard to 
their medical history, i.e., whether a current smoker, a history of bulimia or induced 
vomiting, food allergies, dietary restriction, and therapies/medications the patient has 
utilised in an attempt to resolve the condition.  Only two participants indicated they 
would provide the patient an educational resource on dental care. 
Initial medical management was undertaken by one participant (an endocrine 
registrar) who identified the following: 
“Prescribe antibiotics if needed, review insulin/medication doses and consider 
salivary replacement therapies.” 
However, the majority of responses identified referring the patient to either the 
General Practitioner and/or, where services were available, a dentist for management 
as reflected in the following participant’s statement: 
“If the problem is acute I would refer them to their GP for medical assessment.  I 
would not do a detailed oral inspection/assessment but refer on to a Dentist/GP 
for this assessment and management.” 
A limitation in access to dental services was identified as an issue for DHPs within 
rural and remote locations.  This required a different approach in participants’ 
management in order to achieve appropriate patient care as reflected in the following 
statement: 
“There is not a referral pathway in my area to refer to a Dentist or Periodontist; 
therefore, I would involve the GP in getting the referral done especially if the 
client has financial constraints.” 
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Levels of concern for signs of oral health problems identified in patients with 
oral health complaints.  Participants were asked to consider a practice scenario in 
which they were required to conduct an assessment of a patient’s oral cavity following 
his/her complaint of oral health symptoms.  Participants were asked to rate, on a scale 
of 1 to 5, their levels of concern for the presentation of signs and symptoms identified 
during this assessment.  As shown in Table 4.15, the mean scores for each oral health 
complaint items were between 3.48 and 4.53.  This indicated the participants’ rated 
their levels of concern upon the Likert scale as predominately mid-scale, i.e., 
undecided whether they were concerned or not, or higher, indicating they were 
moderately concerned at their findings during the assessment. 
 
Impact of education in diabetes related oral health complications upon 
participants’ levels of concern for patients’ oral health complaints.  The 
association between the participants’ levels of concern, from a possible range of 1 to 5, 
for patients’ complaints of oral health problems and the undertaking of education in 
diabetes related oral health complications was examined using the Chi-Square with 
Fisher’s Exact Test.  The associations of each subscale item with each of the 
educational forms, part of the professional course, attendance at a session or self-
directed learning was undertaken.  Statistically significant associations were detected 
between the category of self-directed learning and the oral health complaints of: 
Table 4.15 
Descriptive Statistics for Participants’ Level of Concern for Patients’ Oral Health 
Complaint 
Oral health complaint (n = 113) Mean SD 95% CI 
Bleeding gums when brushing 3.97 0.949 [3.80, 4.15] 
Loose teeth 4.31 0.917 [4.14, 4.48] 
Changes in the way teeth fit together 3.90 1.110 [3.70, 4.11] 
Pain when chewing 4.36 0.768 [4.22, 4.51] 
Red, swollen or tender gums 4.53 0.682 [4.40, 4.66] 
Noted halitosis or told by others of breath odour 4.13 8.81 [3.97, 4.30] 
Tartar formation 3.48 1.053 [3.28, 3.67] 
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changes in the way teeth fit together (χ² [4, n = 112] = 12.266, p = 0.011); pain when 
chewing (χ² [3, n = 112] = 10.403, p = 0.009); red swollen or tender gums (χ² [3, n = 
112] = 7.312, p = 0.038); noted halitosis or told by others of breath odour (χ² [3, n = 
112] = 8.005, p = 0.038); and tartar formation (χ² [4, n = 112] = 10.725, p = 0.024). 
 
Correlations between participants’ levels of confidence to assess diabetes 
related oral health status and provide diabetes related oral health information, 
and the levels of concern for patients’ oral health complaints.  A Spearman’s Rho 
Test for correlation was utilised to determine the relationships between the 
participants’ levels of confidence to assess the oral signs and symptoms in patients, 
and provision of diabetes related oral health information, and the levels of concern 
participants had for the signs and symptoms noted at the consultation.  The data 
indicated statistically significant positive relationships between the participants’ rated 
levels of confidence to assess oral signs and symptoms and the levels of concern for 
patients’ oral signs and symptoms of: bleeding gums when brushing (r = .246, p = 
.009); pain when chewing (r = .245, p = .009); red, swollen or tender gums (r = .287, p 
= .002); noted halitosis or told by others of breath odour (r = .250, p = .007); and tartar 
formation (r = .288, p = .002).  This indicated the participants’ levels of concern for 
patients’ oral health complaints, with the exception of loose teeth, rose in relation to 
their increasing levels of confidence to assess the oral signs and symptoms in the 
person with diabetes.  The data for the conditions of loose teeth and changes in the way 
teeth fit together did not meet statistical significance. 
Significant positive relationships between the participants’ levels of confidence to 
provide diabetes related oral health information and their levels of concern when the 
patient was identified as having the oral health signs and symptoms was evident for the 
complaints: bleeding gums when brushing (r = .270, p = .004); pain when chewing (r = 
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.274, p = .003); red swollen or tender gums (r = .219, p = .020); noted halitosis or told 
by others of breath odour (r = .323, p = .000), and tartar formation (r = .193, p = .041).  
This indicated the participants’ levels of confidence to provide diabetes related oral 
health information rose in relation to their increasing levels of concern for these signs 
and symptoms of oral health problems when identified in the patient at the 
consultation.  The data for the condition of loose teeth and changes in the way the teeth 
fit together, did not meet statistical significance. 
 
Likelihood to recommend treatment options to patients with oral health 
complaints.  Participants (n = 113) were presented with a further practice scenario in 
which the patient presented with xerostomia.  Participants were asked to rate, on a 
scale of 1 to 5, their levels of likelihood of managing the problem by recommending 
treatment options.  Table 4.16 provides the descriptive statistics against each of the 
treatment recommendation items, with the lower scores, less than 3, indicating the 
moderately low likelihood of recommending the restriction in the use of substances, 
caffeine and alcohol, which may accentuate dehydration in this individual.  In addition, 
the recommendations for the use of treatments which may offer symptomatic relief, 
such as sugarless gums or mints, saliva substitutes, or fluoride mouthwashes, were also 
lower scoring. 
In contrast, participants strongly endorsed (i.e. Likert score > 4), the 
recommendations that patients improve their glycaemic control and the need for 
review of their oral health status by both their GP and dentist/periodontist.  Participants 
appeared most undecided (Likert score 3-4) whether to recommend to patients the 
options which included taking frequent sips of water and undergoing a medication 
review.  This data suggest the DHPs are reticent to implement oral health knowledge 
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and provide information to patients that may have the potential to reduce the impact of 
xerostomia symptoms. 
Impact of education in diabetes related oral health complications upon 
participants’ levels of likelihood to recommend treatment options to patients with 
oral health complaints.  The Chi-Square with Fisher’s Exact Test detected 
statistically significant associations between those participants who had undertaken 
self-directed education in diabetes and oral health and the greater likelihood to 
recommend a selection of treatment options to the patient with a complaint of 
xerostomia.  The treatment items found to be statistically significant were the use of 
sugarless gum (χ² [4, n = 112] = 23.642, p = 0.000); to take frequent sips of water or 
ice chips (χ² [4, n = 112] = 10.467, p = 0.030) and referral to their GP for review (χ² 
[4, n = 112] = 8.951, p = 0.039).  No other statistically significant associations were 
found between the participants undertaking diabetes related oral health education 
either within the professional course or with their attendance at a session, and the 
likelihood to recommend treatment options to patients with the oral complaint of 
xerostomia. 
Table 4.16 
Descriptive Statistics for Participants’ Level of Likelihood to Recommend Treatment 
Options to Patients With Oral Health Complaints 
Types of treatment recommendations (n = 113) Mean SD 95% CI 
Use sugarless gum 2.86 1.445 [2.59, 3.13] 
Use sugarless mints 2.37 1.344 [2.12, 2.62] 
Take frequent sips of water or ice chips 3.63 1.241 [3.40, 3.86] 
Restrict caffeine intake 2.50 1.296 [2.25, 2.74] 
Restrict alcohol intake 2.80 1.304 [2.55, 3.04] 
Rinse with fluoride mouthwashes 2.32 1.248 [2.09, 2.55] 
Use saliva substitutes 2.70 1.457 [2.43, 2.97] 
Improve glycaemic control 4.28 1.138 [4.07, 4.50] 
Undergo medication review 3.88 1.148 [3.67, 4.10] 
Referral to GP for review 4.22 0.924 [4.04, 4.40] 
Referral to dentist/periodontist for review 4.17 1.141 [3.96, 4.38] 
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Correlation between participants’ levels of confidence to provide diabetes 
related oral health information and the levels of likelihood to recommend 
treatment options to patients with oral health complaints.  A Spearman’s Rho Test 
for correlation indicated statistically significant positive relationships between the 
participants’ levels of confidence to provide diabetes related oral health information 
and the levels of likelihood to recommend a selection of treatment options to the 
patient with xerostomia.  Those treatment options found to be statistically significant 
were the use of sugarless gum (r = .298, p = .001); use of saliva substitutes (r = .276, p 
= .003); restriction in caffeine intake (r = .300, p = .001); restriction in alcohol intake 
(r = .188, p = .046), along with the recommendation to undergo a medication review (r 
= .207 p = .028); referral to the GP for review (r = .223, p = .018); and referral to the 
dentist/periodontist for review (r = .224, p = .017).  This indicated the participants’ 
levels of likelihood to recommend the treatment options identified rose in relation to 
their levels of confidence to provide diabetes related oral health information to the 
person with diabetes. 
 
Diabetes and oral health management of the patient from groups with more 
specific management needs or who are socially isolated.  Nearly all of the 
participants (94.8%, n =145) identified working with patients who were from a range 
of groups with more complex diabetes education and management needs, or who were 
socially isolated thereby limiting their access to oral health services as previously 
identified in Table 4.5.  An exploration of the associations between the variables, 
participants’ ‘levels of confidence to assess the oral health status’; ‘levels of 
confidence to provide diabetes related oral health information’; ‘levels of concern for 
patients oral signs and symptoms’; and ‘levels of likelihood to recommend treatment 
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options’ when the participants worked with the specified groups of patients, was 
undertaken. 
A Pearson Chi-Square with Fisher’s Exact Test did not detect a statistically 
significant association between the participants who worked with patients with more 
specific needs or who were isolated and the participants’ levels of confidence to assess 
oral health signs and symptoms (χ² [4, n = 142]) = 5.071, p = .202) , nor with their 
levels of confidence to provide diabetes related oral health information (χ² [4, n = 142] 
= 4.694, p = .207), nor with their levels of likelihood to recommend any treatment 
option from the range described in Table 4.16. 
The data were examined for associations between the participants who worked 
with the specific needs or isolated patients, and their levels of concern for the oral 
signs and symptoms identified in this patient.  Statistically significant relationships 
existed for the complaints; changes in the way the teeth fit together (χ² [4, n = 112] = 
9.135, p = .012), and pain on chewing (χ² [4, n = 112] = 9.913, p = .007). 
 
Differences in management of diabetes related oral health complications 
between patients with varied levels of need.  The differences between variables: 
participants’ ‘levels of confidence to assess oral health signs and symptoms’, ‘levels of 
confidence to provide diabetes related oral health information’, and the ‘levels of 
concern for the patients’ oral signs and symptoms’ for those participants who worked 
with patients who had more specific needs or who were isolated, compared to those 
participants who did not work with these patient groups, were analysed using the 
Mann-Whitney U Test.  Results of the tests between participant groups for the 
variables; ‘levels of confidence to assess oral health signs and symptoms’ and ‘levels 
of confidence to provide diabetes related oral health information’ are detailed in Table 
4.17. 
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Statistically significant differences were found between those participants who 
either work with, or who do not work with patients who had more specific needs or 
who were isolated, and their levels of concern for patients’ oral health complaints.  The 
descriptive statistics for the differences in participants’ levels of concern for each oral 
health sign and symptom item, detected in patients, are detailed in Table 4.18. 
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Note. *p = <0 .05
Table 4.17 
Descriptive Statistics for Participants’ Levels of Confidence in Oral Health Practice Between Those Participants who Work/Do Not Work With 
Patients who had More Specific Needs or who Were Isolated 
Confidence item 
Work with specific or isolated groups  
Yes (n = 137) No (n = 5) Mann-Whitney U test 
Mean Mean Rank Mean Mean Rank Z* Asymp. Sig * (two-tailed) 
Levels of confidence to assess oral signs and 
symptoms  2.41 72.27 1.80 50.40 -1.218 0.223 
Levels of confidence to provide diabetes related 
oral health information 2.94 72.04 2.60 56.70 -0.851 0.395 
Note. *p = <0 .05 
 
Table 4.18 
Descriptive Statistics for Participants’ Levels of Concern for Patients Oral Health Signs and Symptoms Between Those Participants who Work/Do 
Not Work With Patients who had More Specific Needs or who Were Isolated 
Patient complaints 
Work with specific or isolated groups  
Yes (n = 109) No (n = 3) Mann-Whitney U test 
Mean Mean Rank Mean Mean Rank Z* Asymp. Sig * (two-tailed) 
Bleeding gums when brushing 3.98 57.13 3.33 33.67 -.1.298 0.194 
Loose teeth 4.34 57.15 3.33 33.00 -1.407 0.159 
Changes in the way teeth fit together 3.95 57.72 2.00 12.33 -2.504 0.012* 
Pain when chewing 4.40 57.63 3.00 15.33 -2.464 0.014* 
Red, swollen or tender gums 4.54 56.87 4.33 43.00 -0.853 0.394 
Noted halitosis or told by others of breath odour 4.17 57.33 3.33 26.50 -1.731 0.084 
Tartar formation 3.50 56.92 3.00 41.33 -0.853 0.394 
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The differences in participants’ levels of likelihood to recommend treatment 
option to patients when they worked with special needs or isolated compared to their 
colleagues who did not, was ascertained.  A Mann-Whitney U Test indicated a 
statistically significant difference in the participants’ levels of likelihood to 
recommend that the patients improve their glycaemic control (U = 66.500, z = -2.01, p 
= .044).  The score for this subscale item was higher for the participants who worked 
with special needs and isolated patients was higher (Mean rank = 84.17) than those 
scored by participants who did not see patients in this category (Mean rank = 24.17).  
The descriptive statistics for the differences in the levels of likelihood to recommend 
treatment between participants who worked with special needs and isolated patients 
versus those participants who did not, are outlined in Table 4.19. 
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Table 4.19 
Descriptive Statistics for Participants’ Levels of Likelihood to Recommend Treatment Options to Patients Between Those Participants who 
Work/Do Not Work With Patients who had More Specific Needs or who Were Isolated 
Types of treatment recommendations  
Work with specific needs or isolated groups 
Mann-Whitney U test 
Yes (n = 109) No ( n = 3) 
Mean Mean Rank Mean Mean Rank Z* 
Asymp. 
Sig** 
(two-tailed) 
Use sugarless gum 2.85 56.58 2.67 53.50 -0.166 0.868 
Use sugarless mints 2.38 56.88 1.67 42.67 -0.776 0.438 
Take frequent sips of water or ice chips 3.64 57.12 3.00 34.00 -1.257 0.209 
Restrict caffeine intake 2.52 57.05 1.67 36.67 -1.257 0.270 
Restrict alcohol intake 2.83 57.29 1.67 27.83 -1.587 0.113 
Rinse with fluoride mouthwashes 2.34 56.90 1.67 42.00 -0.812 0.417 
Use saliva substitutes 2.68 55.74 4.00 84.17 -1.535 0.125 
Improve glycaemic control 4.31 84.17 3.33 24.17 -2.011 0.044* 
Undergo medication review 3.92 57.05 3.00 36.50 -1.134 0.257 
Referral to GP for review 4.25 57.18 3.67 31.67 -1.466 0.143 
Referral to dentist / periodontist for review 4.20 56.89 3.67 42.50 -0.840 0.401 
Note.  *p = < .05. 
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Perception of responsibility for professional role in diabetes related oral health 
assessment and management 
In order to ascertain the DHPs’ perceptions of responsibility for oral health care in 
people with diabetes, participants (n = 144) were asked to consider the provision of 
assessment and management of diabetes related oral health care and to identify the 
health professionals they considered had a role in the care.  The individual responses 
were categorised into professional groups and are displayed in Table 4.20, with the 
frequencies against each individual health professional identified within Appendix T.  
While the largest count is attributed to dental health professionals (n =152), the second 
largest count (n = 130) indicates the existence of the perception among the participants 
that DHPs have a major role in the assessment and management of diabetes related 
oral health care within their patient population. 
 
Driving forces in management of diabetes and oral health complications 
In relation to the third objective of this study, participants were asked to identify 
those factors which they believed influenced their ability to improve the diabetes 
related oral health care for patients who they managed.  The availability of diabetes 
and oral care literature for patients was considered to be highly influential by 91% (n = 
131) of participants.  More than 80% indicated that further professional development 
and availability of clinical practice guidelines for diabetes and oral health care was also 
a factor.  Provision of pamphlets outlining oral health service information to patients, 
Table 4.20 
Participants’ Responses Identifying the Health Professionals Having a Role in 
Diabetes Related Oral Health Care 
Health professional type Frequency 
Dental professionals 152 
DHP 130 
Primary care setting health professionals 86 
Allied health professionals 34 
Other health professionals 15 
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and a greater access to dental service especially within the Medicare health system was 
chosen by more than two-thirds of the participants.  Greater than 50% of participants 
identified streamlined referral processes and multidisciplinary team care arrangements 
as a driving force. 
While 8.3% (n =12) participants chose to identify ‘Other’ factors these were 
overwhelmingly related to issues of oral health service delivery.  Despite the 
increasing use of computer technology in healthcare, a low number (5.6%, n = 8) of 
participants indicated that use of an ‘on-line’ chat group would be influential in 
improving their practice.  A minority of participants 3.5% (n =5) identified their scope 
of practice limitation meant they were unable to identify a factor that would positively 
influence the implementation of diabetes and oral health complications.  The frequency 
and percentage rates of responses against the set of proposed factors are identified in 
Table 4.21.  The individual responses received within the ‘Other’ category were 
grouped under predominant themes within Appendix U. 
 
Table 4.21 
Descriptive Statistics of Positive Influences upon Participants’ Ability to Improve 
Care 
Factors improving management Frequency Percent 
‘Diabetes and oral health care’ education pamphlets for 
patients 131 91.0 
Diabetes and oral health care clinical practice guidelines 121 84.0 
Further diabetes and oral health care professional 
development 117 81.2 
Greater access to dental services 111 77.1 
‘Oral health care services’ information pamphlets for 
patients 101 70.1 
Medicare item provision 95 66.0 
Multidisciplinary team care arrangements 89 61.8 
Streamlined referral processes 83 57.6 
Other factors 12 8.3 
On-line chat group 8 5.6 
None, I consider it outside my professional scope of 
practice 5 3.5 
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Restraining forces in managing diabetes and oral health complications 
Further questioning of participants (n = 142) concentrated upon the existence of 
barriers to the provision of diabetes related oral health care to patients within the 
clinical setting.  Again participants were offered a set of proposed factors.  Two-thirds 
(64.1%) identified a lack of access to dental services as the greatest barrier. 
Approximately 60% of participants identified the lack of clinical practice 
guidelines and the lack of knowledge of diabetes and oral health issues as restraining 
forces in their management.  The lack of referral processes and the lack of time to 
include oral health issues in the management of diabetes accounted for one third of 
responses against the perception of barriers. 
The lack of recognition for the DHPs’ role in oral health education, and for those 
with a Medicare provider number in private practice, the lack of reimbursement for the 
time required for management were identified by over 20% of participants.  
Furthermore, 9.2% (n = 13) of participants identified diabetes related oral health care 
was not within their scope of practice as a DHP.  The frequency and percentage rates 
are presented in Table 4.22 
 
Table 4.22 
Descriptive Statistics of Barriers to Diabetes and Oral Health Complication 
Management 
Factors restraining management (n = 142) Frequency Percent 
Lack of access to dental services 91 64.1 
Lack of clinical practice guidelines 85 59.9 
Lack of knowledge of diabetes and oral health issues 81 57.0 
Lack of referral processes 53 37.3 
Lack of time to include oral health issues in my 
management of diabetes 51 35.9 
Lack of recognition of my role in diabetes and oral health 
education 39 27.5 
Lack of reimbursement for management time required 29 20.4 
Other factors 17 12.0 
Not in my professional scope of practice 13 9.2 
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A further 12% of responses were included within an ‘Other’ category which aimed 
to capture the individual responses which may have fallen outside of the choices 
offered.  These have been categorised under themes and are displayed in Appendix V.  
In the main the responses received reflect those within the prior category of proposed 
barriers.  These included lack of, or limitation in accessing appropriate and affordable 
oral health services, lack of educational resources and clinical practice guidelines.  In 
addition scope of practice issues such as the lack of acceptance by the DHP, of their 
role in oral health assessment and management, a lack of diabetes related oral health 
knowledge, and the lack of appropriate equipment to facilitate oral health screening 
within their practice setting, was identified.  Management is further impeded by a 
proportion of the patient population who had a limited perception of not only the need 
for an appropriate level of preventative oral hygiene self-care and dental maintenance, 
but also the need to identify the existence of an oral health problem to the DHP 
managing their care.  
 
Chapter Summary 
This chapter has reported the analysis of the survey responses achieved within this 
descriptive study.  The three main study objectives were to: 
1. Assess Australian DHPs’ levels of knowledge of oral health issues which impact 
upon the person with diabetes. 
2. Determine the DHPs’ scope of practice regarding intervention, health promotion 
and care management of oral health issues in persons with diabetes. 
3. Identify the restraining and driving forces that influence the provision of oral 
health care prevention and intervention for people with diabetes. 
In addition, this study has identified the socio-demographic characteristics of the 
participants, their qualifications, experience, workplace settings and, their role which is 
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primarily to manage the care of people of any age living with one of the four types of 
diabetes mellitus in the varied communities within the Australian continent.  The 
results have identified the associations, relationships and differences in the DHPs’ 
receipt of education in diabetes related oral health complications and, the 
transformation of that knowledge into application of skills across the varied clinical 
settings.  The clinical management of oral health complications within diabetes care 
has been shown to be related to the levels of confidence to assess oral health signs and 
symptoms, and provide diabetes related oral health information.  Furthermore, this is in 
combination with the DHPs’ perception of increased levels of risk for oral health 
complications and the need for frequent surveillance and care recommendations to the 
people living with diabetes. 
The characteristics of the varied diabetes patient population and clinical settings 
appear to be factors influencing the DHPs’ levels of likelihood to investigate, concern 
for verbalised complaints or identified signs and symptoms of oral health 
complications, and the likelihood to recommend treatment options to the person living 
with diabetes.  Participants were able to identify the major driving and restraining 
factors which further manipulates their clinical practice in the area of diabetes and oral 
health management.  The results of the data analysis included within this chapter are 
elaborated within Chapter Five 
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Chapter 5:  Discussion of the results 
 
This study explored the Australian DHPs’ knowledge and management of oral 
health complications in people living with diabetes.  The need for this study was based 
upon the paucity of information which identified the need for considered clinical 
management of oral health complications within the more specialised area of diabetes 
care.  Furthermore, a gap in practice by Australian DHPs was anticipated given the 
lack of specific guidelines for oral complication screening as part of routine care, along 
with the absence of quality improvement initiatives targeting practice interventions by 
diabetes care team members.  With the limited empirical evidence related to diabetes 
and oral health complications, this descriptive, cross-sectional study was specifically 
designed to: 
1. Assess Australian DHPs’ level of knowledge of oral health issues which impact 
upon the person with diabetes. 
2. Determine the DHPs’ scope of practice regarding intervention, health promotion 
and care management of oral health issues in persons with diabetes. 
3. Identify the restraining and driving forces that influence the provision of oral 
health care prevention and intervention for people with diabetes. 
This final chapter discusses the study’s findings by relating them to available 
literature on diabetes and oral health complications, the various guidelines for the 
management of diabetes care by diabetes type, patient age, and the health policies 
which support chronic disease management in Australia.  The limitations of this 
current study are also discussed, along with recommendations for future diabetes-
specific oral health clinical practice and research. 
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Australian DHPs’ level of knowledge of oral health issues which impact upon the 
person with diabetes 
This study is the first which specifically identifies the Australian DHPs’ level of 
knowledge of oral health complications in people living with diabetes.  The findings 
indicate that the majority of DHPs do possess knowledge of the more common oral 
health complications that may develop, and may potentially identify these in patients 
during consultation.  The DHPs do not however; appear to be able to recognise the 
association of the more obscure signs and symptoms of oral complications.  As such 
they may not correctly identify the conditions in patients under their care. 
The relevance of this new knowledge for future diabetes management is that it 
highlights the need for diabetes related oral health clinical guidelines which are 
currently lacking within Australian diabetes care.  These guidelines should include a 
screening tool to direct and focus the DHPs’ attention towards appropriate questioning 
of patients’ oral self-care activities and the occurrence of oral symptoms.  In addition, 
the targeted inspection of the oral cavity and documentation of the oral assessment, in 
conjunction with the medical history and diabetes management strategies, would assist 
in identifying those individuals who have evidence of, or are at greater risk of diabetes 
related oral health complications.  This data in turn would provide much needed 
evidence showing the incidence and prevalence of oral health complications in people 
with diabetes within Australia.  To date this is sadly lacking. 
The data suggests DHPs’ knowledge base of oral health is limited.  This is most 
likely related to the limited promotion of diabetes associated oral health complications 
within the Australian medical, nursing and allied health professional curricula.  It 
would appear that this restriction also occurs outside of Australia.  At a recent New 
York Academy of Sciences symposium entitled ‘Diabetes and Oral Disease: 
Implications for Health Professionals’, Lalla (Albert et al., 2012) reported that within 
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the US, “evidence to date suggested that physicians and nurses do not receive adequate 
training in oral health” (p.10).  In the current study, receipt of education in diabetes 
associated oral health complications amongst the DHPs varied significantly.  Similarly 
Australian DHPs do not receive adequate education and training to manage oral health 
complications within diabetes care.  The data indicates the inclusion of oral health 
information within the formal curriculum is inconsistent and confirms a lack of 
recognition for, and impact of oral health complications within diabetes care at a 
fundamental management level. 
The differences in health professionals’ knowledge with attendance at an 
education session or their undertaking of self-directed learning were not statistically 
significant.  The small sample sizes obtained within the categories of endocrinologists 
and allied health professionals resulted in a non-normal distribution of these variables, 
and influenced the use of non-parametric tests in the analysis.  This may have resulted 
in a loss of power, and therefore the ability to detect a statistical difference resulting in 
a type II error in the analysis of this data. 
The educational sessions on diabetes and oral health complications, that DHPs 
attended, were predominately provided by a professional association.  This was greater 
than that provided within the workplace as an in-service session or other opportunities 
for information arising from attendance at a university lecture, industry sponsored 
seminars or information from a dental company representative.  The data indicates that 
the educational format offered by the diabetes professional associations (the ADS and 
ADEA) is highly effective in disseminating information to the majority of DHPs 
within Australia.  These educational characteristics are clinically important within a 
quality improvement framework.  The lack of diabetes related oral health education 
and training provision could be addressed by the targeting of educational activities 
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within the setting of the ADS and ADEA National and State branch conferences and 
meetings. 
Self-directed learning was reportedly undertaken by one-third of DHPs, who 
utilised journals, and to a lesser extent, web-based instructional modules, core 
textbooks or a combination of all/most of these as resources.  A smaller proportion 
sought individual methods to gain information.  The fact that Australian DHPs utilise 
journals as their primary source of material for self-directed learning in diabetes and 
oral health complications is a matter for concern.  Current research in diabetes related 
oral heath complications has a low profile within medical and nursing journals and 
core curriculum textbooks.  Unless the DHP is proactive in searching the publication 
databases, more specifically pertaining to the dental profession, limited information is 
likely to be found.  This may inadvertently leave the DHP mistaken in the belief that 
oral health problems do not require management in people living with diabetes. 
Within this current study, the association of DHPs who undertook combined forms 
of education with their ability to correctly identify diabetes with a range of diabetes 
related oral conditions was statistically significant for the condition of candidiasis 
alone.  Furthermore, the association of self-directed learning with their ability to 
recognise diabetes with the conditions: stomatopyrosis, candidiasis, and dental caries 
were also statistically significant.  It is acknowledged that sample size may have biased 
the ability to detect statistically significant data results across the remaining oral 
conditions, despite the use of Fisher’s Exact Test for small sample size during the Chi-
Square analysis.  This is most evident across the following variables: DHP categories 
in conjunction with the diabetes and oral health education, and DHPs’ knowledge of 
diabetes association with each of the oral health complaints.  Additionally, it may be 
argued the lack of significant results across the remaining oral health conditions 
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indicates the DHPs, irrespective of the undertaking of education, are able to deduce an 
association as a result of knowledge gained from extensive clinical experience. 
Alternatively, the lack of statistical significance may relate to widespread lack of 
knowledge of oral health complications across the Australian DHP categories.  This 
may be a reflection of the limited attention accorded to it within professional course 
material and diabetes-specific medical literature.  Thus, the data results from this 
current study support the view expressed by Lamster (Albert et al., 2012) that while 
wide dissemination of literature pertaining to periodontal disease associated with 
diabetes has occurred, less attention has focussed on the other oral complications of 
diabetes. 
Overwhelmingly DHPs within this study acknowledged the significance of an 
increased risk of oral health problems in the person living with diabetes.  This is 
despite the absence of evidence which indicates the presence of other diabetes related 
complications.  This indicates that DHPs are aware of the potential for oral health 
complications within the clinical practice setting.  As the DHPs’ level of agreement 
was towards one end of the Likert scale, which indicated a tendency to strongly agree, 
the result suggests DHPs may be influenced by past clinical experience rather than 
previous education in oral health.  One possible explanation is that Australian DHPs 
frequently witness the impact of other diabetes related complications within their 
patient population, thus facilitating experiential knowledge.  In addition, the 
knowledge of complication risk factors gained from large scale diabetes studies, such 
as the UKPDS and DCCT, is promoted within post-graduate diabetes course materials 
and underpins DHP clinical practice guidelines.  This collective knowledge potentially 
enables the deduction of an increased risk of oral health complications, especially 
when the patient has had a longer duration of diabetes with ‘less than ideal’ glycaemic 
control. 
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Diabetes and oral health complications:  DHPs’ scope of practice and efficacy 
Educational impact upon the levels of confidence and scope of practice.  The 
current study proposed that a gap existed in the Australian DHPs’ scope of practice 
regarding intervention, health promotion and care management of oral health issues in 
people living with diabetes.  This was based upon the lack of specific guidelines which 
encompass oral health complication screening within diabetes management.  Lalla 
(Albert et al., 2012) reported that physicians and nurses in the US were, from the 
evidence to date, not only uncomfortable performing a simple periodontal 
examination, but also rarely advised patients regarding the various aspects of oral 
health.  This current study has provided empirical evidence to confirm there is indeed a 
gap in the management of oral health complications that can occur in people living 
with diabetes within Australia.  The Australian DHPs’ scope of practice is not only 
related to their knowledge base, but also their levels of confidence to assess oral health 
signs and symptoms, and to provide diabetes related oral health information to the 
patients they see. 
Correspondingly, Australian DHPs within this current study perceived low levels 
of confidence to undertake an assessment of oral health signs or symptoms (mean 2.37, 
95% CI 2.20, 2.54) and provide diabetes related oral health information (mean 2.91, 
95% CI 2.73, 3.08) to the patients at a consultation.  Additionally DHPs indicated a 
slightly higher level of confidence to provide information to the patient than their level 
of likelihood to investigate the complaints of dental problems if the patient had other 
complications related to their diabetes (mean 2.83, 95% CI 2.62, 3.05).  It is not 
unreasonable to expect the levels of confidence in oral health practices would increase 
in relation to the DHPs’ years of experience in diabetes care.  However, there was no 
evidence of a statistically significant relationship between those DHPs who worked 
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solely in diabetes care and their years of clinical experience to support this expectation, 
and as such may be an area for future investigation. 
The undertaking of education had a positive impact upon DHPs’ levels of 
confidence to assess oral signs and symptoms, and to provide oral health information 
to the person living with diabetes, as observed in the statistically significant differences 
within the Mann-Whitney U Test.  Likewise, the undertaking of education (combined 
forms) and the increase in the levels of confidence to provide information to their 
patients was strongly associated and statistically significant. 
There is an absence of previous studies investigating DHPs’ knowledge of oral 
health complications with which to compare these results.  The current data appears to 
corroborate in the Australian context what was reported by Lalla (Albert et al., 2012) 
in the US, that there is an association between the health professionals’ lack of 
knowledge of diabetes related oral complications and their confidence to undertake 
oral health screening and provide oral health information to people living with diabetes 
at a consultation. 
Of concern is the lack of statistical significance for the association of Australian 
DHPs undertaking education with their level of confidence to assess the oral signs and 
symptoms in the person living with diabetes.  While the statistics may be biased by 
small sample size, an effort to address this was undertaken with the use of the Fisher’s 
Exact Test within the Chi-Square analysis.  Alternatively, the overall statistic achieved 
may indicate the provision of education alone does not translate into the DHPs’ 
increased level of confidence to assess the patient in clinical practice. 
It may be argued that historically the separation of the fields of professional 
practice: dentistry from medicine, nursing and allied health care has had a negative 
impact upon the Australian DHPs.  The separation has restricted the DHPs’ ability to 
acquire oral health knowledge and skills, and thus their likelihood and confidence to 
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undertake practice in this area.  While there is an expectation that DHPs’ educational 
curricula and key resources, such as journals, would comprehensively cover diabetes 
related complications, the lack of attention towards the evidence-based oral health 
issues is most evident. 
In addition, there is a lack of attention to the mastery of diabetes and oral cavity 
assessment skills, and implementation of practice guidelines within diabetes services.  
This is contrary to the current screening practices for other complications within 
diabetes care, such as the neurovascular foot assessment of people with diabetes.  It is 
plausible therefore, that Australian DHPs perceive that the undertaking of oral health 
assessments as part of their service delivery is outside of their scope of practice.  
Indeed, within this current study 13.2% of DHPs identified they would never 
undertake an oral assessment as they perceived it was outside of their scope of 
practice. 
This is a matter for clinical concern.  The DHPs are in a prime position to effect 
positive change in outcomes for people living with diabetes, especially those who are 
at significant risk of diabetes related oral health complications.  A risk, which is not 
unlike other complications associated with diabetes, related to the duration of the 
hyperglycaemic challenge and the bi-directional impact of physical, social and 
psychological factors complicating the diabetes management.  The acquisition of skills 
in assessment and management of diabetes related oral health complications may 
translate into increased activity by DHPs in this area.  It does therefore, deserves much 
greater attention than it currently receives both within health professional curricula and 
the clinical practice setting. 
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DHPs’ management of patients with varied levels of risk of oral health 
complications.  This study revealed Australian DHPs highly acknowledge the 
increased risk of oral health problems in people living with diabetes.  Furthermore, this 
acknowledgement was found to be strongly associated with an increased level of 
likelihood to investigate oral health problems when the DHPs considered the patients 
to be at greater risk.  In addition the DHPs’ higher scores for confidence in assessment 
and provision of information were associated with the higher scores for likelihood to 
investigate the oral health status when other diabetes related complications existed. 
This is clinically important.  Currently there is no provision for DHP assessment 
of oral health complications within the diabetes complication screening regimen in 
Australia.  While DHPs indicated low levels of confidence in diabetes related oral 
health practices, as shown in the mean scores, it appears that current management 
practices do not take into account the clinical indicators of the presence of an 
inflammatory process or other diabetes related complications that may exist.  Thus it 
would appear there is neglect of evidence from previous research studies that have 
shown the inflammatory process associated with oral infections are not dissimilar to 
those of other diabetes related complications (Salvi et al, 1997; Southerland, Taylor & 
Offenbacher, 2005).  This is in addition to research showing the greater prevalence of 
oral health complications being confirmed in individuals with diabetes who also 
experience other complications of diabetes, i.e., retinopathy, nephropathy, and 
cardiovascular disease (Southerland, Taylor, Moss, Beck & Offenbacher, 2006).  
Encouragingly, this current study data suggests there is the potential for the uptake of 
oral health management in diabetes care, and provides a level of evidence to support a 
call for the implementation of oral health screening within diabetes management. 
Within this study, DHPs identified working with patients who were adults 
(96.8%), adolescents (75.2%), and paediatrics (35.9%).  This indicates there is a 
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substantial proportion of patients who may, as previous research indicates, be at 
greater risk of oral complications, as they live with diabetes for an extended period of 
time with potentially limited control of their glucose levels (Kapellas & Slade, (2008).  
In addition the DHPs may have identified a proportion of the same individuals as 
belonging within a specific group of patients.  These groups may have more 
specialised diabetes education and management needs due to their age, ethnicity, 
culture, disability, medical condition/s or who otherwise, due to social circumstances, 
were limited in their access to oral health services.  The groups identified within this 
study were pregnant women, physically and intellectually disabled, Aboriginal and 
Torres Strait Islander people, other clients from culturally and linguistically diverse 
backgrounds, residential aged care clients, clients within secure facilities, or patients 
living in rural and/or remote communities. 
These groups of individuals were, for the purposes of this current study, 
considered vulnerable for the development of oral health complications related to the 
complexity of issues in managing their glucose levels and oral care needs.  This view 
is reflected by Loeppky and Sigal (2007) who identified individuals who were most in 
need for meticulous oral hygiene as those “with physical, developmental, mental, 
sensory, behavioural, cognitive or emotional impairment or a condition that requires 
medical management, health care interventions or use of specialised services or 
programs” (p. 915). 
The Australian DHPs’ management of diabetes related oral health complications 
in patients with specific needs did not appear significantly different to the care 
provided for the remainder of patients with diabetes who they consulted.  While DHPs 
indicated higher levels of confidence to assess and provide information to the patient 
when they were from a specific needs group, as opposed to those who were not, the 
differences between the groups were not statistically significant.  However, the 
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differences in the DHPs’ level of concern for the oral signs and symptoms, changes in 
the way teeth fit together, and pain when chewing, were statistically significant. 
The data suggests DHPs perceive these complaints as being more serious in 
patients with specific needs.  Furthermore, DHPs identified an increased likelihood of 
recommending treatment options to manage xerostomia, with the exception of the 
recommendation to use salivary substitutes, when the participants worked with patients 
they considered belonged within a specific needs group. 
It is plausible that the lower levels in likelihood to recommend the use of salivary 
substitutes to patients with specific needs is related to the perceived appropriateness of 
the treatment.  Language and cultural differences, pregnancy, ageing and disability are 
factors that would be considered in ensuring patient safety with self-medication, which 
may influence the recommendation of this treatment.  In addition salivary substitutes 
may not be appropriate if supplies are difficult to acquire in rural/remote locations.  
Conversely, the DHPs may not fully appreciate the impact of long term xerostomia and 
the relief that salivary substitutes may offer their patient.  These findings may support 
those from a study of oral health care practices within a sample of US hospital-based 
neuroscience nurses.  Cohn and Fulton (2006) found the lack of salivary substitute use 
was related to the personal preferences of staff, with the product features not always 
matched to the patient care needs. 
The differences in DHPs treatment recommendation, between the groups of 
patients who were considered having specific needs and those who were not, were with 
the exception of improving the glycaemic control, not statistically significant.  This 
suggests the DHPs were more aware of the need to manage the glycaemic levels in 
patients with specific needs and were actively promoting diabetes management in the 
context of the managing the xerostomia condition. 
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There is an absence of past studies investigating the DHPs’ levels of agreement in 
oral health risk recognition, and their likelihood and confidence to undertake oral 
health activities within the varied diabetes patient demographic with which to compare 
results.  Additionally, there is a lack of published data regarding Australian service 
delivery for people living with diabetes who are considered ‘special needs’.  It has, 
however, been estimated by the National Advisory Committee on Oral Health (2004) 
that approximately one million people would qualify within the special care category 
as a result of their disability or the complexity of oral health care needs. 
Notwithstanding, evidence from previous dental research clearly identifies there is 
a need for enhanced oral health management in people who are at greatest risk and that 
early clinical intervention positively impacts upon  individuals’ quality of life, 
glycaemic control and overall ability to self-manage their diabetes.  This study, 
therefore, provides a level of evidence to support the call for implementation of 
diabetes related oral health screening guidelines to address this area of need, especially 
in patients with more specific needs. 
 
Initiation and frequency of diabetes related oral health screening within 
diabetes management.  Within this current study, the majority of DHPs reported 
undertaking an investigation of a patient’s oral health status prompted by a specific 
oral health concern or complaint.  Other predominant triggers were hyperglycaemia 
without an identified cause, and pregnancy or pregnancy planning.  While less than 
one-quarter of the DHPs provided ‘Other’ reasons for investigation, the specific cause 
appeared largely dependent upon the initiative of the DHP and the existing service 
delivery model in which the DHP worked. 
 However, less than half of the DHPs reported undertaking screening for oral 
health signs and symptoms as part of their diabetes related complications management.  
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The screening was performed either at the time of the individual’s admission to the 
diabetes service which in the majority of cases would be upon the diagnosis of 
diabetes, or as part of an ongoing diabetes self-management education programme.  
DHPs otherwise reported screening occurred in an ad hoc manner. 
It would appear that the diversity of DHPs employment settings, across the range 
of Government and non-Government agencies, i.e., hospital and correctional facilities, 
community health centres, Aboriginal communities, and in community based private 
practice, had a significant impact upon their diabetes related oral health screening 
practices.  The Australian health system is complex given the array of funding and 
regulatory mechanisms across the multitude of public and private service providers 
(AIHW, 2010a).  The fragmentation of funding and responsibility for service delivery 
across Commonwealth and State/Territory Governments results in varied models of 
care, and levels of resources within the workplace.  These limitations are more 
prevalent in rural and remote areas (Britt et al., 2011a).  Given these constraints, it is 
plausible that DHPs prioritise their service delivery to target issues that are assessed as 
most urgent and significant for the patient in their diabetes self-management.  Thus, if 
DHPs do not screen for and identify oral health complications at his point, attention 
towards the patient’s oral health status may not occur until a much later point in care, if 
at all. 
Furthermore, the absence of sufficient funding for personnel may be a factor 
impeding the DHPs’ ability to both initiate and maintain continuity of a diabetes 
related oral health service.  However, the current absence of a clinical practice 
guideline and oral health screening tool does leads one to question the efficacy of the 
current practices reported by DHPs, to detect and manage oral health complications. 
The associations between the DHPs’ frequency of oral health screening and their 
levels of confidence to both assess and provide information to the patient were 
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statistically significant.  As there is little support for oral health screening within 
diabetes management, the results which showed DHPs’ lower levels of confidence to 
assess oral signs and symptoms being strongly associated with the least frequent 
screening items, ‘Never, it is not within my scope of practice to perform diabetes and 
oral health assessments’ or the item ‘I do not routinely perform diabetes and oral 
health assessments’ is not unexpected.  Similarly the DHPs’ lower levels of confidence 
to provide information was strongly associated with the item ‘I do not routinely 
perform diabetes and oral health assessments’.  This data does appear to confirm, 
within the Australian context, a trend identified in the US by Lalla (Albert et al., 2012) 
that health professionals feel uncomfortable performing a simple periodontal 
examination; rarely advising patients regarding the various aspects of oral health. 
This study has provided empirical evidence of the need for a substantial increase 
in the provision of diabetes related oral health education and training to DHPs to 
achieve higher levels of confidence in practice within the DHP community.  In 
addition, it highlights a need for diabetes-specific oral health clinical practice 
guidelines for patient screening.  Indeed, this screening should occur at the time of the 
patient’s admission to the diabetes service, as well as part of the annual cycle of 
complication screening.  This would allow for targeted management strategies when 
oral complications are detected.  Evidence suggests that pre-intervention assessment 
can reduce both the incidence and severity of oral complications (Miller & Kearney, 
2001). 
 
DHPs’ level of concern for oral complaints.  Australian DHPs reported their 
mean level of concern across the range of oral signs and symptoms indicative of the 
conditions gingivitis and periodontitis as being between 3.48 and 4.52 (out of a 
possible Likert score 1 to 5).  DHPs identified lower levels of concern for evidence of 
 Chapter 5:  Discussion of the results 
119 
tartar formation, changes in the way teeth fit together, and bleeding gums.  This data 
suggest DHPs view these conditions, on a scale of severity, as a lesser oral health 
condition potentially related to a lack of preventative dental care, or minor trauma.  
Whereas patients’ complaints of pain when chewing; red, swollen or tender gums; 
noted halitosis or told by others of breath odour; and loose teeth elicited slightly higher 
levels of concern in the DHPs.  This data suggests the DHPs do recognise these oral 
conditions as indicators of a more extensive disease process occurring within the 
patient. 
Analysis of the associations between the undertaking of diabetes and oral health 
education indicated those DHPs who undertook self-directed learning were the most 
concerned for the patients’ complaints of the questioned oral conditions with the 
exception of bleeding gums when brushing, and loose teeth.  The reason for these two 
oral conditions not meeting statistical significance is unclear.  It is plausible that the 
DHPs recognise the severity of these oral complaints and justifiably have moderately 
high levels of concern when the symptoms are reported by the patient, independent of 
the DHPs undertaking diabetes related oral health education. 
Furthermore, the inability to achieve statistically significant data results across the 
remaining DHPs educational categories may be influenced to a greater extent by 
factors such as the level of concern and motivation, rather than sample size alone.  It is 
also not unreasonable to suspect the motivation to undertake self-directed diabetes 
related oral health education is indicative of a higher level of concern for oral health 
complications.  This is in contrast to those health professionals who, as part of their 
role, have been required to attend an education session or have received education as 
part of their professional course.  As there is a lack of previous studies investigating 
DHP practices in oral health complications, with which to compare results, it would 
appear a valid topic for future research. 
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The correlations between the Australian DHPs’ levels of confidence to assess oral 
health and their levels of concern at the patients’ oral signs and symptoms were 
statistically significant for all but one: the complaint of loose teeth.  In addition, the 
correlations between the DHPs’ levels of confidence to provide oral health information 
and their levels of concern when an oral condition was identified (either patient self-
reported or DHP identified) was again statistically significant for all but two: 
complaints of loose teeth, and the way the teeth fit together. 
It would appear that other variables may be confounding these relationships.  It is 
conceivable that the DHPs’ oral health attitudes and beliefs influence their judgement 
of the patients’ oral health care, especially when a state of poor dentition is identified.  
Furthermore, judgements regarding the patients’ level of self-efficacy to enact any 
previously promoted diabetes and oral care maintenance, in combination with ongoing 
oral health risk-taking behaviours, such as smoking, may negatively influence the 
levels of concern they hold for the patients’ complaint of a loose tooth.  Potentially 
DHPs may perceive patients’ complaints of ill-fitting and loose teeth as an irreversible 
outcome of poor self-care combined with a disease process that has advanced to a 
point which requires dental intervention alone.  While the impact of health 
professionals’ own health beliefs and attitudes upon their service delivery has been 
investigated in some other practice areas, evidence within the area of diabetes related 
oral health assessment and promotion is lacking and may be an area for future 
research. 
The implications of these findings for diabetes management are that it emphasises 
the need for increased diabetes related oral health education and skills mastery in oral 
health assessment within each of the identified professional categories.  In addition, it 
demonstrates the need for a standardised diabetes-specific oral health assessment tool.  
This would enable not only the identification of the incidence and prevalence rates for 
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oral health complications within the population living with diabetes, but also facilitate 
appropriate management when oral health complications are identified. 
 
Likelihood in recommending treatment options to patients with oral health 
complaints.  Within this study DHPs were offered a practice scenario in which the 
patient presented with the oral condition xerostomia.  This condition was chosen as it 
is a common side effect of many oral medications taken by people living with diabetes.  
It is also associated with a hyperglycaemic state and salivary gland dysfunction, and 
predisposes the individual to gingivitis and periodontitis.  DHPs indicated a 
moderately low likelihood of recommending the restricted use of caffeine and alcohol 
which may accentuate dehydration in the person living with diabetes.  However, 
recommendations which may have afforded symptomatic relief, i.e., sugarless gums or 
mints, saliva substitutes, and fluoride mouthwashes, were less likely to be 
recommended. 
Furthermore, the majority of DHPs indicated they were mid-range on the Likert 
scale in recommending to patients the options of frequent sips of water and undergoing 
a medication review as part of the management plan for the xerostomia condition.  The 
data suggest the DHPs are not fully aware of the potential causes of xerostomia, or the 
benefits that short term management can offer.  The treatment options that DHPs 
indicated they were most likely to recommend to the patient were improving the 
glycaemic control, referral of the patient to a GP, and referral to a dentist/periodontist 
for review.  These results demonstrate the DHPs’ scope of practice is essentially 
limited to the area of glycaemic management and that referral to the GP and 
dentist/periodontist for intervention was required in order to manage the oral health 
complication. 
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The association of diabetes related oral health education either within the 
professional course or attendance at an education session with the likelihood to 
recommend the treatment options offered within this study, was not statistically 
significant despite the larger sample size within these educational categories.  
However, recommendations that the patient use sugarless gum, take frequent sips of 
water or ice chips, and see their General Practitioner (GP) was statistically significant 
for DHPs who undertook self-directed learning.  The data suggests the level of 
motivation in DHPs to undertake self-directed learning in diabetes related oral health 
education, as opposed to education received in the professional course or attendance at 
an oral health education session, is a positive influence upon their likelihood of 
recommending self-management options and professional care to their patients. 
The data indicates the scope of practice by those DHPs who undertook self-
directed education is predominately limited to the symptomatic relief of xerostomia  
Clinically this is of concern, as there is apparent neglect not only for improved 
glycaemic management, but also a comprehensive approach to oral health 
management.  While it may reflect the absence of a diabetes-specific oral health 
guideline to direct practice, it also reflects the lack of implementation of research-
based knowledge, which clearly demonstrates the combination of strategies improves 
the individuals’ quality of life (Rubin & Peyrot, 1999) and reduces their risk of 
developing gingivitis and periodontitis in the future (Hirsch, 2004). 
Further investigation revealed statistically significant positive relationships existed 
between the DHPs’ levels of confidence to provide diabetes related oral health 
information and their likelihood of recommending treatment options to the patients 
with xerostomia.  These included: the use of sugarless gum; use of a saliva substitute; 
restriction in caffeine; restriction in alcohol intake; undergoing a medication review; 
referral to the GP; and referral to the dentist/periodontist for review of their oral health 
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condition.  While not all the subscale items within the treatment recommendation 
variable reached the significance level, the data suggest the DHPs, when presented 
with a patient with xerostomia, would to a large extent implement management 
strategies that were relevant to the xerostomia condition.  The lack of statistically 
significant data related to the recommendations: use of sugarless mints; to take 
frequent sips of water or ice chips; use of a fluoride mouthwash, and improving the 
glycaemic control.  The findings suggest the DHPs were not fully confident in 
providing diabetes related information, in particular relating the risks associated with 
the patients’ hyperglycaemia to that of the xerostomia condition. 
While this data suggest DHPs’ lack knowledge regarding the association of 
diabetes with the xerostomia condition, it also indicates a broader lack of knowledge of 
oral health complications.  It is also plausible that DHPs may not readily recommend 
treatment options which they may consider offer dubious benefit to their patients.  This 
evidence, in the absence of other studies with which to compare results, is worthy of 
further investigation given knowledge and beliefs is at the core of DHP scope of 
practice.  The data however, provides further evidence from an Australian context 
which supports the view of Lalla (Albert et al., 2012), that health professionals not 
only feel uncomfortable performing a simple periodontal examination in the person 
living with diabetes, but also rarely advise their patients regarding the various aspects 
of oral health. 
 
Driving and restraining forces in management of diabetes and oral health 
complications 
In accordance with the third objective of this study the restraining and driving 
forces that influence the Australian DHPs’ provision of oral health care prevention and 
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intervention for people living with diabetes were identified.  These forces are explored 
within the context of current health system policies. 
The DHPs in this study identified the positive factors that would influence their 
ability to improve oral health care in the patients they manage, in greater numbers, 
over those items that were considered barriers to being able to provide oral health care 
to patients in their practice.  While there is an absence of previous data with which to 
compare results from this study, it does suggests a readiness by Australian DPHs to 
implement clinical practice behaviour change.  This may be facilitated through the 
future introduction of diabetes related oral health clinical practice guidelines.  In 
addition diabetes related oral health education provision via the professional 
organisations and institutional health professional curricula would be advantageous. 
 
Perception of responsibility for professional role in diabetes related oral 
health care assessment and management.  Australian DHPs perceived the provision 
of assessment and management of diabetes related oral health care to the population of 
people living with diabetes was largely the role and responsibility of the dental health 
and DHPs.  This was in addition to more than half of the DHPs who identified a role 
by health professionals employed within the primary care setting, and to a lesser extent 
allied health professionals and professionals from other health disciplines. 
This perception of role responsibility is of clinical importance.  In essence it is 
another force impacting upon the DHPs’ levels of concern for patients’ oral health 
signs and symptoms, their likelihood to investigate any oral health complaints further, 
and their likelihood to recommend treatment when diabetes related oral health 
complications are identified.  In conjunction with the range of driving and restraining 
forces identified, the perception of role responsibility reflects the limited resources 
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which are available to DHPs to enable management of patients with oral health 
complications. 
 
Overcoming the barriers. 
Access to oral health services.  Within this study, the differences in the response 
rates for access to dental services, either as driving or restraining force, was seven 
percent.  This suggests the Australian DHPs consider the patients’ access to dental 
services is both a significant driving and restraining force to their implementation of 
diabetes related oral health management.  The data also indicates people with diabetes 
receive somewhat limited support from the DHPs due to the confines of the current 
oral health service delivery model.  Nonetheless, this may improve with increased 
awareness and knowledge of oral health complications, greater provision of diabetes 
related oral health education at the consultation, and with improved referral options to 
oral health services.  Despite these difficulties, DHPs indicated a high likelihood to 
refer patients with an oral health complaint to a dentist/periodontist (Mean 4.17, SD 
1.141, CI 3.96, 4.38).  There will, with the potential increase in DHPs activity, be the 
requirement for dental services to be available, affordable and hence accessible for the 
patient, in order for referrals to be initiated and actioned. 
Dental service access for patients was identified by 64.1% of DHPs as the primary 
barrier encountered in management of oral health complications.  The difficulties 
appear most pertinent for those patients living in rural and remote communities and are 
in agreement with that reported within ‘Australia’s dental generations: National survey 
of adult oral health 2004-2006’ (Slade, Spencer & Roberts-Thomson, 2007) indicating 
a significant proportion of the population with diabetes, indeed have an unmet need for 
oral health care.  The issues in accessing oral health services due to supply of dental 
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professionals is not significantly different to that of medical practitioner services in 
inner regional, outer regional and remote areas (AIHW, 2010a). 
The provision of medical and oral services to people with diabetes in Australia is 
complex.  Current separation of Commonwealth funding for medical and dental 
services limits access to oral health care.  Additional differences among the 
States’/Territories’ impacts further on oral health service delivery.  In 2010-2011 the 
Commonwealth funded medical expenditure to the value of 17,600 million dollars.  In 
contrast dental services in the same period received both Commonwealth and 
State/Territory funding to the value 2,136 million dollars (AIHW, 2012a, p. 115).  
While this represents 27.2% funding by Commonwealth and States/Territories 
Governments for dental service expenditure, the bulk of funding (58.1%), was supplied 
by individuals with ‘out-of-pocket’ payments (AIHW, 2012a, p 76).  The remaining 
funds (14.7%) were largely sourced from private health insurance companies, with a 
minor proportion provided by Workers’ Compensation and compulsory third-party 
motor vehicle insurers (AIHW, 2012a, p 119).  Furthermore, the reported real growth 
in dental services expenditure averaged 4.0% per year.  This is identified as 1.5 
percentage points below the average annual real growth in total recurrent health 
expenditure of 5.5% for the period 2003–04 to 2010–11 (AIHW, 2012a).  The 
Commonwealth Government does not collect data identifying the current level of oral 
health service delivery to people living with diabetes, nor the level of need for oral 
health care that is unmet in this cohort.  Therefore, this data indicates that not only do 
current provisions not meet the needs of the wider Australian population, but also the 
needs of individuals with oral health complications managed by Australian DHPs. 
Despite increased funding for public oral health services, available data identified 
dental care waiting times across Australia (June 2002) was 18 to 39 months, leading to 
an increased proportion of people being managed as emergency dental cases (National 
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Advisory Committee on Oral Health, 2004).  While newer data is not available, the 
funding over the decade has not increased significantly suggesting waiting times for 
services would remain relatively stable to the present time.  Therefore, this provides a 
possible explanation for difficulties DHPs reported in this study, in being able to have 
their patients seen in a timely manner.  Evidence shows the long waiting lists in the 
public dental sector “result in late presentation of dental problems necessitating 
extraction, which may be the treatment of choice of either the patient or the dentist” 
(Roberts-Thomson & Loc Do, 2007).  This supports additional data that indicates most 
dental service funds were “allocated to the reparation of tissue injury caused by dental 
caries and periodontal disease” (National Advisory Committee on Oral Health, 2004, 
p. 8). 
 
Funding of oral health service provision.  Within this current study, access to 
Medicare funded oral health services were identified as a driving force by 66% of 
DHPs.  Access to the Medicare Chronic Disease Dental scheme allowed people living 
with diabetes who had a Medicare GP Management Plan in place, access to a private 
dentist for care (DOHA 2010c, 2010d).  With the closure of this scheme as of the 1st 
December, 2012, these individuals will now face an extended wait upon the public 
service listings. 
Evidence of dental service utilisation rates reported within the ‘Australia’s dental 
generations: National survey of adult oral health 2004-2006’ showed “59.4% of the 
Australian population aged 15 years or more had visited a dentist within the last 12 
months” (Spencer & Harford, 2007, p. 143).  The greater numbers of dental visits in 
the preceding 12 months were associated with the respondent living within a capital 
city, having a higher level of education, with a higher percentage of those also being 
ineligible for public dental services.  However, 11.8% of all Australians 15 years old 
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and over had not attended a dentist within the last 5 years.  These individuals were 
therefore, considered to be ‘outside’ of the dental care system (Spencer & Harford, 
2007).  This data was reported as being “strongly associated with usually visiting for a 
dental problem and edentulism; and moderately associated with being uninsured, 
eligible for public dental care, having less schooling, living in places other than capital 
cities and being Indigenous” (Spencer & Harford, 2007, p. 148). 
Many individuals in Australia receive income above the minimum Henderson 
Poverty Line income level of $26, 000, and therefore are deemed ineligible for public 
dental services.  To access alternative oral health services is dependent upon the 
patient’s capacity to pay to attend a private dentist, which according to the Australian 
Dental Association (2003), “costs an average of $295 per hour (ranging from $200 to 
$450)” (As cited in National Advisory Committee on Oral Health, 2004, p. 11).  The 
responses received from DHPs within this current study identified the cost of services 
is prohibitive to many individuals and their dependants accessing dental care, 
especially when there is an ongoing financial demand associated with managing a 
chronic disease such as diabetes.  The evidence within the AIHW (2012b) report 
entitled ‘Chronic disease and oral health’, identified people living with diabetes were 
less likely, than people with any other chronic condition, to make a dental visit for a 
check-up, and less likely to visit a private dental practice (Spencer & Ellershaw, 2011, 
as cited in AIHW 2012b).  This issue is consistent with findings from ‘Australia’s 
dental generations: The national survey of adult oral health 2004–06’, which found 
30.0% of the Australian population aged 15 years or more, who were surveyed 
reported they either delayed or avoided dental care due to the cost (Spencer & Harford, 
2007). 
Despite this evidence, a differing view is reported by the National Advisory 
Committee on Oral Health (2004) that contradicts, in part, the financial burden for 
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people with diabetes to seek regular oral health care, stating “while there is a 
predominance of privately funded dental services, it reinforces a perception by some 
that oral health services are essentially elective in nature, and hence of low priority” (p 
11).  Regardless of the financial barriers, the identified gap in service provision to a 
ever increasing diabetes population neglects to acknowledge the need for improved 
management of not only diabetes related oral health complications, but also the 
ongoing need for preventative oral care, which places the individuals at significant 
future risk. 
 
Referral of patients with oral health complications to the GP.  Within this study 
DHPs identified the availability of multidisciplinary team care arrangements and 
streamlined referral processes as a driving force.  Additionally they identified a greater 
likelihood to recommend referral of the patient to the GP when signs and symptoms of 
oral health conditions were evident (Mean 4.22, SD 0.924, CI 4.04, 4.40).  While this 
may relate to DHPs having greater access to a GP than a dentist, especially within rural 
and remote communities, it may also relate to DHPs’ assessment findings; regarding 
the type and severity of the patients’ oral condition, which influences the referral. 
However, the relationships between the DHPs’ likelihood to refer to the 
GP/dentist when a specific type of oral condition was identified, and their levels of 
concern for those conditions, were not investigated within this current study.  This may 
be an area worthy of research in future studies. 
The DHPs’ referral of the patient with diabetes related oral health complications to 
the patients’ GP for management is not without problems.  Evidence within reports 
entitled, i.e., ‘National oral health plan 2004-2013’, ‘General practice activity in 
Australia 2010–11’, ‘A decade of Australian general practice activity, 2001-02 to 
2010- 11’ and ‘Australia’s health 2010’, show the issues faced by both health 
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professionals and individuals who seek management of oral health complications.  
These issues in management will be elaborated further. 
Evidence of GP management of oral health complications to date within ‘National 
oral health plan 2004-2013’ suggest the number of visits to a GP for dental problems in 
the period 1998 to 2000 were estimated to be in the order of over 500,000 (Britt et al., 
1999, as cited in NACOH, 2004).  However, the allocation of over $10 million of 
Medicare resources to these services was later deemed by the Australian Health 
Ministers’ Advisory Council to be an inappropriate use of medical services for oral 
health problems that were best managed by an oral health practitioner (NACOH, 2004) 
Additionally teeth and gum disease was identified in the ‘General practice activity 
in Australia 2010-2011’ as the problem most likely to result in a GP referral to an 
allied health professional (which includes dentist), with 3.4% of all patient contacts 
resulting in a referral to a dentist.  This accounted for 2.9% of all referrals generated 
within general practice (Britt et al., 2011a).  The review of GP management over the 
past decade indicated referrals both in the number of patients presenting requiring 
dental treatment for problems with their teeth/gum disease, and in GP referral rates to 
dentists for the number of patients encountered had doubled since 2008.  The data 
however, does not identify incidence and prevalence rates of diabetes related oral 
health complications in patients within the general practice setting.  Neither is it known 
whether GP management of patients, who are referred by DHPs for oral health 
complications, occurs in an appropriate, affordable and timely manner which meets 
patients’ satisfaction. 
However, an indicator of the extent of GP management of care for people living 
with diabetes is potentially the RACGP ‘diabetes annual cycle of care’.  The AIHW 
(2010a) reported the percentage of people with diabetes who received entitlement to 
the Medicare Benefits Scheduled rebate for the diabetes annual cycle of care service in 
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2008-2009 was 19.1%, with only 8% of people living in remote areas receiving this 
service.  While the annual cycle of care is considered best-practice management of 
people with diabetes, it does not encompass oral health complication screening as part 
of the care provision. 
From the evidence to date, it appears that despite the AIHW data identifying the 
ever increasing incidence of diabetes in the Australian population, in addition to the 
increased number of patients presenting to GPs with oral health complications (Britt et 
al., 2011b), the current system for planned management of patients with diabetes may 
not identify oral health complications.  This suggests that patients receive a low level 
of oral health service as part of primary health.  Therefore, increased referrals of 
patients with severe oral health complications, as a result of increased screening by 
DHPs, would not be appropriately managed within this setting. 
As can be seen, access to timely, affordable and appropriate oral health services, is 
difficult for the majority of Australians.  A greater level of difficulty exists for those 
who live in rural and remote areas, or have more specific needs.  Given the 
fragmentation in oral health service access and provision, it is comprehensible that 
preventable oral health care is neglected.  For DHPs managing the care of people 
living with diabetes, this study suggests it is not until oral symptoms of advanced 
periodontal disease affects the patient’s diabetes management, general health and 
quality of life, that the individual will seek input from a health professional. 
According to Spencer, Slade, Sendzuik & Harford (2007), patients’ “perceptions 
of dental treatment needs are a complex interplay of people’s current burden of oral 
disease, their expectations, and the availability and obtainability of dental care” p. 245.  
Unfortunately the outcome of this increases the demand upon the finite personnel and 
fiscal resources of Australia’s health system further. 
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Strengths and Limitations of the study 
This is the first Australian study to assess DHPs’ knowledge of diabetes related 
oral health complications, and their scope of practice in managing these conditions in 
people living with diabetes.  The level of evidence achieved within the Australian 
context will not only provide a baseline for which to compare future research, but also 
assist in the development of educational materials, clinical practice guidelines and 
further research studies. 
There were several limitations to this study.  These related to the study 
methodology, sampling method and instrument.  As a result caution is needed in the 
interpretation of the findings and generalising them to other populations of DHPs 
outside of this study.  Potential sources of bias were recognized as threats to the 
internal and external validity of this study and its results, which are discussed further. 
 
Study design.   This study utilised a cross-sectional design.  This design 
investigates a subject of interest and the health variables in the study subjects at a 
single point in time (Levin, 2006); therefore, it is not possible to make judgements 
regarding their cause and effect.  The discussion of the data considered the 
relationships between the variables to meet the study objectives; therefore, the cross 
sectional design was deemed appropriate methodology to achieve this. 
 
Sampling issues.  Members of the ADS and ADEA were recruited as they were 
considered the most appropriate peak body organisations representing DHPs who have 
greater specific knowledge and input into the management of people living with 
diabetes.  It was not anticipated that changes in both the ADS and ADEA executive 
board membership would cause delays, resulting in a secondary approval process of 
the study proposal and documents.  The impact of these changes was the need for a 
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renewal of the Curtin University Human Research Ethics Committee approval.  Access 
to the DHPs was further impeded by the distribution of the study invitation within the 
ADS and ADEA electronic newsletters coinciding with the period where many 
members were absence from their normal duties attending annual international and 
national scientific conferences, or school term holidays. 
 
Response rate.  The expected sample size quoted in Chapter 3 was not achieved 
due to the inability to fully access the ADS and ADEA membership.  This is 
recognised as a significant source of response bias, given the number representing the 
two member associations were significantly different, with membership of the ADS 
significantly under-represented.  The data results achieved from the DHPs may also be 
substantially different from those members who did not participate in the study, and as 
such the results may neither be truly representative nor able to be generalised to the 
wider population of Australian DHPs (Barratt & Kirwan, 2009).  With hindsight, the 
electronic newsletter invitation format singularly, is not considered the most 
appropriate form of distribution.  Potentially clinicians will not read newsletters during 
their busy clinical practice activities, and when administration time is available, will 
often skip over items they consider of lesser importance to them on the day.  An 
individualised invitation distributed by personal email or letter may have achieved a 
greater response to the study invitation.  While this was not an option available in this 
study, future researchers may benefit from the ADS and ADEA supporting a direct 
approach to their memberships.  It  has since been identified that the targeting of a 
paper invitation to members at a trade stand at the ADS/ADEA annual scientific 
conference would more than likely have achieved a greater awareness of the study and 
hence a greater response rate to the study invitation. 
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An extensive literature search was performed to seek an established instrument; 
however, as previous studies have not investigated diabetes health professionals’ 
knowledge of oral health complications or their management within a diabetes 
population, there was an absence of a tool to use within this study.  As a result it was 
necessary to develop a survey tool based upon the literature review, mapping of 
clinical evidence-based guidelines from dental and diabetes associations within the US, 
Canada and Europe, and the research objectives guiding the study.  Response rates to 
individual questions across the survey tool did vary.  Layout of the questionnaire 
during the pilot phase considered the specific grouping of questions to meet the needs 
for requirements for data collection against the three study objectives.  Consideration 
of the likely practices of the participants informed the layout of the questionnaire 
during the pilot phase of the study.  Attempts to keep participants’ interest was 
considered important, and enabled by allowing omission (by skipping) of questions by 
participants that were not applicable to their clinical practice.  Earlier completion of 
the questionnaire by those participants who did not directly see patients in their 
practice was considered appropriate. 
However, the impact of a participant closing the web-based SurveyMonkey 
questionnaire page prior to the completion of the questionnaire was not anticipated.  
The researcher had not foreseen the potential for participants to either be interrupted 
mid-completion and close the web-page, or inadvertently close the webpage instead of 
clicking the ‘next page’ tab on the electronic questionnaire.  As a result, information 
regarding ‘how to re-access’ their partially completed questionnaire had not been 
included at the start of the questionnaire.  During analysis, it was noted that the loss of 
six participants from the survey at Question 11 and a further three at Question 17 
corresponded with the end of the questionnaire pages.  A further 22 participants, 19 of 
whom identified it was not within their scope of practice to perform diabetes and oral 
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assessments, correctly exited the questionnaire at that point.  Therefore a total of 12 
participants did not complete the questionnaire in its entirety as expected.  It is 
recognised therefore, that these occurrences has introduced another source of response 
bias into the data results. 
 
Self-report and recall bias.  In addition, participants’ responses may be 
influenced by what they believe is socially acceptable answers rather than the truth 
(Barratt & Kirwan, 2009).  Participants, although responding anonymously, had a 
personal desire to provide answers that the researcher may see as favourable, or alter 
their responses as a result of not wanting to be seen as being unaware of the issues on 
diabetes and oral health complications.  Participants’ recall of details, such as 
provision of education on diabetes and oral health complications as part of their 
course, or the length of time when last undertaking educational activities, may be 
altered over time thus introducing further bias into the data results. 
 
Study instrument validity and reliability.  The data results achieved within a 
study are considered to have greater meaning when the study instrument is reliable and 
valid (Bland, 2005).  A reliability analysis was undertaken upon the tool generated for 
use within this current study.  To assess the internal consistency of six subscales, the 
Cronbach’s alpha statistic was examined.  Participants’ demographic information, with 
the exception of two items which identified the patient population consulted, were 
omitted from the analysis as the inclusion of these items was deemed by the researcher 
not to be appropriate given their categorical nature.  The reliability coefficients for the 
subscales within the questionnaire ranged from .38 to .87.  Two subscales; the ‘patient 
population managed’, and ‘diabetes and oral health complications education’, showed 
a Cronbach’s alpha <.70, which suggested they were not reliable measures within the 
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study.  The correlations between each item and the remaining items’ scale scores in 
was examined in order to test the items internal consistency The descriptive statistics 
for the reliability analysis of the items are described in Appendix W. 
The removal of lower scoring items (less than <.40) from these subscales, in order 
to increase the internal consistency, did not result in an improvement in the Cronbach’s 
alpha scores to the acceptable minimum level of >.70.  In accordance with that 
reported by Peat (2001), the removal of items was not considered favourable as this 
approach severely limits the ability to capture clinically important data across a broad 
range of domains, with the results being of limited value within this cross sectional, 
descriptive study.  Peat reports “It is better to sacrifice internal consistency for content 
validity, that is, to maintain a broad scope by including questions that are both 
comprehensive in the information they obtain and are easily understood.”(p. 109).  As 
such, attempts to improve the validity of this study have taken a balanced approach 
which considered the clinical experience of pilot phase team members and their 
interpretation of each item, the aims of the study, the length of the questionnaire for 
participants, the interpretation of the data test results, and the repeatability statistics 
achieved.  Further psychometric tests were not undertaken on the scale questions, with 
this recognised as a weakness of this study.  However, an assessment of the data 
indicated further tests would be of limited value in confirming reliability. 
 
Statistical analysis.  Data screening indicated small sample size across the health 
professional categories resulted in the skewing of data results across the variables: ‘the 
undertaking of education in diabetes and oral health complications’, ‘the levels of 
confidence to assess oral health signs and symptoms’, and ‘provide diabetes and oral 
health information to patients’ in particular.  The normality of the data could not be 
assured despite regrouping of appropriate variables and the logarithmic 
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transformations.  Therefore, the tests of significance were limited to the non-
parametric methods such as the Chi-Square with Fishers Exact Tests, Mann-Whitney 
Tests and Pearson’s Rank Correlation Tests.  While these were applied appropriately 
and consistently to maintain the validity of the study data, it is recognised the use of 
these distribution-free tests may have resulted in a loss of power to detect clinically 
important differences.  Thus, a type II error in the reporting of non-significant data 
results may have erroneously occurred (Peat, 2001). 
 
Recommendations 
There are a number of recommendations that arise from this study.  Before the 
findings of this study can be considered valid, the validity and reliability of the study 
instrument must be tested using a larger sample of Australian DHPs.  A future 
Australian study may consider including countries such as New Zealand, Canada and 
America, with appropriate adjustment to the study tool to reflect the ethnic differences 
that exist in patients residing in those countries.  New Zealand, Canadian and 
American health systems provide for DHP practices and management of diabetes that 
is similar to that undertaken by Australian DHPs.  The knowledge to be gained from 
future studies could have a positive impact upon practices and policies addressing the 
needs of people living with diabetes. 
This current study identified a need for more education and training in oral health 
complications and assessment skill mastery.  To address the limitation in DHPs’ 
knowledge and confidence to undertake oral health practices, it is recommended that 
an education programme be developed and delivered by the ADS and ADEA.  To 
achieve maximum exposure to members, these activities should be provided at both 
National and State conferences. 
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The DHPs in this study indicated their scope of practice in diabetes related oral 
health complications was limited by not only their lack of knowledge and levels of 
confidence to undertake practice in their clinical setting, but also by a lack of guidance.  
This could be remedied with the provision of a clinical guideline and diabetes specific 
oral health assessment tool to focus the DHPs’ attention towards assessment of their 
patients’ oral cavity.  This is especially so when specific signs and symptoms, or risk 
factors for oral complications are identified.  As diabetes is a significant factor in the 
pathogenesis of periodontal disease, it would appear that a group of DHPs committed 
to quality improvement from within the ADS and ADEA would be best placed to 
develop these clinical tools further. 
Finally, the biggest barrier to DHPs’ provision of improved care in the area of 
diabetes related oral health complications identified from this study was the limited 
access to oral health services.  The availability and access to affordable dental care, 
particularly for those whose income is marginally above the minimum level to receive 
public dental services was a major factor identified from DHPs’ statements.  In the 
absence of public oral health services, private dental fee-for-service was prohibitive for 
many seeking care, with rebates only available if they afforded private health 
insurance.  As a result, a significant proportion of people living with diabetes were 
reported as not seeking regular long-term management of their oral health.  The 
outcome of which is a state of poor dentition with progression to periodontal disease, 
and poorer outcomes associated with their diabetes management.  Given the ever 
increasing rate of diabetes within Australia, it is a recommendation that the 
Commonwealth Government reconsider the specific oral health needs of people living 
with diabetes and make provision for the funding of a diabetes-specific oral health 
service.  In order to meet the service gap identified from this study authorised DHPs, 
as currently occurs under the Australian National Diabetes Supplies Scheme, would be 
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entitled to directly refer patients to this service, who they have assessed and identified 
as being individuals at high risk for oral health complications. 
 
Conclusion 
This study has assessed the Australian DHPs’ level of knowledge of oral health 
issues which impact upon the person with diabetes.  It has described the scope of 
practice regarding intervention, health promotion and care management of the oral 
health issues.  It has identified the restraining and driving forces that influence DHPs’ 
provision of oral health care interventions for people with diabetes in Australia.  The 
findings of this study were discussed in the context of the current health system 
policies and their impact upon DHP management of diabetes related oral health 
complications. 
Although the results of this study are not able to be generalised beyond the sample 
of Australian DHPs surveyed, the finding have shown DHPs do possess knowledge of 
the more common oral health complications that may develop in people with diabetes, 
and may potentially identify these in a patient presenting at a consultation, however 
they are unable to recognise the association of the more obscure signs and symptoms 
of oral complications.  As such they may not correctly identify the conditions in the 
patient under their care. 
DHPs’ knowledgebase of oral health is limited.  The receipt of education in 
diabetes related oral health complications amongst the DHPs varied significantly.  It 
appears that Australian DHPs do not receive adequate education and training to 
manage oral health complications within diabetes care.  This is most likely related to 
the limited promotion of diabetes related oral health complications within the 
Australian medical, nursing and allied health professional curricula and diabetes-
specific medical literature.  DHPs have traditionally received little in the way of 
training in oral health.  They lack the skill mastery to confidently assess their patients’ 
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oral cavity, and provide diabetes related oral health information, the absence of the 
clinical practice guideline and diabetes-specific oral health screening tool contributes 
to this deficit.  As a result many DHPs identified oral health complication management 
was outside of their scope of practice. 
Overwhelmingly DHPs acknowledged the significance of an increased risk of oral 
health problems in the person living with diabetes.  This positively illustrates that 
DHPs are aware of the potential for oral health complications within the clinical 
practice setting.  The management of patients who DHPs considered to be at risk 
because they were within a specific needs category were not managed differently from 
the general population of patients with diabetes who they consulted.  However, there 
was a strong association between the DHPs’ acknowledgement of increased risk of 
oral complications with the increased levels of likelihood to investigate the patients’ 
complaints of signs and symptoms.  Furthermore, higher scores in levels of confidence 
to assess the oral health status and provide diabetes related oral health information to 
patients were detected when other diabetes complications were identified in the 
individual. 
This is an encouraging sign.  The DHPs were cognisant of the need to monitor 
outcomes for people that were at greater risk.  The DHPs’ levels of confidence to 
assess oral signs and symptoms, to provide diabetes related oral health information, 
and to recommend treatment options to their patients’ could be increased through 
provision of education.  Opportunities to enhance assessment skills would be most 
effective if offered within the forums provided by the ADS and ADEA.  In addition, 
the promotion of oral health complications from within the member organisations with 
their support for the development of both a clinical practice guideline and diabetes 
specific assessment tool would enable DHPs to practice with greater levels of 
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confidence and thus increase the levels of concern and likelihood to recommend 
treatment options to patients who are affected by oral health complications. 
This study has shown there is a potential to change the practice behaviours of 
DHPs, especially in those who have previously believed oral health complication 
management is outside of their scope of practice.  However, the driving and restraining 
forces for DHP management of patients experiencing oral health complications are 
predominately those related to the current health system policies which determine the 
delivery of oral health services across the metropolitan, regional and remote areas of 
Australia.  While education and skill mastery can go some way towards improving 
outcomes in care, it is ultimately the provision of oral health services which needs the 
greatest change.  With increased education of DHPs in the area of diabetes related oral 
health complications, it is hoped that a united voice will sound from members of the 
ADS and ADEA to advocate for Commonwealth Government recognition of the 
impact of oral health complications on the lives of people with diabetes.  Only then 
will change in policy and funding for programs which will meet this area of specific 
need be forthcoming to enable Australia’s DHPs to practice to their full potential. 
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DIABETES AND ORAL HEALTH COMPLICATIONS: KNOWLEDGE AND 
SCOPE OF PRACTICE QUESTIONNAIRE   
 
1. Which of the following organisations are you currently a member of? 
 Australian Diabetes Society 
 Australian Diabetes Educators Association 
 
2. Are you a credentialed member of the ADS or ADEA organisations? 
 Yes 
 No 
 
3. What is your principle profession? (Please select ONE only) 
 Endocrinologist 
 Registered Medical Practitioner 
 Scientist 
 Diabetes Nurse Educator 
 Nurse Practitioner 
 Dietitian 
 Pharmacist 
 Podiatrist 
 Other (please specify) 
 
4. Do you work solely in diabetes care? 
 No, I work in a generalised health care area → go to Question 6 
 Yes  
 Other (please specify)  
 
5. How many years of experience do you have specifically in diabetes care? 
(Please round to the nearest category) 
 Less than 1 year 
 1 to 5 years 
 6 to 10 years 
 11 to 15 years 
 16 to 20 years  
 21 to 25 years  
 More than 25 years  
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6. What is your primary employment setting?  (Please select ONE only) 
 Private practice 
 GP practice 
 Public hospital  
 Private hospital 
 Community health centre  
 Other (please specify)  
 
7. What is the postcode of this position? 
 
8. Do you work directly with patients/clients in your role?  
 No → go to question 11 on the next page 
 Yes 
 
9. What is the age group of the patients/clients with whom you work?  (Please 
number in sequence, 1, 2, 3, where 1 indicates the patients/clients you see most.   
Please record a 0 if you do not see the age group) 
 Paediatrics  
 Adolescents 
 Adults 
 
10. Do you work with patients/clients who are from the following groups? (Please 
select all that apply) 
 Pregnant women 
 Physically and intellectually disabled 
 Aboriginal and Torres Strait Islander 
 Other clients from CALD (culturally and linguistically diverse) backgrounds 
 Residential aged care clients 
 Clients within secure facilities 
 Rural and/or Remote communities 
 No, I do not see any of the above patient/client groups 
  Other (please specify type of patient/client) 
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11. Was oral health complications in diabetes covered during your professional 
education? 
 Yes 
 No 
 Cannot recall 
 
12. Have you ever attended an education session on diabetes and oral health 
complications? 
 No → go to Question 14 
 Yes,  attended this in last 5 years 
 Yes,  attended this more than 5 years ago 
 
13. In what form was this education delivered? (Please select ONE only) 
 University lecture 
 A professional association conference session /seminar  
 Industry sponsored seminar  
 In-service session delivered by a member of the health care team 
 Other (please specify)  
 
14. Have you undertaken any self-directed learning in the area of diabetes and 
oral health complications? 
 No → go to Question 16 
 Yes 
 
15. Which of the following forms did you use to acquire extra knowledge? (Please 
select ONE only) 
 CD-rom self-instructional tools 
 Web-based instructional modules 
 Core textbooks 
 Journals 
 All/Most of the above 
 Other (please identify the education form)  
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16. Research indicates that diabetes is known to be associated with certain oral 
manifestations.   
From your clinical experience and knowledge of diabetes, is there an 
association between diabetes and the following oral health problems? 
   Yes No Don’t know 
 
Glossodynia and or stomatopyrosis    
 (Burning mouth syndrome)  
Candidiasis     
Dental caries     
Gingivitis      
Mouth ulcers     
Lichen planus 
 (Lichenoid autoimmune mucositis)    
Oral neurosensory dysesthesia    
 (Well localised, irritating sensations)  
Oral cancerous lesions     
Periodontitis     
Excessive salivation     
Taste impairment      
Xerostomia     
 (Dry mouth) 
Dysphagia     
 (Difficulty swallowing) 
 
17. “The significance of an increased risk of oral health problems in people with 
diabetes is only relevant if the patient/client has been diagnosed with another 
diabetes related complication”. 
When considering this above statement, I.. 
 
Strongly disagree 1 2 3 4 5 Strongly agree  
 
18. On a scale of 1 to 5 (1 being not confident and 5 being very confident), please 
indicate how confident you feel in: 
a. Assessing oral health signs and symptoms in the people with diabetes you 
see?  
 Not confident  1 2 3 4 5 Very confident 
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b. Providing diabetes related oral health information to the patients/clients 
you see? 
 Not confident  1 2 3 4 5 Very confident 
 
19. If a patient/client with diabetes presents with signs of diabetes related 
complications e.g. retinopathy, nephropathy, neuropathy; how likely are you 
to investigate for signs and symptoms of dental problems at this consultation? 
Please indicate: 
Highly unlikely  1 2 3 4 5 Highly likely 
 
20. In considering provision of care to people with diabetes, which health 
professionals do you consider has a role in the assessment and management of 
diabetes related oral health care? 
 
21. What factors will influence your ability to improve the diabetes related oral 
health care for people that you manage?  (Please select all that apply) 
 
 None, I consider it outside my professional scope of practice 
 Further ‘diabetes and oral health care’ professional development  
 On line chat group 
 Diabetes and oral health clinical practice guidelines 
 ‘Diabetes and oral health care” education pamphlets for patients/clients 
 ‘Oral Health Care Services’ information pamphlets for patients/clients 
 Greater access to dental services 
 Streamlined referral processes 
 Medicare item provision 
 Multidisciplinary team care arrangements 
 Other (please specify) 
 
22. What do you consider are barriers to you being able to provide diabetes 
related oral health care in your practice? (Please select all that apply) 
 
 Not in my professional scope of practice 
 Lack of knowledge of diabetes and oral health issues 
 Lack of clinical practice guidelines 
 Lack of referral processes 
 Lack of access to dental services 
 Lack of reimbursement for management time required 
 Lack of time to include oral health issues in my management of diabetes 
 Lack of recognition of my role in diabetes and oral health education 
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 Other (please specify) 
 
23. When assessing/screening for complications in the person with diabetes, how 
often would this include oral health signs and symptoms?  
 Never, it is not within my scope of practice to perform diabetes and oral health 
assessments → if you have selected this response you have completed the 
survey. 
 Each visit 
 Quarterly 
 Half yearly 
 Yearly  
 I do not routinely perform diabetes and oral health assessments  
 Other (please specify) 
 
24. Please indicate which of the following actions are included in your assessment 
of the patient/client with diabetes.  (Please select all that apply) 
 Routine oral health screening questions 
 Specific diabetes and oral health risk assessments 
 Discuss risk-related behaviours and outcomes upon oral health e.g. poor oral 
hygiene, smoking and glycaemic control  
 Discuss preventative oral health care behaviour e.g. brushing, flossing and 
mouthwash use 
 I recommend to the patient that they attend a dentist/periodontist appointment 
for assessment and care follow -up 
 I refer to a dentist/periodontist if I perceive the need 
 
25. In which presenting circumstances, would you investigate the oral health 
status of this patient/client?  (Please select all that apply) 
 When the patient/client is hyperglycaemic with known cause 
 When the patient/client is hyperglycaemic without identified cause 
 When the patient/client is pregnant or planning pregnancy 
 Only when a specific oral health concern or complaint is identified by the 
patient/client 
 When referred by a dentist/periodontist 
 Other (please specify) 
 
26. A person with diabetes presents with a complaint of a “sore mouth” and a 
history of mouth ulcers.  Please indicate which of the following actions you 
are likely to undertake at this consultation?  
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  Yes No 
a. Inspection of the hard and soft tissues in the mouth cavity   
b. Inspection of the teeth    
c. Note number of teeth present or missing   
d. Note presence of oral infections   
e. Note presence of oral lesions    
f. Document oral findings and diagnosis   
g. Question the patient regarding: 
I. Glycaemic control    
II. Frequency of personal dental care activity   
III. Frequency of professional dental care visits   
IV. Recent changes in taste sensation   
V. Recent changes to food choices in respect to flavours   
VI. Oral medications intake   
VII. Level of hydration    
VIII. Referral to dentist/periodontist   
h. Other actions undertaken (please 
specify) 
 
27. The patient /client who complained of a sore mouth and a history of mouth 
ulcers now reports further symptoms.  You conduct an assessment of the oral 
cavity and find the following problems. 
Please indicate on a scale of 1 to 5 (1 being no concern and 5 being very 
concerned), the level of concern you would have. 
 
a. Bleeding gums when brushing: 
 No concern   1 2 3 4 5 Very concerned 
  
b. Loose teeth: 
 No concern   1 2 3 4 5 Very concerned 
 
c. Changes in the way the teeth fit together: 
 No concern   1 2 3 4 5 Very concerned 
 
d. Pain when chewing: 
 No concern   1 2 3 4 5 Very concerned 
 
e. Red, swollen or tender gums: 
 
Appendix A: Sample Study questionnaire 
178 
 No concern   1 2 3 4 5 Very concerned 
 
f. Noted halitosis or is informed by others of breath odour: 
 No concern   1 2 3 4 5 Very concerned 
 
g. Tartar formation: 
 No concern   1 2 3 4 5 Very concerned 
 
28. A patient/client presents complaining of a symptom of a “dry mouth”.  Please 
indicate on a scale of 1 to 5 (1 being highly unlikely and 5 being highly likely), 
how likely you are to suggest the following recommendations in treatment 
options to this person?  (Please select all that apply) 
 
 
 
 
 
a. To use sugarless gum    1 2 3 4 5 
 
b. To use sugarless mints    1 2 3 4 5 
 
c. To take frequent sips of water or ice chips 1 2 3 4 5 
 
d. To restrict caffeine intake    1 2 3 4 5 
 
e. To restrict alcohol intake    1 2 3 4 5 
 
f. To rinse with fluoride mouthwashes  1 2 3 4 5 
 
g. To use saliva substitutes    1 2 3 4 5 
 
h. To improve glycaemic control    1 2 3 4 5 
 
i. To undergo a medication review   1 2 3 4 5 
 
j. Referral to the GP for review    1 2 3 4 5 
 
k. Referral to dentist/periodontist for review 1 2 3 4 5 
 
  
Thank you for your time in completing this survey. 
Catherine McLaine, RN, CDE. 
 
Highly 
Unlike1y  
  1 
 
    
 2 
 
    
 3 
 
 
 4 
Highly  
Likely 
   5 
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Ms Helen McCausland,  Catherine McLaine, 
Podiatry Department,  10 Umfrevilles Road, 
7th floor, A block  Kaoota,   7150,  
Royal Hobart Hospital. 13/08/2009 
 
Dear Helen, 
I am enrolled within the Master of Science (Research) course at Curtin University of 
Technology in Western Australia.  I am currently undertaking a study into diabetes and 
oral health complications, looking specifically at the Australian diabetes health care 
providers’ knowledge and scope of practice in this area or need. 
An extensive literature search has failed to identify any established instruments 
suitable for inclusion within this study.  I have therefore, developed a quantitative 
questionnaire based upon the an extensive literature review, mapping of clinical 
evidence-based guidelines from Dental and Diabetes Associations within the United 
Stated of America, Canada and Europe and the research objectives guiding the study. 
The instrument is comprised of three parts: 1. Socio-demographic data:  six questions 
survey, professional membership, employment setting and diabetes population 
managed; 2. Diabetes and oral health education: four knowledge questions including 
the form of education received and 3. Practice and Efficacy: eleven questions relate to 
diabetes and oral complication management practices undertaken and the level of 
confidence in decision making.  The form of questioning is a mixture of open, closed 
and Likert scale items. 
I am requesting your assistance in reviewing the enclosed questionnaire to enable 
modifications to be made to ensure the validity and reliability of this instrument prior 
to circulation to the Australian Diabetes Society (ADS) and Australian Diabetes 
Educators Association (ADEA) members. 
Review of this instrument will require: 
1. Completion of the questionnaire twice.  I will provide you the instrument upon 
two separate occasions to measure the test-retest reliability.  
2. I will also require you to complete a separate scale against each of the questions 
contained within the questionnaire.  This measurement of the content validity of 
the instrument can be completed after the first administration of the questionnaire.   
I understand that as you are not a current member of the proposed sample of ADS or 
ADEA organisation membership, that you will not be included within the final study.  
Your expert opinion as a care provider to people living with diabetes is highly valuable 
to my study and I am grateful for your time and effort in participating in this pilot 
phase of the study. 
Yours sincerely 
 
Catherine McLaine, 
Clinical Nurse/Credentialed Diabetes Educator, 
RHH Diabetes Centre, 7th Floor A Block
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Content Validity Index (Waltz, C.F and Bausell, R.B., 1983) 
Question 
Number 
Relevance 
1= Not relevant 
2=Item needs 
some revision 
3=Relevant but 
needs minor 
revision 
4= Very relevant 
Clarity 
1= Not clear 
2=Item needs 
some revision 
3=Clear but 
needs minor 
revision 
4= Very clear 
Simplicity 
1= Not simple 
2=Item needs some 
revision 
3=simple but needs 
minor revision 
4= Very simple 
Ambiguity 
1= Doubtful 
2=Item needs some 
revision 
3=No doubt but 
needs minor 
revision 
4= Meaning is clear 
Suggested changes 
1      
2      
3      
4      
5      
6      
7      
8      
9      
10      
11      
12      
13      
14      
15      
16      
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DIABETES AND ORAL HEALTH COMPLICATIONS: KNOWLEDGE AND 
SCOPE OF PRACTICE QUESTIONNAIRE  
 
1. Which of the following organisations are you currently a member? 
 Australian Diabetes Society 
 Australian Diabetes Educators Association 
 
2. To which professional category do you belong? 
 Endocrinologist 
 Registered Medical Practitioner 
 Scientist 
 Diabetes Nurse Educator 
 Nurse Practitioner 
 Accredited Practicing Dietitian 
 Registered Pharmacist 
 Podiatrist 
 Other_____________________________________ 
 
3. How many years of experience do you have specifically in diabetes care 
management? 
 Less than 1 year 
 1 to 5 years 
 5 to 10 years 
 10 to 15 years 
 15 to 20 years  
 20 to 25 years  
 More than 25 years  
 
4. What is your current employment setting?  (Please select all that apply) 
 Private practice 
 GP practice 
 Public hospital  
 Private hospital 
 Community health centre  
 Other_______________________________________ 
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5. With which client population do you work?  (Please select all that apply) 
 Paediatrics 
 Adolescents 
 Adults 
 Pregnant women 
 Physically and intellectually disabled 
 Aboriginal and Torres Strait Islander 
 Clients from CALD (culturally and linguistically diverse) backgrounds 
 Residential aged care clients 
 Clients within secure facilities 
 Rural and/or Remote communities 
 Other_______________________________________________ 
 
6. What is the postcode of your main position in diabetes care?  
 
7. Have you ever attended an education session on diabetes and oral health 
complications?  
 Yes1  →  go to Q 8 
 No2   →  go to Q 9 
 
8. In what form has this education been delivered? (Please select all that apply) 
 A professional body conference session 
 University lecture 
 Industry sponsored seminar  
 Peer delivered in-service session 
 Independent learning  
 CD-rom self-instructional tools 
 Web-based instructional modules 
 Core textbooks 
 Journals 
 Other________________________________________ 
 
9. Was diabetes and oral health complications content covered during your 
endocrinology studies or diabetes education course? 
 Yes1 
 No2 
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10. Research indicates that diabetes is known to be associated with certain oral 
manifestations.   
From your clinical experience and knowledge of diabetes, is there an 
association between diabetes and the following oral health problems? 
 
 Yes1 No2 
Burning mouth syndrome   
Candidiasis   
Dental caries   
Gingivitis    
Glossodynia and or stomatopyrosis   
Mouth ulcers   
Lichen planus   
Neurosensory dysesthesia   
Oral cancerous lesions   
Periodontitis   
Excessive salivation   
Taste impairment    
Xerostomia   
Dysphagia   
 
11. “The significance of an increased risk of oral health problems in people 
with diabetes is only relevant if the patient has been diagnosed with another 
diabetes related complication”. 
When considering this above statement, I.. 
 
Strongly disagree  1 2 3 4 5 Strongly agree 
  
 
12. On a scale of 1 to 5 (1 being not confident and 5 being very confident), please 
indicate how confident you feel in assessing oral health signs and symptoms 
in the diabetic patients you see?  
 
 Not confident    1 2 3 4 5 Very confident 
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13. On a scale of 1 to 5 (1 being not confident and 5 being very confident), please 
indicate how confident you feel in providing diabetes related oral health 
information to the patients you see? 
 
 Not confident    1 2 3 4 5 Very confident 
 
 
14. If a client/patient with diabetes presents with signs of diabetes related 
complications e.g.  retinopathy, nephropathy, neuropathy; how likely are you 
to investigate for signs and symptoms of dental problems at this 
consultation? 
 
 Highly unlikely   1 2 3 4 5 Highly likely 
 
 
15. When performing complication screening tests in the diabetic patient, how 
often would this include oral health signs and symptoms?  
 Each visit 
 Quarterly 
 Half yearly 
 Yearly  
 Other__________________________________________  
 I do not routinely perform oral health assessments  
 
16. Please indicate which of the following you undertake with your diabetic 
patients.  (Please select  all that apply) 
 Oral health screening questions 
 Oral health and diabetes risk assessment  
 Discuss risk-related behaviours and outcomes upon oral health e.g. poor oral 
hygiene, smoking and glycaemic control  
 Discuss preventative oral health care behaviour e.g. brushing, flossing and 
mouthwash use 
 I recommend to the patient that they attend a dentist/periodontist 
appointment for assessment and care follow -up 
 I refer to a dentist/periodontist if I perceive the need 
 
17. In which presenting circumstances, would you investigate the oral health 
status of this patient?  (Please select  all that apply) 
 When the patient is ill with known cause 
 When the patient is ill without identified cause 
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 When the patient is pregnant or planning pregnancy 
 Only when a specific oral health concern or complaint is identified by the 
patient 
 When referred by a dentist/periodontist 
 Other________________________________________ 
 
18. A person with diabetes presents with a complaint of a “sore mouth” and a 
history of mouth ulcers.  Please indicate which of the following actions you 
are likely to undertake at this consultation?  
   Yes1 No2 
a. Inspection of the hard and soft tissues in the mouth cavity   
b. Inspection of the teeth     
c. Note number of teeth present or missing   
d. Note presence of oral infections   
e. Note presence of oral lesions    
f. Document oral findings and diagnosis   
g. Question the patient regarding: 
i. Glycaemic control    
ii. Frequency of personal dental care activity   
iii. Frequency of professional dental care visits   
iv. Changes taste sensation   
v. Food choices in respect to flavours   
vi. Use of oral medications   
vii. Level of hydration    
viii. Referral to dentist/periodontist   
h. Other actions undertaken_____________________________ 
 
19. The above patient reports further symptoms in conjunction with your 
assessment of the oral cavity.  Please indicate on a scale of 1 to 5 (1 being no 
concern and 5 being very concerned), the level of concern you would have, if 
the patient is also identified as having the following problems: 
 
a. Bleeding gums when brushing: 
  No concern   1 2 3 4 5 Very concerned 
  
b. Loose teeth: 
  No concern   1 2 3 4 5 Very concerned 
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c. Changes in the way the teeth fit together: 
  No concern   1 2 3 4 5 Very concerned 
 
d. Pain when chewing: 
  No concern   1 2 3 4 5 Very concerned 
 
e. Red, swollen or tender gums: 
  No concern   1 2 3 4 5 Very concerned 
 
f. Noted halitosis or is informed by others of breath odour: 
  No concern   1 2 3 4 5 Very concerned 
 
g. Tartar formation: 
  No concern   1 2 3 4 5 Very concerned 
 
 
20. A patient presents complaining of a symptom of a “dry mouth”.  Please 
indicate on a scale of 1 to 5 (1 being highly unlikely and 5 being highly likely), 
how likely you are to suggest the following recommendations in treatment 
options to this patient?  (Please select all that apply) 
 
 
 
 
 
a. Using sugarless gum  1 2 3 4 5 
 
b. Using sugarless mints  1 2 3 4 5 
 
c. Frequent sips of water or ice chips 1 2 3 4 5 
 
d. Restricting caffeine/ETOH intake 1 2 3 4 5 
 
e. Rinsing with fluoride mouthwash 1 2 3 4 5 
 
f. Use of saliva substitutes  1 2 3 4 5 
 
g. Improving glycaemic control 1 2 3 4 5 
 
h. Undergoing a medication review 1 2 3 4 5 
 
i. Referral to GP for review 1 2 3 4 5 
 
j. Referral to dentist/periodontist for review 1 2 3 4 5 
  
Highly 
unlikely 1 
 
 
2 
 
3 
 
4 
Highly  
Likely 5 
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21. What changes would assist you in being able to improve the oral health care 
in the people with diabetes you manage? 
 
_________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
 
Thank you for your time in completing this survey. 
Catherine McLaine, RN, CDE.
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Diabetes and Oral Health Complications:  Knowledge and Scope of Practice questionnaire amendments 
Pilot phase question stem and/or 
answer options 
Adjustment made to question stem and/or 
answer options for final version 
Rationale for change 
Section One: Socio-demographic questions 
“To which professional category do you 
belong?” 
With an answer option: “Accredited 
Practicing Dietitian”. 
“What is your principle profession?” 
 
Changed to read “Dietitian”. 
Improved clarity of question 
Pilot phase testing indicated that not all Dietitians may 
be accredited. 
How many years of experience do you 
have specifically in diabetes care 
management? 
The categories indicating the years of 
experience, other than less than one year and 
more than 25 years, were changed to five 
year increments 
Numbered to ensure exclusivity in respondent’s 
answers for data analysis. 
“What is your current employment 
setting? (Please select all that apply)” 
What is your primary employment setting? 
(Please select ONE only)”. 
Identified that diabetes care providers often work 
across several organisations/have varied or multiple 
roles in their place of employment. 
Single forced ranking to capture respondent’s role 
where they spent the most time in diabetes care and to 
ensure sufficient numbers within the categories to 
enable the statistical t-test and ANOVA to be 
undertaken on the data.  
Question stems containing the word 
‘patient’ 
‘patient/client’ To reflect varied service delivery models 
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Pilot phase question stem and/or answer 
options 
Adjustment made to question stem and/or 
answer options for final version 
Rationale for change 
“With which client population do you 
work? (Please select all that apply)” 
“What is the age group of the 
patients/clients with whom you work?  
(Please number in sequence, 1, 2, 3, where 1 
indicates the patients/clients you see most.   
Please record a 0 if you do not see the age 
group)”. 
and 
“Do you work with patients/clients who are 
from the following groups? (Please select all 
that apply)”. 
Improved data collection from splitting answer 
option into two new questions and rewording of the 
question stems.  
The numbering allocation in the answer allows for an 
improved data collection in each variable and data 
analysis which identifies frequency counts for each 
age group. 
Allows identification of the association between risk 
factors for diabetes and oral health complications in 
the diabetes type by age category. 
“What is the postcode of your main 
position in diabetes care?” 
“What is the postcode of this position?”   Rewording reflected an improved relationship to the 
previous question regarding the respondent’s primary 
employment setting. 
Enabled comparison of frequency counts of 
respondents and cross tabulation analysis of 
knowledge and scope of practice questions with 
Australian state. 
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Pilot phase question stem and/or 
answer options 
Adjustment made to question stem 
and/or answer options for final version 
Rationale for change 
Section Two:  Diabetes and oral health education questions 
“Have you ever attended an education 
session on diabetes and oral health 
complications?” with the answer options: 
“Yes and No”. 
“No, go to question 14, Yes, attended in last 
5 years and Yes, attended more than 5 years 
ago”.   
Allowed the respondent to skip questions regarding 
education if not applicable to them. 
Allowed analysis of the extent and currency of the 
respondent’s knowledge in diabetes and oral health 
complications. 
“In what form has this education been 
delivered? (Please select all that apply)” 
with answer options: “A professional 
body conference session; University 
lecture; Industry sponsored seminar; Peer 
delivered in-service session; Independent 
learning CD-rom self instructional tools; 
Web-based instructional modules; Core 
textbooks; Journals; and Other”. 
Three new questions formed: 
“In what form was this education delivered? 
(Please select ONE only)” with answer 
options:  “University lecture; A professional 
association conference session/seminar; 
Industry sponsored seminar; In-service 
session delivered by a member of the health 
care team; and Other (Please specify)”. 
And 
“Have you undertaken any self directed 
learning in the area of diabetes and oral 
health complications?” With the answer 
options: “No, go to Question 15 and “Yes” 
And 
“Which of the following forms did you use 
to acquire extra knowledge? (Please select 
ONE only)” with answer options: “CD-rom 
self instructional tools; Web-based 
Allowed the respondent to skip questions that were not 
applicable to them.  To keep themed questions grouped 
together thus improving the flow of questioning in 
order to keep respondent interest.   
 
 
 
Enabled collection of data regarding formal versus self-
directed education which in the analysis of the data is 
considered in the context of resources and enabling 
factors for practice. 
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instructional modules; Core textbooks; 
Journals; All/most of the above; and Other 
(please identify the education form)”. 
Pilot phase question stem and/or 
answer options 
Adjustment made to question stem 
and/or answer options for final version 
Rationale for change 
“Was diabetes and oral health 
complications content covered during 
your endocrinology studies or diabetes 
education course?”  The answer options 
were “Yes and No”. 
“Was oral health complications in diabetes 
covered during your professional 
education?”  With answer options “Yes, No 
and Cannot recall”.   
Pilot testing indentified need for wording which was 
more inclusive of Allied Health Professional categories 
and/ respondents who had did not have these specific 
course qualifications. 
“Research indicates that diabetes is 
known to be associated with certain oral 
manifestations.  From your clinical 
experience and knowledge of diabetes, is 
there an association between diabetes 
and the following oral health problems?” 
The answer options were “Yes and No”.   
Addition of some ‘layman’s terms’ for the 
more unusual medical terminology in the 
question along with the addition of the 
‘Don’t know’ answer option.  
Pilot testing identified a health professional should 
have the option of identifying a lack of knowledge in 
the clinical area rather than a forced ranking of ‘yes’ or 
‘no’, which may result in an inaccurate capture of the 
participant’s level of knowledge. 
The concern that a health professional may not want to 
be identified as not knowing information that others 
may perceive as necessary, was considered further.  A 
decision to identify to the within the Participant 
information sheet (Appendix 3) the statement: “Some 
content within the questionnaire may be unfamiliar to 
all members, however your responses to each question 
is highly valuable in the overall results of this study and 
are welcomed”. 
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Pilot phase question stem and/or 
answer options 
Adjustment made to question stem and/or 
answer options for final version 
Rationale for change 
Section Three:  Diabetes and oral health complication management practice questions 
On a scale of 1 to 5 (1 being not confident 
and 5 being very confident), please 
indicate how confident you feel in 
assessing oral health signs and symptoms 
in the diabetic patients you see?”   And 
“On a scale of 1 to 5...how confident do 
you feel in providing diabetes related oral 
health information to the patients you 
see?” 
Two questions combined to become one 
question, number 18 in the final version with 
two parts two parts: a) “Assessing oral health 
signs and symptoms in the people with 
diabetes you see?” and b) “Providing diabetes 
related oral health information to the 
patients/clients you see? 
Improved wording and removal of excess question. 
The single question stem reflected the same wording 
for a Likert scale of confidence. 
When performing complication screening 
tests in the diabetic patient, how often 
would this include oral health signs and 
symptoms? With answer options: “Each 
visit; Quarterly; Half yearly; Yearly; 
Other; and I do not routinely perform oral 
health assessments”. 
“When assessing/screening for complications 
in the person with diabetes, how often would 
this include oral health signs and symptoms?” 
with answer options:  “Never, it is not within 
my scope of practice to perform diabetes and 
oral health assessments → if you have 
selected this response you have completed 
the survey; Each visit; Quarterly, Half yearly; 
Yearly, I do not routinely perform diabetes 
and oral health assessments; and Other 
(please specify)” option. 
Inclusion of the wording ‘Never, not within my 
scope of practice’ enabled the respondent who does 
not perform diabetes and oral health complication 
screening to exit the survey thereby skipping the 
final four questions which related to the 
circumstances and actions undertaken in clinical 
practice when screening the patient/client for 
diabetes and oral health complications. 
The wording and order of the last two answer 
options allow identification of the respondent who 
may perform the ad hoc oral health assessment as 
part of diabetes care. 
The ‘Other’ option allowed the respondent to 
identify more specific or individualised information 
about their clinical practice. 
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Pilot phase question stem and/or 
answer options 
Adjustment made to question stem and/or 
answer options for final version 
Rationale for change 
“Please indicate which of the following 
you undertake with your diabetic patients.  
(Please select  all that apply)” with answer 
options “Oral health screening questions; 
Oral health and diabetes risk assessment; 
Discuss risk-related behaviours and 
outcomes upon oral health e.g. poor oral 
hygiene, smoking and glycaemic control; 
Discuss preventative oral health care 
behaviour e.g. brushing, flossing and 
mouthwash use; I recommend to the 
patient that they attend a 
dentist/periodontist appointment for 
assessment and care follow-up; and I refer 
to a dentist/periodontist if I perceive the 
need”. 
First and second answer options reworded as 
‘Routine oral health screening questions’ and 
‘Specific diabetes and oral health risk 
assessments’. 
Allowed the respondent to more accurately identify 
their screening practices. 
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“In which presenting circumstances, 
would you investigate the oral health 
status of this patient?  (Please select all 
that apply)”, with the answer options: 
“When the patient is ill with known cause.  
When the patient is ill without identified 
cause; When the patient is pregnant or 
planning pregnancy; Only when a specific 
oral health concern or complaint is 
identified by the patient; When referred by 
a dentist/periodontist; and Other”. 
A single wording change from “ill” to 
‘hyperglycaemic’ was undertaken 
To identify the respondent who recognised the need 
for screening of oral health complications when 
combined with an increased risk factor of 
hyperglycaemia, as identified from the literature 
review. 
Pilot phase question stem and/or 
answer options 
Adjustment made to question stem and/or 
answer options for final version 
Rationale for change 
“The above patient reports further 
symptoms in conjunction with your 
assessment of the oral cavity.  Please 
indicate on a scale of 1 to 5 (1 being no 
concern and 5 being very concerned), the 
level of concern you would have, if the 
patient is also identified as having the 
following problems: bleeding gums; loose 
teeth; changes in the way the teeth fit 
together; pain when chewing, red, swollen 
or tender gums; noted halitosis or is 
informed by others of breath odour; and 
tartar formation”. 
“The patient/client who complained of a sore 
mouth and a history of mouth ulcers now 
reports further symptoms.  You conduct an 
assessment of the oral cavity and find the 
following problems...Please indicate on a 
scale of 1 to 5 (1 being no concern and 5 
being very concerned), the level of concern 
you would have.   
Improved wording links this question with the 
previous question.  Improved layout of the question 
stem and answer options is aimed at keeping the 
respondent’s interest and streamlining the answers. 
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Pilot phase question stem and/or 
answer options 
Adjustment made to question stem 
and/or answer options for final version 
Rationale for change 
“What changes would assist you in being 
able to improve the oral health care in the 
people with diabetes you manage?”  
“What factors will influence your ability to 
improve the diabetes related oral health care 
for people that you manage?  (Please select 
all that apply) with the answer options 
“None, I consider it outside my professional 
scope of practice; Further ‘diabetes and oral 
health care’ professional development; On 
line chat group; Diabetes and oral health 
clinical practice guidelines; ‘Diabetes and 
oral health care’ education pamphlets for 
patients/clients; ‘Oral health care services’ 
information pamphlets for patients/clients; 
Greater access to dental services; 
Streamlined referral processes; Medicare 
item provision; Multidisciplinary team care 
arrangements; and Other (please specify)”. 
The answer options were identified by the pilot phase 
participants and the researcher.  It was determined that 
offering answer options would prompt the respondent 
to further identify individual driving forces affecting 
their practice in the free text field offered.  
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Diabetes and Oral Health Complications:  Knowledge and Scope of Practice questionnaire amendments continued 
Additional question s in final version 
Question Type and Number Rationale for inclusion 
Question 2: “Are you a credentialed member of the ADS or 
ADEA organisations?  With answer options; “Yes; No; and 
Not applicable”. 
For respondents who cannot meet a credentialing category due to their profession 
type; a “Not applicable” option was offered. 
To capture information from members who have met the additional criteria of 
credentialing which for the ADEA sample members requires: 
A post graduate qualification in an accredited diabetes education and 
management course 
Evidence of a clinically mentored relationship with a credentialed diabetes 
educator, 
A minimum 1800hrs of clinical practice in the specialty of diabetes and 
satisfactory completion of practice across the key areas of professional and 
community involvement, continuing education, professional responsibility and 
accountability, and quality improvement.   
In the later chapter in data analysis the additional knowledge and skills possessed 
by a credentialed versus non-credentialed respondent in their knowledge and 
scope of practice in diabetes oral health complication care was considered. 
Question 4:  “Do you work solely in diabetes care?” with 
answer options “Yes; No, I work in a generalised health care 
area; and Other” option was provided. 
This question was added to differentiate the respondents from the varied health 
professional groups whose work role is solely with people with diabetes in 
comparison with those who may see a patient population both with and without 
diabetes.  It also identifies the health professionals who may work within 
educational, research or administrative roles. 
The options in this question provided clarity in the following question which 
asked the respondents to identify the ‘years of experience specifically in the 
diabetes care area”.  A pilot participants’ feedback indicated difficulty otherwise 
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in be able to accurately identify length of time in diabetes care especially if their 
role was in a more general population of patients/clients as opposed to working 
specifically with people living with diabetes.  
Question number Rationale for inclusion 
Question 8:  “Do you work directly with patients/clients in 
your role?” with answer options “No, go to question 11, and 
Yes” 
Allowed the respondent who did not directly provide care to skip questions that 
were specific to a patient/client population.  This was also an attempt to maintain 
the respondent’s interest in continuing the questionnaire. 
Question 20:  “In considering provision of care to people 
with diabetes, which health professionals do you consider has 
a role in the assessment and management of diabetes related 
oral health care?” 
To identify whether the respondent believed they or others in the patient’s health 
team had a responsibility for the diabetes and oral health complication 
management practices. 
Analysis of the answers obtained in the Likert scale items for the confidence, 
likelihood and concern the respondent has in their practice were cross tabulated 
with questions that identified a responsibility for diabetes and oral health 
screening, promotion and patient/client education by professional category and is 
discussed in the later chapters. 
Question 22: “What do you consider are barriers to you being 
able to provide diabetes related oral health care in your 
practice? (Please select all that apply). 
This question identifies the restraining forces for the health professional to 
improve diabetes and oral health care provision to people living with diabetes. 
Question 22: Answer options included: “Not in my 
professional scope of practice; Lack of knowledge of diabetes 
and oral health issues; Lack of clinical practice guidelines; 
Lack of referral processes; Lack of access to dental services; 
Lack of reimbursement for management time required; Lack 
of time to include oral health issues in my management of 
diabetes; Lack of recognition of my role in diabetes and oral 
health education; and Other (please specify)”. 
The answer options were added to stimulate the respondent to reflect upon their 
own employment setting and clinical practices as well as the “Other” free text 
option for stating more individualised factors. 
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Dear diabetes health care provider. 
My name is Catherine McLaine; I am a Credentialed Diabetes Educator and enrolled in 
a Master of Science at Curtin University of Technology in Western Australia.  As part 
of this course I am currently undertaking a study into diabetes and oral health 
complications, looking specifically at the Australian diabetes health care professionals’ 
knowledge and scope of practice in this area of need.  
 
The Background to the study: 
There is growing acceptance within the dental and medical health professions that 
diabetes is associated with increased occurrence, extent and severity of oral health 
problems.  International studies have shown that people with diabetes are at increased 
risk of more severe periodontal disease compared with those without diabetes.  The 
research indicates a two-way connection between diabetes and periodontal disease, 
proposing that not only is the diabetic person more prone to periodontal disease, but 
the presence of periodontal disease affects control of blood glucose.  The risk is 
independent of whether the diabetes is Type 1 or Type 2.  The extent of the risk 
however relates to the duration and control of the diabetes with the likelihood of the 
periodontal disease increasing markedly when diabetes is poorly controlled. 
Management of oral health problems associated with diabetes within the Australian 
health care system appears to be neither well identified nor implemented.  Currently 
the promotion of oral health issues in diabetes by health care providers in clinical 
practice and management appears to be insufficient, given the magnitude of the 
problems that can arise.  With the significant increase in the incidence and prevalence 
of diabetes mellitus and further projected increases with the associated health cost 
burden, Australia’s health care system and health care providers cannot continue to 
ignore this important aspect of diabetes care, which up to the present has been largely 
overlooked.  
 
I therefore wish to extend an invitation to you to participate in this study by completing 
an on-line questionnaire.   You may access the PARTICIPANT INFORMATION 
SHEET to find out more about the study as well as complete the survey at the 
following link: 
 
http://www.surveymonkey.com/s/CT8WC29 
 
Please take the time to complete this survey; the findings may lead to useful clinical 
protocols to guide oral health care for people with diabetes.  Your opportunity to 
participate will close at Midnight on June 6th, 2010. 
 
Thank you for your valued time and feedback 
 
Catherine McLaine  RN, CDE 
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PARTICIPANT INFORMATION SHEET 
 
Research study title 
 
“Diabetes and oral health complications: Australian diabetes health care 
professionals’ knowledge and scope of practice.” 
 
There is growing acceptance within the dental and medical health professions that 
diabetes is associated with increased occurrence, extent and severity of oral health 
problems.  International studies have shown that people with diabetes are at increased 
risk of more severe periodontal disease compared with those without diabetes.  The 
research indicates a two-way connection between diabetes and periodontal disease, 
proposing that not only is the diabetic person more prone to periodontal disease, but 
the presence of periodontal disease affects control of blood glucose.  The risk is 
independent of whether the diabetes is Type 1 or Type 2.  The extent of the risk 
however relates to the duration and control of the diabetes with the likelihood of the 
periodontal disease increasing markedly when diabetes is poorly controlled. 
 
Management of oral health problems associated with diabetes within the Australian 
health care system appears to be neither well identified nor implemented.  Currently 
the promotion of oral health issues in diabetes by health care providers in clinical 
practice and management appears to be insufficient, given the magnitude of the 
problems that can arise.  With the significant increase in the incidence and prevalence 
of diabetes mellitus and further projected increases with the associated health cost 
burden, Australia’s health care system and health care providers cannot continue to 
ignore this important aspect of diabetes care, which up to the present has been largely 
overlooked.  
 
Aims of the study:  
The purpose of this study is to ascertain the current level of knowledge and scope of 
practice amongst Australian diabetes health care providers in the prevention, 
promotion and management of diabetes related oral health complications in the varied 
patient population that they manage. 
 
Participation in the study: 
You are invited to participate in this study through completion of an online electronic 
questionnaire, which may take up to 30 minutes to complete.  
 
The purpose of the questionnaire is: 
1. To measure Australian diabetes health care professional’s level of knowledge 
of oral health issues which impact upon the person with diabetes. 
 
2. To describe the diabetes health care professional’s scope of practice regarding 
intervention, health promotion and care management of oral health issues in 
persons with diabetes. 
 
3. To identify the restraining and driving forces that influences the provision of 
oral health care prevention and intervention for people with diabetes. 
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Your consent: 
• Participation is voluntary; participants will not be coerced into participation 
through inducements nor payments.   
• Completion of the electronic questionnaire will be considered implied consent. 
• Personal identification details will not be required and the information obtained 
will remain anonymous.   
• The study is considered to be minimal risk; no harm will be caused to any 
participants.   
 
Results of the Study: 
The results achieved from the questionnaire will be analysed as part of a Curtin 
University of Technology, Masters of Nursing (Research) thesis and will be made 
available upon completion to the Australian Diabetes Society and Australian Diabetes 
Educators Association.  It is anticipated that the outcome of the questionnaire may 
provide a level of evidence to support clinical practice guideline development and an 
improved level of diabetes care management in the future. 
 
Complaints:   
This study has been approved by the Curtin University of Technology Human 
Research Ethics Committee (Approval number -pending).  
 
If needed, verification of approval can be obtained either by writing to: 
 
Curtin University Human Research                     
Ethics Committee                                                
c/- Office of Research and Development            
Curtin University of Technology                          
GPO Box U1987                                                 
Perth, WA 6845                                                   
or by telephoning 08 9266 2784                         
or emailing hrec@curtin.edu.au  
                         
Contact Details of Researcher. 
If you require further information or if you have any concerns regarding this study, the 
Masters student or Study Supervisor may be contacted. 
 
Masters Student                                    Study Supervisor 
 
 
Mrs Catherine McLaine, RN, CDE Mrs Karen Glaister, 
Diabetes Centre, Director, Teaching and Learning 
Royal Hobart Hospital, School of Nursing and Midwifery  
48 Liverpool Street,  Faculty of Health Sciences 
Hobart,  Curtin University of Technology, 
Tasmania, 7000   GPO Box U1987, 
Australia.  Perth, WA, 6845 
Tel (03) 62 228788  Tel (08) 9266 2214 
Email:  catherine.mclaine@dhhs.tas.gov.au  Fax (08) 9266 2959          
                  Email:  k.glaister@curtin.edu.au 
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Dear diabetes health care provider. 
My name is Catherine McLaine; I am a Credentialed Diabetes Educator and enrolled in 
a Master of Science at Curtin University of Technology in Western Australia.  As part 
of this course I am currently undertaking a study into diabetes and oral health 
complications, looking specifically at the Australian diabetes health care providers’ 
knowledge and scope of practice in this area of need.  
 
I wish to extend an invitation to you to participate in this study by completing an on-
line questionnaire.  
 
Please read the attached PARTICIPANT INFORMATION SHEET to find out more 
about the study.   You may access the survey at the following link: 
 
http://www.surveymonkey.com/s/CT8WC29 
 
Please take the time to complete this survey; the findings may lead to useful clinical 
protocols to guide oral health care for people with diabetes.  Your opportunity to 
participate will close at Midnight on May 31st, 2010. 
 
Thank you for your valued time and feedback 
 
Catherine McLaine RN, CDE 
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Participant Information Sheet 
 
Aims of the study: 
The purpose of this study is to ascertain the current level of knowledge and scope of 
practice amongst Australian diabetes health care providers in the prevention, 
promotion and management of diabetes related oral health complications in the varied 
patient population that they manage.  It is acknowledged that some content within the 
questionnaire may be unfamiliar to all members, however your responses to each 
question is highly valuable in the overall results of this study and are welcomed. 
 
Participation in the study: 
You are invited to participate in this study through completion of the following 
questionnaire, which may take up to 20 minutes to complete.  
 
The purpose of the questionnaire is: 
1. To measure Australian diabetes health care professional’s level of knowledge of 
oral health issues which impact upon the person with diabetes. 
2. To describe the diabetes health care professional’s scope of practice regarding 
intervention, health promotion and care management of oral health issues in 
persons with diabetes. 
3. To identify the restraining and driving forces that influences the provision of oral 
health care prevention and intervention for people with diabetes. 
 
Your consent: 
• Participation is voluntary; participants will not be coerced into participation 
through inducements nor payments.   
• Completion of the electronic questionnaire will be considered implied consent. 
• Personal identification details will not be required and the information obtained 
will remain anonymous.   
• The study is considered to be minimal risk; no harm will be caused to any 
participants.   
 
Results of the Study: 
The results achieved from the questionnaire will be analysed as part of a Curtin 
University of Technology, Masters of Science thesis and will be made available upon 
completion to the Australian Diabetes Society and Australian Diabetes Educators 
Association.  It is anticipated that the outcome of the questionnaire may provide a level 
of evidence to support clinical practice guideline development and an improved level 
of diabetes care management in the future. 
 
Complaints: 
This study has been approved by the Curtin University of Technology Human 
Research Ethics Committee (Approval number – SON&M 9/2009).  
 
If needed, verification of approval can be obtained either by writing to: 
Curtin University Human Research Ethics Committee 
c/- Office of Research and Development            
Curtin University of Technology                          
GPO Box U1987                                                   
Perth, WA 6845                                                   
or by telephoning 08 9266 2784                         
or emailing hrec@curtin.edu.au 
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Contact Details of Researcher: 
If you require further information or if you have any concerns regarding this study, the 
Masters student or Study Supervisor may be contacted. 
 
Masters Student: 
Catherine McLaine, RN, CDE, 
Diabetes Centre, 
Royal Hobart Hospital 
48 Liverpool Street  
Hobart, Tas 7000 
Ph: 03 62228788 
Email: catherine.mclaine@dhhs.tas.gov.au   
 
Study Supervisor: 
Karen Glaister, 
Director, Teaching and Learning 
School of Nursing and Midwifery, 
Faculty of Health Sciences, 
Curtin University of Technology, 
GPO Box U1987, 
Perth, WA, 6845 
Australia. 
Tel (08) 9266 2201 
Fax (08) 9266 2959          
Email:  k.glaister@curtin.edu.au 
 
Please click 'Next' to start the questionnaire.
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Diabetes & Oral Health Complications Study 
 
This is your final opportunity to participate in a ‘Diabetes & Oral Health 
Complications Study’ by completing an on-line questionnaire.  Catherine McLaine 
RN, CDE Master of Science Student from 
 
Curtin University of Technology, WA, is currently undertaking a study into diabetes 
and oral health complications, looking specifically at the Australian diabetes health 
care provider’s knowledge and scope of practice in this area of need.   You may access 
the PARTICIPANT INFORMATION SHEET to find out more about the study as 
well as complete the survey at the following link: 
 
http://www.surveymonkey.com/s/CT8WC29 
 
Please take the time to complete this survey; the findings may lead to useful clinical 
protocols to guide oral health care for people with diabetes. Your opportunity to 
participate will close at Midnight on Sunday 22nd August, 2010. 
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Participants’ description of ‘Other’ employment setting 
Type of Setting Frequency Percent of Na 
Aboriginal health Service 2 1.3 
Centre covers community and public hospital 1 0.7 
Correctional health facility 1 0.7 
Diabetes Australia 1 0.7 
Diabetes clinical trials and Private practice 1 0.7 
Diabetes organisation 2 1.3 
District Nursing Service 1 0.7 
Division of General Practice 1 0.7 
Non-Government Organisation, Not-for-profit 
organisation and Private practice one day per 
week 
1 
0.7 
Non Government Organisation 1 0.7 
Not-for-Profit Organisation 1 0.7 
Private mobile practice within Adelaide city and 
metropolitan areas 1 
0.7 
Remote Aboriginal communities 1 0.7 
Remote area health service 1 0.7 
Residential Aged Care 1 0.7 
Shared partnership between Queensland Health 
and Rural Health Queensland. 1 
0.7 
University 1 0.7 
Total 19 12.4 
Note. aN = Total number 153 participants. 
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Description statistics of the participants’ identification of ‘Other’ forms of  self-
directed educational resources used to gain diabetes and oral health knowledge 
Education form Frequency Percent 
Audio conferencing series 1 0.65 
Both texts and journals 1 0.65 
Diabetes Australia resource information website 1 0.65 
Discussions with dentist and oral hygienist 1 0.65 
Information from Dental Association 1 0.65 
Lecture a 1 0.65 
Total 6 3.90 
Note. a No further explanation provided by respondent 
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Participants’ identification of ‘Other’ timeframes in initiating diabetes and oral 
health complication assessment and screening in patients 
Participants statements (Participants identification number) 
Within existing service delivery: 
“At diagnosis and annually in non-complex Type 2.  As part of annual cycle of 
care for paediatric and transitioning adolescent and non- complex Type 1.  
Each trimester during pregnancy, and biannually in complex Type 2.” (152) 
“At the initial visit.”(123) 
“During initial visit, assess and provide education about oral complications.” 
(17) 
“On admission of new client, ask about most recent dental review and any 
current dental issues.” (28) 
“Initial assessment, education groups, first review appointment and then annual 
review - unless further review required.”(54) 
“Each assessment, suggest a yearly dental review as part of the annual cycle of 
care.” (85) 
“During the education process, oral health is highlighted as an important part of 
the clients self-management of their diabetes.” (66) 
“Include dental care within education session, suggest dental review if BGLs 
persistently elevated.” (146) 
“This will vary from person to person.  As part of the self-management 
education.” (118) 
“When giving Living with Diabetes talks, advise clients to use one or two of their 
five health professional annual Medicare allowable visits through the GP 
chronic disease care plan for dental checkups.” (75) 
“Briefly when discussing complications.” (23) 
“Varies on patient needs - whenever talking about potential of DM complications 
- oral/dental health is discussed as part of that education.” (14) 
Investigation of signs and symptom  
“Do not routinely include it.  To identify the cause of hyperglycaemia, will then 
ask about the oral health care, admittedly this is still infrequent.” (135) 
“Oral health assessments are undertaken when problems are observed e.g. 
halitosis.” (92) 
“Sporadically, if dental issues affect eating.” (89) 
“When dental care issues or related issues are raised by client.” (60) 
Lack of service delivery: 
“Currently not included in the complication assessment tool used.” (13) 
“Currently oral issues not routinely discussed but are now to be included on 
assessment form therefore attended on referral to service and annual review.”  
(127) 
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Participants’ reasons for investigation of patients’ oral health status (Participants’ 
identification number) 
Existing service delivery models: 
“As part of an annual Team Care Arrangement referral process.” (56) 
“At diagnosis and review.” (143) 
“On admission of new clients.” (28) 
“When newly referred to service, on their second visit or, if they have any 
complaints about their oral health.” (145) 
“When someone is newly diagnosed with diabetes, would go through education 
but if not, would only discuss if it came up as part of counselling.” (133) 
“With new patients, as part of the long term complications awareness.” (92) 
“Clients are referred to our Centre and as part of the education program for all 
clients whether newly diagnosed, GDM or long term diabetics, ‘touching’ on 
oral health is part of the education program.” (66) 
“As part of the educational/assessment visits.” (50) 
“I discuss and look in the mouth of every patient at least twice a year.” (8) 
“Discussed at each review and additional discussion in-between, if client 
expresses it is a problem e.g. gums start bleeding or report tender areas.” (98) 
“Only during annual diabetes review.” (137) 
“Education topic staying healthy - preventative management includes discussion 
of oral hygiene/dental reviews.  I recommend minimum of annual review with 
dentist and referral back to GP if requiring Medicare Dental Health plan to 
assist access.  Discuss risk of gum recession/bone infection/cardiac risk and 
linkage.” (14) 
“I have learnt in my career early on, to look at the mouth and gums.  With the 
right foods, if the gums and teeth are playing up then their diabetes will play 
up.” (107) 
“Each person with diabetes, irrespective of glycaemic control or complications 
or if patient expressed concern.” (45) 
“I ask about teeth as part of the routine assessment, but I have just realised I do 
not talk about gum disease as such.” (63) 
“General discussion of issues, but not investigated.” (37) 
Identification of oral health signs and symptoms: 
“When I can see their teeth are in terrible condition during a conversation. When 
they ask about soft drinks.” (89) 
“When I see bad teeth, I ask when they last had a dental check.” (85) 
“When poor dental health is disclosed and client has not followed up with a 
dentist.” (54) 
“When the patient identifies issues with their ability to eat certain foods or other 
symptoms related to their teeth and gums.” (141) 
“If fever or any oral symptoms in diabetes of any cause.” (48) 
Appendix R: Participants’ identification of ‘Other’ presenting circumstances 
for investigation of patients’ oral health status. 
213 
 
 
Participants’ reasons for investigation of patients' oral health status (Participants’ 
identification number) continuation. 
Co-existing medical conditions:  
“When there is known cardiovascular disease.” (130) 
“Pre-surgery especially cardiac or osteo-surgical procedures.” (73) 
“Obviously need to think about it in relation to all cases of hyperglycaemia, 
gastroparesis and gastric reflux.” (152) 
“Those clients who take liquid meal replacements for weight loss.” (41) 
Lack of service delivery: 
“It should probably be in all conditions mentioned but not in my usual role.” (110) 
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Participants’ identification of ‘Other’ actions undertaken in the investigation of a 
patients’ oral health complaints (Participants’ identification number) 
Assessment: 
“Ask about therapies/medications already tried by the patient to resolve the 
condition.” (155) 
“Ask whether it has been discussed and assessed by GP.”(28) 
“Assess if there is any dietary restrictions or food allergies/potential increase in 
hypos/medication compliance and query if any new medications.  Referral to 
GP for assessment-medication requirement/ensure communication with GP of 
this clinical information.” (14) 
“Check if client is a smoker.” (101) 
“Document oral findings in notes, but not give a diagnosis.”(58) 
“Question patient about their ability to chew raw foods, dry mouth symptoms, 
history of bulimia or induced vomiting.” (89) 
“Question when last visit to GP and dentist in regard to oral problems.” (59) 
Education: 
“Give the client a Diabetes Australia fact sheet on dental care.” (141) 
Further management: 
“Prescribe antibiotics if needed, review insulin/medication doses and consider 
salivary replacement therapies.” (8) 
“Advise client to attend a Dentist.  No Periodontist available except in 
Melbourne, which is a 2-3 hour drive away.” (127) 
“Advise follow up with GP and Dentist.” (73) 
“I would recommend to the patient that they seek dental care.” (87) 
“If the problem is acute I would refer them to their GP for medical assessment.  I 
would not do a detailed oral inspection/assessment but refer on to a Dentist/GP 
for this assessment and management.” (92) 
“Recommend that they see their GP and a Dentist.”(85) 
“Recommend they see a Dentist/relevant specialist.  I would recommend they 
visit the GP.” (110) 
“Recommend visit to GP if infection, and if they are unable to afford or receive 
timely access to a Dentist.” (129) 
“Refer back to GP for assessment and treatment as required.  Clients are 
provided with a leaflet on diabetes and oral health at initial consultation also.” 
(98) 
“Refer to GP for review”. (149) 
“Referral to GP.” (27;31;141) 
“Referral to GP if infection noted to commence antibiotics.”(55) 
“There is not a referral pathway in my area to refer to a Dentist or Periodontist; 
therefore I would involve the GP in getting the referral done especially if the 
client has financial constraints.”(66) 
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Participants’ identification of individual health professionals who have a 
responsibility for diabetes and oral health management. 
Health professional type Frequency 
Dental professionals  
Dentist 
Periodontist 
Dental hygienist 
Orthodontist 
Dental technician,  
Dental therapist 
Dental nurse  
Total 
 
111 
17 
16 
3 
2 
2 
1 
152 
Primary care setting  
GP 
Practice nurse 
Nurse 
Community nurse  
Health worker 
Aboriginal health worker 
Primary care staff 
Total 
 
69 
7 
4 
2 
2 
1 
1 
86 
Diabetes Health Professionals 
Diabetes Educator 
Endocrinologist  
Diabetes Nurse Practitioner  
Total 
 
75 
54 
1 
130 
Allied Health professionals 
Dietitian  
Podiatrist 
All Allied Health Professionals 
Physiotherapist 
Psychologist 
Speech pathologist 
Total 
 
27 
2 
2 
1 
1 
1 
34 
Other Health Professionals 
Pharmacist  
All health care providers 
All health professionals (no category) 
All health care team 
Ophthalmologist 
Optometrist 
Oral surgeon  
Other medical specialists 
Paediatrician 
Total 
 
5 
3 
1 
1 
1 
1 
1 
1 
1 
15 
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Participants’ identification of ‘Other’ influencing factors which improve 
management of diabetes and oral health complications.  
Participants’ statements (participants identification number) 
Service delivery: 
“Medicare dental items. Include dental assessment in multidisciplinary 
paediatric transition clinics with service provision from State dental service.” 
(11) 
“Decreased public dental service waiting times.  Greater awareness of Medicare 
funded dental services.” (28) 
“Medicare dental items.” (33) 
“Greater access to affordable and culturally appropriate dental services.  
Medicare dental services with a bulk bill facility for low income people.” (126) 
“Dental access for all clients.” (53) 
“Ease of access to public dental services, prioritised treatment and care 
expedited listing.” (123) 
“Prioritising patients on the local public health waiting list.” (92) 
“Linkage to dental services to enable prompt triage especially if problems 
identified or poor glycaemic control.” (145). 
“Better communication from Dentist after referral.” (103) 
“Care through private health funds.” (106) 
Scope of practice: 
“Screening tools which indicate referral is necessary.” (152) 
“Discuss smoking cessation and options for quitting.” (101) 
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Participants’ identification of ‘Other’ barriers to the management of diabetes and oral 
health complications.  
Participants’ statements (Participants identification number) 
Service delivery: 
“Ability to access dental care.  Lack of knowledge regarding access to Medicare 
dental services, need for a GP Care plan prior to achieve this.” (22) 
“Other health care providers including GPs being unaware of Medicare funded 
dental processes, inadequate public dental services, expensive dental care for 
those that don't qualify for public or Medicare dental services and it not being 
recognised as a priority by the clients and some health professionals.” (28) 
“Not knowing the systems and referral process for dental services.” (107) 
“Waiting times to be seen at Public Dentist are currently 2-3 years.” (137) 
“Two years waiting time at the community dental health service for most 
clients.” (145) 
“Access to timely appointments at the public dental service.  There is a 5 month 
wait list currently.” (123) 
“Lack of access to affordable dental services. Need to be covered by Medicare 
similar to GP services and have a bulk bill facility for low income people.” 
(126) 
“Absent services for those of low income.” (68) 
“Cost to patient, no rebate available, long waiting list for public services.” (129) 
“Communication from Dentist after referral.” (103) 
Educational resources: 
“Lack of educational resources.” (11) 
“Need clinical guidelines and more resources e.g. patient information 
pamphlets.” (92) 
Scope of  practice: 
“Lack of knowledge about which oral problems are diabetes related. Believe it is 
outside my scope of practice to physically examine the oral cavity.” (89) 
“I do not have appropriate equipment to check in the mouth.” (118) 
“Not fully into consciousness.”(152) 
“Prefer dental specialist in the area to look at teeth.” (33) 
Patient education: 
“Unless there is pain or discomfort, the patients’ lack of understanding of the 
importance or oral care can be a barrier.” (86) 
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Descriptive Statistics for Scale Item Reliability Analysis  
Scale items 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number  
Question label  
Scale element 1:  Management of  patient population  12 150 0.485 7.65 2.788  
Question 9:  What is the age group of the patients/clients with whom you 
work?       
Paediatrics    0.95 1.325 0.202 
Adolescents    1.55 0.901 0.408 
Adults    1.04 0.325 -0.035 
Question 10:  Do you work with patients/clients who are from the 
following groups? 
   .   
Pregnant women     0.68 0.468 0.517 
Disabled patients    0.71 0.454 0.423 
Aboriginal and Torres Strait Islander people    0.63 0.485 0.380 
Patients from culturally and linguistically diverse backgrounds    0.76 0.429 0.200 
Patients living within residential aged care facilities    0.53 0.501 0.197 
Patients within secure facilities    0.27 0.447 -0.025 
Patients within rural and remote communities    0.43 0.496 0.170 
No, I don’t work with patients from these groups    0.03 0.180 -0.316 
‘Other’    0.07 0.262 -0.059 
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Continuation:  Descriptive Statistics for Scale Item Reliability Analysis 
Scale items 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number 
Question label 
Scale element 2:  Diabetes and oral health complications knowledge  5 145 0.383 7.63 3.323  
Question 11:  Was oral health complications in diabetes covered during 
your professional education?    1.92 0.800 -0.239 
Question 12:  Have you ever attended an education session on diabetes and 
oral health complications?    1.64 0.653 0.349 
Question 13:  In what form was this education delivered?    1.31 1.382 0.314 
Question 14:  Have you undertaken any self directed learning in the area of 
diabetes and oral health complications?    
1.33 0.472 0.716 
Question 15:  Which of the following forms did you use to acquire extra 
knowledge?    
1.43 2.111 0.281 
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Continuation:  Descriptive Statistics for Scale Item Reliability Analysis 
Scale items 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number 
Question label 
Question 16:   From your clinical experience and knowledge of diabetes, is 
there an association between diabetes and the following oral 
health problems? 
14 147 0.714 27.12 5.089 
 
Glossodynia and stomatopyrosis    2.58 0.802 0.267 
Candidiasis    1.37 0.768 0.296 
Dental caries    1.27 0.645 0.329 
Gingivitis    1.10 0.434 0.396 
Mouth ulcers    1.59 0.898 0.410 
Lichen planus    2.57 0.802 0.315 
Oral neurosensory dysesthesia    2.48 0.871 0.365 
Oral cancerous lesions*    2.62 0.601 0.404 
Periodontitis    1.29 0.692 0.318 
Excessive salivation*    2.50 0.696 0.363 
Taste impairment    2.13 0.938 0.419 
Xerostomia    1.53 0.870 0.317 
Dysphagia*    2.31 0.775 0.355 
 
Question 17:  Significance of increased risk of oral health complication 
relevant in patient with another diabetes complication. 
1 113  1.80 1.059 0.173 
Note: * denotes false oral conditions 
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Continuation:  Descriptive Statistics for Scale Item Reliability Analysis 
Scale item 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number 
Question label 
Scale element 3:  Scope of practice in diabetes oral health complication 
management  113 0.779 101.96 12.067  
Question 26:  Likelihood to investigate oral signs and symptoms 14 113 0.816 18.85 3.235 0.562 
Inspection of the hard and soft tissues in the mouth cavity    1.42 0.497 0.539 
Inspection of the teeth    1.49 0.502 0.444 
Note number of teeth present or missing    1.57 0.498 0.586 
Note presence of oral infections    1.20 0.404 0.649 
Note presence of oral lesions     1.24 0.428 0.624 
Document oral findings and diagnosis    1.35 0.478 0.317 
Question the patient regarding glycaemic control    1.07 0.258 0.374 
Question the patient regarding Frequency of personal dental 
care activity    
1.21 0.411 0.374 
Question the patient regarding  frequency of professional 
dental care visits    
1.09 0.285 0.262 
Question the patient regarding  recent changes in taste 
sensation    
1.74 0.439 0.298 
Question the patient regarding recent changes to food choices 
in respect to flavours    
1.76 0.428 0.343 
Question the patient regarding oral medications intake    1.31 0.464 0.518 
Question the patient regarding level of hydration    1.27 0.448 0.347 
Question the patient regarding referral to dentist/periodontist    1.12 0.331 0.248 
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Continuation:  Descriptive Statistics for Scale Item Reliability Analysis 
Scale items 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number 
Question label 
Question 27:  Levels of concern at the presenting circumstances  
Bleeding gums when brushing 
Loose teeth 
7 113 0.872 28.69 4.837  
   3.97 0.949 0.677 
   4.31 0.917 0.679 
Changes in the way teeth fit together    3.90 1.110 0.629 
Pain when chewing    4.36 0.768 0.702 
Red, swollen or tender gums    4.53 0.682 0.649 
Noted halitosis or told by others of breath odour    4.13 0.881 0.636 
Tartar formation    3.48 1.053 0.646 
Question 28:  Likelihood to recommend treatment 11 113 0.813 35.73 8.150  
To use sugarless gum    2.86 1.445 0.543 
To use sugarless mints    2.37 1.344 0.533 
To take frequent sips of water or ice chips    3.63 1.241 0.508 
To restrict caffeine intake    2.50 1.296 0.617 
To restrict alcohol intake    2.80 1.304 0.470 
To rinse with fluoride mouthwashes     2.32 1.248 0.579 
To use saliva substitutes    2.70 1.457 0.456 
To improve glycaemic control    4.28 1.138 0.452 
To undergo a medication review    3.88 1.148 0.373 
Referral to the GP for review    4.22 0.961 0.289 
Referral to dentist/periodontist for review    4.17 1.141 0.396 
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Continuation:  Descriptive Statistics for Scale Item Reliability Analysis 
Scale item 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number  
Question label 
Question 21: What factors will influence your ability to improve the 
diabetes related oral health care for people that you manage? 
10      
None, I consider it outside my professional scope of practice    0.03 0.178 -0.165 
Further ‘diabetes and oral health care’ professional 
development     0.76 0.426 0.472 
On line chat group    0.05 0.223 0.200 
Diabetes and oral health clinical practice guidelines    0.79 0.408 0.550 
‘Diabetes and oral health care” education pamphlets for 
patients/clients    0.86 0.352 0.611 
‘Oral Health Care Services’ information pamphlets for 
patients/clients    0.66 0.475 0.478 
Greater access to dental services    0.73 0.448 0.540 
Streamlined referral processes    0.54 0.500 0.545 
Medicare item provision    0.62 0.487 0.599 
Multidisciplinary team care arrangements    0.58 0.495 0.525 
‘Other’ factors    0.08 0.270 0.112 
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Continuation:  Descriptive Statistics for Scale Item Reliability Analysis 
Scale item 
No of 
items 
No of 
cases 
Cronbach’s 
alpha Mean SD 
Corrected item-
Total correlation 
(Pearson 
correlation 
coefficient) 
Question number  
Question label 
Question 22:  What do you consider are barriers to you being 
able to provide diabetes related oral health care in 
your practice? 
10      
Not in my professional scope of practice    0.80 0.280 0.024 
Lack of knowledge of diabetes and oral health issues    0.53 0.501 0.215 
Lack of clinical practice guidelines    0.56 0.499 0.405 
Lack of referral processes    0.35 0.477 0.486 
Lack of access to dental services    0.59 0.493 0.471 
Lack of reimbursement for management time required    0.19 0.393 0.251 
Lack of time to include oral health issues in my management of 
diabetes    0.33 0.473 0.365 
Lack of recognition of my role in diabetes and oral health education    0.25 0.437 0.269 
‘Other’ factors    0.11 0.315 -0.017 
 
 
